Blog
Practical guidance on manuscript preparation, peer review strategy, and getting published in top journals.
AI and manuscript integrity
These are the emerging concerns that matter before submission: AI screening by journals, citation and disclosure risk, hidden-prompt attacks on naive AI review, and what a safer manuscript-review workflow should actually look like.
Detection reality
What editors can catch, what detectors still miss, and why reference problems usually matter more than style classifiers.
Publisher workflow
A practical read on where publishers are moving and what that changes for authors before they submit.
Security risk
A direct explanation of prompt injection risk and why naive manuscript-review tools are easier to manipulate than they look.
Category standard
The checklist serious authors should use when deciding whether an AI review product is safe enough for a high-stakes submission.
Upload your manuscript for a free readiness scan.
Publishing Strategy · 12 min read
Compare Grants.gov, NIH RePORTER, Instrumentl, Grantsights, and Candid for finding R01, R21, K awards, and foundation grants in 2026.
BMJ desk rejects ~70% of submissions within days. Verify these 10 items covering clinical practice impact, international relevance, and what editors evaluate in the first read.
JAMA desk rejects ~85% of submissions but decides fast (~14 days). Verify these 10 items covering clinical practice impact, statistical rigor, and the JAMA Network transfer option.
Before you submit to PLOS ONE, use this checklist to verify methods depth, data availability, reporting completeness, and the specific items editors screen during soundness review.
Before you submit to Scientific Reports, use this checklist to verify you meet the soundness bar, data requirements, and reporting standards that editors check first.
Before you submit to Science Advances, use this checklist to verify significance, scope fit, data availability, and the items editors evaluate in the first read.
Before you submit to Cell, verify these 10 items covering mechanistic depth, first figure impact, breadth of significance, and the specific editorial tests that cause 70-80% of submissions to be desk rejected.
83% of high-impact journals now have AI policies. Here is what you must disclose, what is prohibited, and how to stay compliant across different journals.
The Lancet desk rejects over 80% of submissions within 1-2 weeks. Verify these 10 items covering global health relevance, clinical significance, and what editors screen for first.
NEJM desk rejects ~90% of submissions within 2 weeks. Before you submit, verify these 12 items covering clinical impact, trial registration, statistical rigor, and what editors screen for first.
Your paper was rejected and you are about to resubmit to another journal. Here is when review before resubmission prevents another 3-6 month rejection cycle and when you can skip it.
Before submitting to Angewandte Chemie, verify these 10 items covering the novelty argument, characterization completeness, and cover letter strategy that in-house editors evaluate first.
JACS desk rejects 40-50% of submissions. Verify these 10 items covering novelty, characterization depth, the title word restrictions, and what associate editors screen first.
Language editing fixes grammar. Pre-submission review fixes the framing, claim calibration, and editorial positioning that non-native English speakers struggle with most. Here is why you probably need both.
Before you submit to Nature Communications, use this checklist to verify scope fit, data availability, reporting completeness, and the specific items editors screen in the first read.
Nature Biotechnology desk rejects ~70% of submissions. Verify these items covering technical innovation, validation depth, scalability, and what editors screen first.
A practical guide to the Journal of Biological Chemistry submission process, covering what editors screen for first and what to fix before upload.
Use this submission readiness checklist before you submit a paper. It covers journal fit, claims, methods, figures, compliance, and revision risk.
Manuscript rejected what to do: use this 72-hour plan to diagnose the decision and choose revise, retarget, or appeal.
Use this claim-to-evidence map template to test whether every manuscript claim is actually supported by the figures, analyses, and methods.
Use this journal fit score template to rank target journals by audience, scope, evidence bar, review burden, and strategic risk before submission.
Physical Review B review time is often about 2-4 months to first decision, but the real variable is condensed-matter scope fit and referee depth.
Cell review time is about 8 days to immediate rejection and 2.8 months to first review. Full 2026 timeline, delays, and follow-up timing.
Circulation review time is about 17 days to first decision, with full review often taking 4 to 8 weeks. Full 2026 timeline and AHA workflow.
Lancet Oncology review time is usually about 3 weeks to first review and around 1.2 months total handling on current SciRev data.
Nature Biotechnology review time is about 25 days to desk rejection and 2.9 months to first review. Full 2026 timeline and delay patterns.
PNAS review time is usually 2-4 weeks to editorial triage and 6-12 weeks after review. Direct-submission timing and delays explained.
If an AI review tool can be steered by hidden text inside the manuscript, it is not a serious review system. Here is what authors should know.
Ageing Research Reviews impact factor is 12.4 with a 5-year JIF of 14.9. See rank, trend, and what that means before you submit.
Aging Cell impact factor is 7.1 with a 5-year JIF of 8.9. See the trend, rank, and what it means before you submit.
Allergy impact factor is 12.0 with a 5-year JIF of 11.3. See rank, trend, and what the number means before submission.
AJHG publicly aims to reach decisions within 4 weeks, but the real speed depends on whether the paper reads as broad human-genetics work from the first editorial pass.
A practical AJHG submission guide for authors deciding whether the paper is really a human-genetics paper, broad enough for the field, and mature enough for flagship-community review.
Analytic Methods in Accident Research impact factor is 12.6 with CiteScore 23.3. See the trend, timing, and what that means before submission.
Annual Review of Chemical and Biomolecular Engineering impact factor is 12.8. See the trend, SJR, h-index, and what that means.
Annual Review of Earth and Planetary Sciences impact factor is 13.0. See the trend, secondary metrics, and what that means before pitching a review.
Annual Review of Food Science and Technology impact factor is 12.4. See the trend, secondary metrics, and what that means before pitching a review.
Applied Sciences impact factor is 2.5 with a 5-year JIF of 2.7. See the rank, trend, and what that means before submission.
Applied Surface Science is quicker than many materials journals, but the useful question is not just how fast the desk screen moves. It is whether the manuscript is truly about surfaces and interfaces at the level the editors and reviewers expect.
Archives of Computational Methods in Engineering impact factor is 12.1. See the trend, SJR, and what that means.
Artificial Intelligence in Agriculture impact factor is 12.4 with CiteScore 23.0. See the trend, SJR, and what that means.
Astronomy & Astrophysics impact factor is 5.8 with a 5-year JIF of 6.1. See the rank, trend, and what that means before submission.
A&A is not usually a fast-turn astronomy journal. The real timing variable is whether the paper has broad enough astrophysical consequence for a flagship field venue.
Biomaterials impact factor is 12.9 with a 5-year JIF of 13.4. See rank, quartile, Scopus metrics, and what this means for biomaterials authors.
Biomaterials exposes one of the clearest official public timing dashboards in the field, and it shows a serious multi-month path to acceptance.
Biotechnology Advances impact factor is 12.5 with a 5-year JIF of 15.7. See the trend, rank, and what it means before you submit.
Brain impact factor is 11.7 with a 5-year JIF of 12.8. See the rank, trend, and what that number means before submission.
Carbohydrate Polymers is quicker than many polymer journals, but the practical question is not just how fast the editorial system moves. It is whether the manuscript is truly about the carbohydrate polymer itself rather than an application paper using a familiar polysaccharide as a vehicle.
Carbon Neutrality impact factor is 12.5. See the JCR trend, SJR, h-index, first-decision speed, and what that means for authors.
Cell Discovery impact factor is 12.5 with a 5-year JIF of 14.3. See rank, quartile, Scopus metrics, and what the number means for biology authors.
Cell Stem Cell impact factor is 20.4 with a 5-year JIF of 21.8. See the rank, trend, and what that number means before submission.
Cell Systems impact factor is 7.7 with a 5-year JIF of 11.2. See rank, quartile, trend, and what the number means for submission.
Ceramics International impact factor is 5.6 with a 5-year JIF of 5.2. See the rank, trend, and what that number means before submission.
Ceramics International is quicker than many ceramics journals, but the practical question is not just how fast the first decision arrives. It is whether the manuscript already has the full processing-structure-property package that the journal expects.
Chemical Society Reviews is not a normal primary-research journal. The useful timing question is how long peer-reviewed full manuscripts take after synopsis approval.
Circulation Research impact factor is 16.2 with a 5-year JIF of 20.8. See the rank, trend, and what that means before submission.
Clinical Cancer Research impact factor is 10.2 with a 5-year JIF of 11.2. See rank, trend, and what it means before submission.
Clinical Gastroenterology and Hepatology impact factor is 12.0 with a 5-year JIF of 11.7. See rank, trend, and what the number means.
CGH exposes an unusually clear official timing dashboard, and it shows a quick editorial front end but a real multi-month path to acceptance.
Clinical Psychology Review impact factor is 12.2 with a 5-year JIF of 16.8. See rank, trend, and what the number means before submission.
Computer Science Review impact factor is 12.7 with CiteScore 38.4. See the rank, trend, and what that means before submitting a survey.
A practical Computer Science Review submission guide for authors deciding whether their survey is broad enough, expert enough, and useful enough for a general computer-science readership.
Endoscopy impact factor is 12.8 with a 5-year JIF of 10.3. See rank, quartile, JCI, and what this number really means for gastroenterology authors.
Endoscopy does not publish a polished median dashboard, but official accepted-manuscript pages make the accepted-paper path visible enough to plan around.
Environmental Science & Technology impact factor is 11.3 with a 5-year JIF of 12.4. See the rank, trend, and what that means before submission.
A practical ES&T submission guide for authors deciding whether the paper is broad enough, realistic enough, and application-ready enough for this ACS flagship.
European Heart Journal impact factor is 35.6 with a 5-year JIF of 34.4. See rank, trend, and what that means before submission.
Experimental and Molecular Medicine impact factor is 12.9 with a 5-year JIF of 14.2. See rank, trend, and what that means before submission.
FEMS Microbiology Reviews impact factor is 12.3 with a 5-year JIF of 13.4. See rank, trend, and what it means before submission.
Food Hydrocolloids impact factor is 12.4 with CiteScore 21.7. See the trend, secondary metrics, and what that means before submission.
A practical FnT IR submission guide covering the abstract-plus-TOC first step, monograph scope, and editorial fit.
Frontiers in Microbiology impact factor is 4.5 with a 5-year JIF of 5.2. See rank, trend, and what that means before submission.
Frontiers in Microbiology is fast compared with many traditional microbiology journals, but the useful question is not just how quickly the system moves. It is whether the paper is in the right section and whether the biology goes beyond description.
Frontiers in Plant Science is quicker than many traditional plant journals, but the useful question is not just how fast the platform moves. It is whether the manuscript is in the right section and mechanistically complete enough to benefit from that speed.
Fuel can look quick from the outside because the journal posts a fast first-decision metric. The practical question is whether the manuscript is truly fuel-science first and strong enough to survive a heavier full-review path.
Gastroenterology impact factor is 25.1 with a 5-year JIF of 26.9. See rank, trend, and what that number means before submission.
Genes & Development does not publish a clean average review-time dashboard, but its article histories make the accepted-paper path visible enough to plan around.
A practical Genes & Development submission guide for authors deciding whether the paper is mechanistically complete, biologically important, and strong enough for a fast editorial triage.
Genome Research has historically promoted fast turnaround, but current public evidence suggests a materially slower real-world review path for many papers.
Global Change Biology impact factor is 12.0 with a 5-year JIF of 14.0. See rank, quartile, trend, and what the number means for authors.
Gut impact factor is 25.8 with a 5-year JIF of 25.3. See the trend, rank, and what that number means before submission.
Hepatology impact factor is 15.8 with a 5-year JIF of 14.5. See the trend, rank, and what that number means before submission.
Avoid desk rejection at Ageing Research Reviews with a review that is mechanistically sharp, current, and strong enough to move aging biology forward.
Avoid desk rejection at Aging Cell by proving aging is central, the mechanism is real, and the paper is more than an old-versus-young comparison.
Avoid desk rejection at Allergy by proving allergy-specific scope, stronger translational design, and a clearer clinician-facing consequence.
Avoid desk rejection at AJHG by proving broad human-genetics consequence, not just local association, variant, or methods value.
Avoid desk rejection at AMAR by proving analytical novelty, accident-specific justification, and clearer safety consequence than model fit alone.
Avoid desk rejection at ARCBE by treating it as an invitation-led Annual Reviews journal and proposing a topic broad enough for field synthesis.
Avoid desk rejection at AREPS by understanding its invitation-led model, broad review scope, and field-level synthesis expectations.
Avoid desk rejection at Annual Review of Food Science and Technology by treating it as an invitation-led review journal, not a cold-submission venue.
Avoid desk rejection at ACME by submitting a real state-of-the-art review with broad computational scope and balanced criticism.
Avoid desk rejection at AI in Agriculture by proving both the AI contribution and the agricultural contribution are real and operationally meaningful.
Avoid desk rejection at Biomaterials with stronger biointerface logic, deeper mechanism, and biology that fully carries the claim.
Avoid desk rejection at Biotechnology Advances by proving a real biotechnology application path, not just interesting biology or a broad review topic.
Avoid desk rejection at CGH by proving immediate GI clinical utility, realistic generalizability, and a sharper clinical relevance case.
Avoid desk rejection at Clinical Psychology Review with a real review article, rigorous methods, clinical utility, and broad enough scope.
Avoid desk rejection at CACM by writing for a broad computing audience, not submitting a specialist paper in magazine clothing.
Avoid desk rejection at Computer Science Review by submitting a real survey with broad CS scope, critical synthesis, and clear open-problem framing.
Avoid desk rejection at Endoscopy with stronger procedural consequence, more credible study design, and a clearer endoscopist-facing lesson.
Avoid desk rejection at ES&T by proving real environmental consequence, not just strong technical work under idealized conditions.
Avoid desk rejection at Experimental and Molecular Medicine by pairing molecular mechanism with disease relevance and a believable translational path.
Avoid desk rejection at FEMS Microbiology Reviews by sending a proposal that is timely, broad enough, critical, and clearly worth prioritizing now.
Avoid desk rejection at Food Hydrocolloids by proving real food-system function, mechanism, and value beyond hydrocolloid characterization.
Avoid desk rejection at FnT IR by pitching a real monograph proposal, not a normal survey or disguised research paper.
Avoid desk rejection at Genes & Development by proving broad mechanistic significance, not just a strong local pathway story.
Avoid desk rejection at Genome Research with stronger biological consequence, cleaner data-access readiness, and less methods-first framing.
Avoid desk rejection at Global Change Biology by proving mechanism, global-change relevance, and biological consequence beyond correlation.
Avoid desk rejection at IEEE RBME by submitting a critical review with broad BME value, clear article type, and a strong future-directions frame.
Avoid desk rejection at IEEE TEVC by proving a field-level EC contribution, not just benchmark gains on one application.
Avoid desk rejection at International Journal of Oral Science with broader oral-science fit and stronger mechanistic depth.
Avoid desk rejection at International Journal of Plasticity by proving a real plasticity advance, not just a competent simulation or materials case.
Avoid desk rejection at ISPRS Journal by proving a real geospatial contribution, strong validation, and value beyond one benchmark or local case.
Avoid desk rejection at JACC: CardioOncology with a clearer cardio-oncology care consequence, stronger journal fit, and a more actionable first read.
Avoid desk rejection at JCI Insight with stronger field advance, broader physician-scientist relevance, and cleaner translational logic.
Avoid desk rejection at Journal of Biomedical Science with stronger biomedical breadth, deeper mechanism, and clearer medical consequence.
Avoid desk rejection at Journal of Cell Biology with stronger cellular mechanism, cleaner figure logic, and a clearer JCB readership case.
Avoid desk rejection at JCI by proving a real medicine-facing advance, not just strong mechanism with speculative translational language.
Avoid desk rejection at JECCR with a stronger translational bridge, more actionable oncology consequence, and a cleaner bench-to-bedside first read.
Avoid desk rejection at JEM by combining strong mechanism with disease relevance instead of sending pure phenotype or narrow specialty work.
Avoid desk rejection at Journal of Nanobiotechnology with a stronger nano-bio interface, better validation, and cleaner journal fit.
Avoid desk rejection at Kidney International with stronger nephrology consequence, broader readership fit, and a cleaner kidney-disease signal.
Avoid desk rejection at Microbiome with stronger causality, better controls, real data readiness, and broader field consequence.
Avoid desk rejection at Molecular Systems Biology by proving real systems integration, not a biology paper plus decorative computation.
Avoid desk rejection at Molecular Therapy with stronger platform relevance, cleaner translational support, and a clearer flagship-journal fit.
Avoid desk rejection at Nature Metabolism by making metabolism the real story, not a supporting result inside another field.
Avoid desk rejection at Nature Microbiology with broader field consequence, faster first-read clarity, and stronger editorial positioning.
Avoid desk rejection at Nature Protocols by proving protocol maturity, broad utility, and real procedural value beyond the original paper.
Avoid desk rejection at NEJM Evidence by proving real clinical-evidence value, not just a decent study under a strong brand.
Avoid desk rejection at Pharmacology & Therapeutics by treating it as an invitation-gated review venue, not a normal cold-submission journal.
Avoid desk rejection at PLOS Biology with broader significance, clearer advance framing, stronger evidence shape, and a cleaner package.
Avoid desk rejection at PNAS Nexus by proving real interdisciplinary value, not just using it as a broad-scope fallback.
Avoid desk rejection at Progress in Quantum Electronics by submitting a true long-form review with enough scope, authority, and field judgment.
Avoid desk rejection at Protein & Cell with stronger breadth, cleaner mechanism, and a more submission-ready first read.
Avoid desk rejection at Science Immunology with stronger broad-interest consequence, tighter mechanism, and a cleaner first-read significance case.
Avoid desk rejection at Science by proving broad significance, causal clarity, and a true cross-disciplinary reason for the paper to be there.
Avoid desk rejection at SmartMat by proving real functional consequence, not just synthesis, characterization, and one strong metric.
Avoid desk rejection at TEM with a stronger review thesis, cleaner article type, and a sharper endocrinology or metabolism angle.
IEEE RBME impact factor is 12.0 with a 5-year JIF of 13.1. See rank, trend, and what it means before submission.
A practical IEEE TEVC submission guide for authors deciding whether the paper offers a true evolutionary-computation contribution rather than only a strong benchmark result.
International Journal of Oral Science impact factor is 12.2 with a 5-year JIF of 13.6. See rank, trend, and what it means before submission.
International Journal of Oral Science does not publish a simple public median decision clock. The useful signals are the journal's explicit fast-screen posture, two-referee review model, and selective oral-science fit bar.
International Journal of Plasticity impact factor is 12.8 with a 5-year JIF of 11.6. See rank, trend, and what it means before submission.
A practical ISPRS Journal submission guide for authors deciding whether their geospatial or remote-sensing paper is broad enough, validated enough, and important enough for this flagship journal.
JACC: CardioOncology impact factor is 13.4. See the trend, Q1 status, and what that number means before you submit.
JACC impact factor is 22.3 with a 5-year JIF of 24.2. See the rank, trend, and what that means before submission.
JAMA Cardiology impact factor is 14.1 with a 5-year JIF of 15.6. See the rank, trend, and what that means before submission.
JAMA Oncology impact factor is 20.1 with a 5-year JIF of 24.7. See the rank, trend, and what that number means before submission.
JCI Insight is one of the more transparent clinical investigation journals on timing, but authors still need to distinguish between desk, reviewed, and transfer pathways.
JAFC impact factor is 6.2 with a 5-year JIF of 6.4. See the rank, trend, and what that number means before submission.
Journal of Applied Physics is not built for instant desk churn. The useful question is whether the paper is complete and applied enough to justify JAP's full-length format.
Journal of Biomedical Science impact factor is 12.1 with a 5-year JIF of 12.0. See rank, trend, and what it means before submission.
JCB advertises a very fast editorial screen, but accepted papers still show a wide spread depending on how much revision the paper needs.
Journal of Clinical Investigation impact factor is 13.6 with a 5-year JIF of 14.4. See the rank, trend, and what that means before submission.
A practical JCI submission guide for authors deciding whether the manuscript truly advances the practice of medicine, or is still better owned by a narrower specialty journal.
JCIS is quicker than many authors expect, but the useful question is not just how fast the decision comes. It is whether the paper is genuinely owned by colloid and interface science rather than borrowing the language.
JECCR impact factor is 12.8 with a 5-year JIF of 12.2. See rank, trend, and what it means before submission.
JEM publicly says initial decisions come in 5 days and peer review averages 38 days. That makes it one of the clearer high-end biomedical journals on review timing.
A practical JEM submission guide for authors deciding whether the paper really bridges mechanism and disease biology, and whether the initial package already meets Rockefeller-level editorial screening.
Journal of Nanobiotechnology impact factor is 12.6 with a 5-year JIF of 12.3. See rank, trend, and what it means before submission.
Journal of Neuroscience impact factor is 4.0 with a 5-year JIF of 5.0. See the rank, trend, and what that number means before submission.
JPC C is faster than many authors expect, but the useful question is whether the paper is truly physical chemistry at a surface, interface, or nanoscale system.
Kidney International impact factor is 12.6 with a 5-year JIF of 13.7. See rank, trend, and what it means before submission.
Kidney International is one of the cleaner flagship-journal timing cases because official ISN materials publish concrete workflow numbers. The desk screen is fast. The real question is whether the paper deserves flagship nephrology review.
Lancet Infectious Diseases impact factor is 31.0 with a 5-year JIF of 26.9. See the rank, trend, and what that means before submission.
Lancet Neurology impact factor is 45.5 with a 5-year JIF of 56.2. See the rank, trend, and what that means before submission.
Materials impact factor is 3.2 with a 5-year JIF of 3.5. See the rank, trend, and what that means before submission.
Materials is known for speed, but the useful question is not whether the platform moves quickly. It is whether the manuscript is complete enough for a broad materials journal to move it without repeated evidence requests.
Microbiome impact factor is 12.7 with a 5-year JIF of 16.6. See rank, trend, and what it means before submission.
Microbiome gives authors a better public timing picture than many specialist journals: current official signals show a median 22 days to first editorial decision, but author-side reports show the reviewed path can still stretch materially longer.
Molecular Psychiatry impact factor is 10.1 with a 5-year JIF of 11.8. See the rank, trend, and what that number means before submission.
Molecular Systems Biology has a relatively fast author-reported review path, but the real pacing variable is whether the paper truly integrates computation and experiment at a systems level.
A practical Molecular Systems Biology submission guide for authors deciding whether the paper really integrates computation and experiment strongly enough for MSB.
Molecular Therapy impact factor is 12.0 with a 5-year JIF of 12.4. See rank, trend, and what it means before submission.
Molecular Therapy's official public timeline points to a several-month path, even though small-sample community reports can look much faster.
Nature Cell Biology moves quickly on immediate rejections, but full review and revision can still take months. Here is the realistic timeline.
Nature Metabolism can reject quickly, but article histories show that accepted papers often spend many months in review and revision. The desk and full-review clocks are very different.
A practical Nature Metabolism submission guide for authors deciding whether metabolism is truly the paper's core story and whether the package already meets a Nature-level editorial screen.
Nature Microbiology impact factor is 19.4 with a 5-year JIF of 20.7. See the trend, rank, and what that number means before submission.
Nature Microbiology can reject quickly, but public article histories show that papers surviving desk review often spend months in review and revision.
Nature Protocols review time is not uniformly fast or slow. The journal screens hard up front, and accepted papers show a wide spread depending on how mature the protocol already is.
A practical Nature Protocols submission guide for authors deciding whether the protocol is mature enough, broad enough, and detailed enough for this methods journal.
Nature Reviews Cancer is not a standard unsolicited research journal. The timing question starts with commissioning, editorial shaping, and only then formal peer review.
Nature Reviews Molecular Cell Biology is not a standard unsolicited journal path. The process begins with commissioning, editorial shaping, and then formal peer review.
A practical NEJM Evidence submission guide for authors deciding whether the manuscript truly belongs in a methods-conscious clinical-evidence journal from NEJM Group.
Nutrients impact factor is 5.0 with a 5-year JIF of 6.0. See the rank, trend, and what that number means before submission.
Nutrients moves faster than many traditional nutrition journals, but the speed only helps if the paper is genuinely about nutrition and the compliance surface is already clean.
Pharmacology & Therapeutics impact factor is 12.5 with a 5-year JIF of 14.0. See rank, trend, and what it means before you pitch.
PLOS Biology review time is fast at the first screen and slower after review. Here is the timeline authors should realistically plan around.
PNAS Nexus review time is not opaque, but the key signal is variability. SciRev points to a relatively quick first round, while official article histories show accepted papers often taking about 4 to 8 months to final acceptance.
A practical PNAS Nexus submission guide for authors deciding whether the paper is broad enough, cross-disciplinary enough, and finished enough for this NAS journal.
A practical Progress in Quantum Electronics submission guide for authors deciding whether their manuscript is authoritative enough, broad enough, and review-shaped enough for this long-form photonics journal.
Protein & Cell impact factor is 12.8 with a 5-year JIF of 19.5. See rank, trend, and what it means before submission.
Remote Sensing impact factor is 4.1 with a 5-year JIF of 4.8. See the rank, trend, and what that number means before submission.
Remote Sensing moves faster than many remote-sensing and geoscience journals, but the timeline only helps when the manuscript has enough benchmarking and cross-case value to justify a broad journal.
RSER impact factor is 16.3 with a 5-year JIF of 17.5. See the rank, trend, and what that number means before submission.
Renewable & Sustainable Energy Reviews is not a fast-turn original-research venue. The useful question is whether the manuscript is truly review-led enough to justify the journal's longer editorial path.
RNA publicly says the current average time from submission to final acceptance is 93 days. That is a useful signal, but the real speed still depends on whether the paper is truly RNA-centered.
A practical RNA submission guide for authors deciding whether the paper is truly RNA-centered, mechanistically strong, and properly packaged for this specialist journal.
Science Immunology impact factor is 16.3 with a 5-year JIF of 17.7. See rank, trend, and what it means before submission.
Science Immunology can reject quickly, but the papers that survive the first screen usually enter a real multi-month review process.
Small is selective and broad across nanoscience, so the real timing question is not just speed. It is whether the paper is strong enough to avoid a quick fit rejection.
A practical SmartMat submission guide for authors deciding whether their smart-materials manuscript is broad enough, device-relevant enough, and complete enough for editorial screening.
TEM impact factor is 12.6 with a 5-year JIF of 12.5. See rank, trend, and what it means before you pitch.
Water Research is one of the clearer high-end environmental journals on timing because Elsevier publishes current workflow metrics. The hard part is not the clock. It is proving that the manuscript is truly a water-science paper rather than a general environmental paper with a water application.
ACS Catalysis publishes official review-speed metrics, but the useful question is still whether the catalyst story is complete enough to survive them.
Analytical Chemistry publishes clear review-speed metrics, but the real submission issue is whether the paper advances measurement science strongly enough.
Applied Catalysis B publishes unusually clear timing metrics, but the real submission issue is still whether the catalyst solves an energy or environmental problem under believable conditions.
Applied Physics Letters can move quickly, but the useful submission question is not just speed. It is whether the manuscript truly fits a concise letters journal.
Applied Sciences moves quickly at the front end, but the real decision is whether a broad MDPI applied-science venue is the right home for the paper.
Current Biology moves quickly at the front end, but the useful distinction is between the very fast triage clock and the slower path for papers that really enter review.
Genome Biology tends to move quickly on poor-fit papers and more slowly on manuscripts that survive to real review. The useful question is how the journal handles biology-first genomics submissions.
A practical guide to the papers Gastroenterology rejects before review, and what to fix before submitting a GI flagship manuscript.
JAFC often moves faster than authors expect, but the useful question is whether the chemistry and real-system validation are strong enough to survive review.
Nature Neuroscience looks fast at the first screen and slow across the whole path. Both are true. The journal decides quickly whether the paper belongs in the conversation, then takes much longer to turn a live file into an accepted one.
Formatting checklists won't get your paper through triage. Editors screen for six things: journal fit, claim calibration, methods completeness, figure quality, citation integrity, and reporting compliance. Here is how to check each one before you submit.
Most manuscript rejections fall into predictable, fixable categories. This page breaks down why papers fail at desk review versus peer review, what failure patterns look like by discipline, and what the data actually shows about rejection rates by stage.
How to avoid desk rejection at NEJM: prove broad clinical consequence, hard endpoints, and study authority strong enough for general medicine.
Nucleic Acids Research does not publish a current official acceptance rate. The real planning signal is the journal's very fast editorial triage and its preference for mechanistic or high-utility work.
Scientific Reports' official editorial-board FAQ says the journal's overall accept rate is approximately 50%. The real question is whether the paper is scientifically valid and methodologically complete.
ACS Applied Materials & Interfaces APC is $4,500 for CC BY or $4,000 for CC BY-NC-ND, with lower ACS hybrid options.
ACS Nano is hybrid. Here is what ACS open-access pricing actually looks like, when authors pay nothing, and when the APC is worth it.
ACS Nano is relatively efficient for a top nanoscience journal, but the useful submission question is still fit. Function and nanoscale consequence matter more than one neat timeline.
Advanced Functional Materials charges a $5,790 APC for hybrid open access in 2026. Current Wiley pricing, agreement coverage, and fit.
Analytical Chemistry APC is $4,500 for CC BY or $4,000 for CC BY-NC-ND, with cheaper ACS green and delayed-OA routes.
Angewandte Chemie often tells authors relatively quickly whether a result belongs in a flagship chemistry journal, but the real submission question is broad chemical consequence, not just speed.
Annals of Oncology APC is EUR 5,556. Hybrid ESMO pricing, 12-month embargo rules, agreement coverage, and oncology fit guidance.
Applied Catalysis B APC is USD 5,980. Hybrid Elsevier model, 13% acceptance, fast review, and route tradeoffs.
Applied Energy APC is $4,210 under Elsevier's current hybrid model. Current fee, agreement coverage, review timing, and energy-journal comparison.
Applied Surface Science currently reports a 19% acceptance rate. The more useful planning question is whether the paper is truly surface-led and strong at the atomic or molecular level.
Applied Surface Science APC is USD 4,210. Gold OA is optional, subscription publishing is free, and Elsevier agreements may cover the fee.
Bioinformatics is now fully open access. OUP uses article-type APCs, ISCB discounts, R&P coverage, and no page or color charges.
Bioresource Technology charges a $4,670 APC for open access in 2026. Hybrid model, current timing, agreement coverage, and manuscript-fit guidance.
BMJ Open now reports a 27% acceptance rate on its journal statistics page. The real filter is still methodological soundness, transparent reporting, and broad medical relevance.
BMJ Open charges GBP 2,163 (~$2,850 USD) for gold open access. Open peer review, clinical focus, institutional deals. Full cost breakdown and comparisons.
Cancer Cell APC is currently $10,400. Hybrid Cell Press pricing, agreement uncertainty, metrics context, and when paying makes sense.
Cancer Research APC runs about $4,200 for AACR members or $5,000 for nonmembers, with page charges on subscription papers.
Cell Host & Microbe APC is currently $10,400. Hybrid Cell Press pricing, agreement uncertainty, metrics context, and fit tradeoffs.
Cell Metabolism lists a USD 10,400 APC for optional open access. Subscription publication is free, so fit, funding, and audience matter most.
Cell Reports is fully open access and currently lists a USD 5,620 APC. Here is what that means for budgeting, GPOA discounts, and journal choice.
Chemical Engineering Journal APC is USD 5,070. Hybrid Elsevier model, 24-month green OA, and route tradeoffs for CEJ authors.
Chemical Reviews APC is $4,500 for CC BY or $4,000 for CC BY-NC-ND, with lower ACS delayed and green routes.
Circulation APC is roughly $4,000-$5,000. AHA hybrid OA, coverage options, metrics context, and when the fee is worth paying.
Clinical Infectious Diseases APC is USD 5,001, and page composition charges still apply. OUP hybrid model and route tradeoffs.
Diabetes Care APC runs about $3,000-$4,000, with page charges on subscription papers and strong clinical-diabetes reach either way.
Current eLife publication fee is $3,000 at peer-review entry. Reviewed-preprint model, waivers, metrics, and when the fee is worth paying.
Energy APC is USD 4,050. Gold OA is optional, subscription publishing is free, and Elsevier agreements often cover the fee.
ES&T is hybrid: subscription is free and ACS routes OA pricing through a live estimator. Agreements, discounts, metrics, and when OA is worth it.
European Heart Journal APC starts with a free standard route, then an optional OUP OA charge shaped by article type, discounts, and agreements.
Food Chemistry does not disclose an official acceptance rate. The editorial filter that matters is whether your paper solves a real food problem, not just validates an analytical method on a food matrix.
Food Chemistry charges a $4,680 APC for open access in 2026. Hybrid model, current timing, institutional coverage, and editorial fit guidance.
Frontiers in Immunology charges CHF 3,150 (~$3,400) for open access. Gold OA model, institutional deals, waivers, and how it compares to other immunology.
Fuel (Elsevier) charges ~$4,000-$5,450 for open access. IF ~7, core Elsevier R&P journal. Comparison with Combustion and Flame, Energy & Fuels, and more.
Gastroenterology APC is currently $4,180. Hybrid AGA pricing, immediate accepted-manuscript posting, metrics context, and OA tradeoffs.
Genome Biology APC is USD 5,690 for most article types and USD 4,280 for Brief Reports. Fully OA with Springer support.
Hepatology APC uses the latest public LWW fee schedule: $3,510 CC BY-NC-ND or $3,900 CC BY. Coverage, metrics, and fit.
IEEE Access APC is $2,160. IEEE members get 5% off and IEEE society members get 20% off. Current fully open-access pricing and discounts.
International Journal of Biological Macromolecules APC is USD 4,170. Hybrid Elsevier model, 12-month green OA, and route tradeoffs.
International Journal of Hydrogen Energy charges ~$4,200 for open access. Hybrid model, Elsevier R&P deals, waivers, and comparisons with J Power Sources.
IJMS APC is CHF 2,900 in 2026. This page explains the MDPI gold-OA fee, discounts, speed, and whether the journal model fits your manuscript.
JACS often tells authors relatively quickly whether the chemistry belongs in a flagship ACS journal, but the real submission question is broad chemical consequence, not just speed.
JAMA Oncology is better judged through practice-changing clinical evidence than through a guessed acceptance percentage. The current official signal is clearer than it used to be.
JAMA Oncology's current APC is $6,000 for eligible gold OA articles. Standard publication is free, with delayed access after 12 months.
Journal of Applied Physics APC is $3,800 through AIP Author Select in 2026. S2O ended, so OA now depends on agreements or payment.
JBC is fully open access. Official 2026 sources show member and nonmember pricing, plus the rule that controls who gets the discount.
Journal of Cleaner Production charges a $4,620 APC for open access in 2026. Hybrid model, 24-month embargo, agreements, and fit.
JCO is better judged through practice-changing clinical evidence than through a guessed percentage. The useful question is whether the study clears the ASCO flagship evidence bar.
JCO APC planning is simple: the standard route is free, while the optional OA upgrade does not have one clean fixed public ASCO sticker price.
Elsevier now reports a 14% acceptance rate for Journal of Colloid and Interface Science. The more useful submission question is still whether interface science is the paper's central intellectual claim.
Journal of Colloid and Interface Science currently lists a USD 4,690 APC. Here is the fee, metrics, agreement context, and whether it makes sense.
Journal of Hazardous Materials charges a $4,900 APC for open access in 2026. Hybrid model, subscription route, agreements, timing, and editorial fit.
Journal of Immunology APC is $2,800 for AAI members and $3,500 for nonmembers. Standard publication costs $1,500 or $1,875.
Journal of Materials Chemistry A APC is GBP 3,100. Gold OA is optional, subscription publishing is free, and RSC agreements may cover the fee.
Journal of Physical Chemistry C APC is $4,500 CC BY or $4,000 CC BY-NC-ND, with current ACS open-access route details.
Journal of Power Sources does not publish a current official acceptance rate. The useful planning signal is its strong electrochemical-device screen, current metrics, and fast initial triage.
Journal of Power Sources APC is USD 4,150 for OA; subscription is free. Current metrics, agreements, waivers, and whether OA is worth paying.
Materials publishes over 10,000 articles per year with Q2 ranking. Here is what the acceptance rate data actually tells you.
Molecular Cell lists a USD 10,400 APC for optional open access. Here is what that price means in practice.
Molecules APC is CHF 2,700 in 2026. See the MDPI gold-OA fee, discount paths, speed, and how Molecules compares with ACS Omega and RSC Advances.
Monthly Notices of the Royal Astronomical Society does not publish a current official acceptance rate. The real decision signal is scope fit, concision, and whether the paper belongs in the mainstream astronomy conversation.
MNRAS review time is often manageable for clean astronomy papers, but the practical submission question is whether the manuscript already fits a serious field-journal review.
Nature Biotechnology charges $12,850 for open access. Current pricing, institutional coverage, and waiver support.
Nature Communications APC is $7,350 / EUR 6,150 / GBP 5,490. Current fully open-access pricing, funding support, waiver policy, and journal context.
Nature Immunology charges $12,850 for open access. Current Nature Portfolio pricing, agreement coverage, waivers, and immunology-journal comparisons.
Nature Medicine charges $12,850 for open access. Current pricing, institutional coverage, and waiver support.
Nature Methods charges $12,850 for open access. Current Nature Portfolio pricing, agreement coverage, waivers, and methods-journal comparisons.
Nature Methods often tells authors relatively quickly whether the method is the real contribution, but the real submission question is benchmarked utility, not just speed.
Neuron lists a USD 10,400 APC for optional open access. Here is what the fee means in practice.
Neuron often decides quickly at the desk, but the real cost comes later if the paper enters review. Mechanistic depth and revision burden matter more than one neat timeline number.
NAR is fully open access and currently charges $4,192. Current OUP pricing, agreements, waivers, metrics, and whether the APC is worth paying.
Physical Review D review time is usually steady rather than dramatic. The useful submission question is significance, authority, and fit, not just speed.
Remote Sensing publishes ~6,000 articles per year with Q1 ranking in Earth Sciences. Here is what the acceptance rate data tells you.
Remote Sensing APC is CHF 2,700 in 2026. See the MDPI gold-OA fee, discounts, speed, and how it compares with stronger hybrid alternatives.
Renewable & Sustainable Energy Reviews charges ~$5,450-$5,000 for open access. Elsevier hybrid model, Read & Publish deals, and how it compares to Applied.
RSC Advances APC is £2,200 for 2026 submissions, with lower-country discounts and waivers. Current metrics and whether the fee is worth it.
Scientific Reports APC is $2,850 / €2,490. Fully open access, funding coverage, metrics context, and when the fee is worth paying.
Sensors charges CHF 2,600 for open access. Here is the current MDPI fee, discount structure, journal metrics, and how it compares with peer options.
Water Research APC is $4,840 under Elsevier's current hybrid model. Current fee, agreement coverage, timing, and water-journal comparison.
Before you submit to Nature Medicine, verify these 10 items covering clinical significance, translational depth, study design adequacy, and the editorial standards that stop 70-80% of submissions.
eLife's editorial screen rejects 80-85% of submissions, but the reviewed preprint model means every paper that passes gets public reviews and an eLife Assessment. Verify readiness before entering a transparent process.
Journal submissions surged dramatically in late 2025. Desk rejection rates are rising. Review times are stretching. Here is what is happening, why, and how to adapt your submission strategy.
A practical guide to the Circulation Research submission process, including editorial triage, reviewer routing, and what to tighten before upload.
Use this Clinical Infectious Diseases submission process guide to understand editorial triage, reviewer routing, common delays, and what to tighten.
Cell Stem Cell submission process. Practical guidance for Cell Stem Cell, plus what authors should do next. See the full timeline from upload.
A workflow-focused JAMA Oncology submission process guide covering what happens after upload, what triage is testing, and where papers lose time.
A practical Journal of Neuroscience submission process guide focused on what happens after upload, what editors test first, and how to interpret early movement.
Use this Lancet Neurology submission process guide to understand editorial triage, clinical-fit screening, likely delays, and what to tighten first.
Use this Ceramics International submission process guide to understand editorial screening, reviewer routing, common delays, and what to tighten.
Use this Chemical Communications submission process guide to understand editorial screening, reviewer routing, common delays, and what to tighten.
Use this Chemical Reviews submission process guide to understand proposal review, editorial commissioning, common delays, and what to clarify first.
Top cardiology journals reject most submissions before external review. Circulation, JACC, and European Heart Journal have distinct reviewer expectations. Here is what pre-submission review looks like for manuscripts targeting this tier.
CNS journals are among the hardest venues in biomedical research. Here is what reviewers actually look for and how pre-submission review helps close the gap before you submit.
how to avoid desk rejection at Lancet Neurology. Practical guidance for Lancet Neurology, plus what authors should do next. See how to avoid it.
How to avoid desk rejection at BMJ: what editors screen for first, and how to frame a clinically important paper for a broad medical audience.
Advanced Materials is one of the most selective materials science journals, with a JIF of 26.8 (JCR 2024) and aggressive desk rejection for work that doesn't reach its impact standard. Here's what actually gets in.
Advanced Materials takes 6-12 weeks to a first decision for papers that pass desk review. Desk rejection decisions arrive in 2-4 weeks. Here's a realistic timeline breakdown for one of materials science's top journals.
JACS desk rejects papers when the chemistry feels incremental, the mechanism is thin, the scope is narrow, or the manuscript does not show why working chemists should care.
Angewandte desk rejects chemistry that looks incremental, underexplained, weakly benchmarked, or not useful enough to matter to a broad chemistry readership.
Nature desk-rejects more than 90% of submissions, usually within 4-6 weeks. For papers that reach peer review, total time to a first decision runs 4-6 months. Here's what the timeline looks like at every stage.
Science rejects more than 90% of submissions at the desk, often within 2-4 weeks. Papers that go to peer review take 3-5 months for a first decision. Here's the full timeline.
ACS Applied Materials & Interfaces accepts around 25-30% of submissions, making it selective but accessible for applied materials research. Here's what the review process looks like.
Physical Review Letters typically delivers a first decision in 4-8 weeks, but desk rejection rates are high. Here's what happens at each stage of the PRL review process.
ACS Applied Materials & Interfaces typically delivers a first decision in 5-8 weeks from submission. Here's how the editorial process works and what you can do to keep things moving.
Astrophysical Journal review time is often manageable by astronomy standards, but the practical submission question is whether the manuscript is clean enough for a smooth field-journal review.
Before submitting to Nature, verify these 12 items covering breadth of significance, data availability, reporting completeness, and what editors evaluate in the first 5 minutes.
A practical Cell Discovery fit verdict for authors deciding whether their manuscript is strong enough, broad enough, and complete enough for this open-access Nature Portfolio biology journal.
A practical NSMB fit verdict for authors deciding whether their structural biology paper is mechanistically strong and broad enough.
Cancer Cell fit verdict with key metrics, comparison to Nature Cancer and Cancer Discovery, and practical guidance for cancer biology authors.
Cell Metabolism fit verdict with key metrics, comparison to Nature Metabolism and Cell, and practical guidance for authors in metabolism research.
A practical Cell Systems fit verdict for authors deciding whether their manuscript is truly systems biology rather than biology plus computation.
A practical Annals of Oncology fit verdict for authors deciding whether their study is clinically important enough for the ESMO flagship oncology journal.
A practical Nature Reviews MCB fit verdict on best fit, weak fit, and when it is the wrong target.
A practical Chemical Society Reviews fit verdict for authors deciding whether their review proposal is broad, synthetic, and authoritative enough for Chem Soc Rev.
A practical MNRAS fit verdict for authors deciding whether their paper is a disciplined astrophysics submission with enough evidence, scope, and field relevance for a core astronomy journal.
A practical Diabetes Care fit verdict for authors deciding whether their paper has real clinical diabetes-management consequence.
A practical Current Biology fit verdict for authors deciding whether their paper is broad and concise enough for the journal.
A practical JACC fit verdict for authors deciding whether their study really belongs in the flagship cardiology journal rather than a specialty title.
A practical Chemical Engineering Journal fit verdict for authors deciding whether their paper is truly engineering-driven enough for CEJ.
Most researchers know peer review exists but haven't seen it from the reviewer's side. Here's the full process from submission to published decision - including where most papers die, what reviewers actually check, and how long each stage takes.
The discussion section is where many good papers lose reviewers. Here is the structure that works, what to cut, and the failures editors notice first.
Review speed is one of the most misread journal signals. Fast decisions can mean efficient editorial systems, harsh desk triage, or both.
Cancer Cell review time splits into a very fast desk screen and a costly flagship review path. Here's the full timeline, what editors want, and why most papers do not make it past screening.
Scientific Reports has one of the longest review timelines in open-access publishing: around 120 days on average. Here's what happens at each stage and why it takes so long.
Nature Communications gets 50,000+ submissions per year and accepts about 8% of them. The review process moves faster than most journals at this impact factor, but initial screening is strict.
Reviewers don't need a statistics PhD to spot these errors. Here are the 10 statistical mistakes that get papers rejected, and how to fix each one before you submit.
Reviewers decide how they feel about your paper in the first 90 seconds. Most of that time is spent on the abstract. Here's how to make those seconds count.
PLOS ONE's median time to first decision is 35-45 days, but that number hides a lot of variation. Some papers get decisions in 18 days. Others wait 90+. Here's what determines your timeline and what y...
AI manuscript review is fast and cheap. Human expert review is slow and expensive. Here is an honest framework for when each is the right choice, based on the stakes, the journal, and the paper.
The definitive guide to pre-submission manuscript review: what it is, what it costs across providers, when AI is enough vs when you need a human expert, and how to decide if it is worth it for your paper.
Editage and Enago are the two largest manuscript editing services. Here is an honest comparison of what each offers, where they overlap, and what neither provides.
AJE is a solid editing service backed by Springer Nature, but alternatives now offer deeper scientific analysis that goes beyond what any editing service provides.
We compared every major manuscript review service by what they actually deliver, not what they claim. Here is what each offers, what they charge, and why the differences matter more than the prices.
Editage and AJE are the two most-searched manuscript editing services. Here is an honest comparison of pricing, editing quality, and pre-submission review depth.
AJE and Enago are both large manuscript editing services. Here is an honest comparison of pricing, editing depth, and when you need something different entirely.
Is AJE worth $289 for pre-submission review? Here is what the service actually delivers based on their own documentation, what it misses, and when cheaper alternatives provide more actionable feedback.
Editage is the most recognized name in manuscript editing, but alternatives now offer deeper scientific review including citation verification and figure analysis that Editage does not provide.
Enago is a large editing service with an AI+human hybrid tier, but alternatives now offer deeper analysis including live citation verification and journal-specific scoring that Enago does not provide.
Paperpal is a $25/month AI writing assistant from Cactus Communications. It handles grammar, paraphrasing, and academic English well. It does not handle scientific review at all.
Pre-submission review is not always the right choice. Here are the specific situations where you should skip it, when a free check is sufficient, and when the investment genuinely pays for itself.
Neuroscience manuscripts face heightened scrutiny on reproducibility, statistical methods, and sample sizes. Here is what editors and reviewers at top neuroscience journals actually look for.
Materials science manuscripts face specific scrutiny on characterization completeness, performance benchmarking, and data presentation. Here is what reviewers at top materials journals actually look for.
Computational biology manuscripts face unique reproducibility scrutiny. About half of published computational models are not reproducible. Here is what to verify before submission to avoid being part of that statistic.
There are now dozens of manuscript review services. Here is a practical decision framework that helps you choose based on what your paper actually needs, not on marketing.
Publishing your first academic paper is harder than your advisor told you. The mistakes first-time authors make are predictable, preventable, and often invisible until a reviewer points them out.
Immunology manuscripts face specific scrutiny on controls, flow cytometry gating strategies, and mechanistic depth. Here is what reviewers at Nature Immunology and Immunity actually look for.
Oncology manuscripts face unique scrutiny on clinical endpoints, translational depth, patient outcomes, and reporting standards. Here is what reviewers at top oncology journals actually look for.
Environmental science manuscripts need field data, cross-compartment thinking, and realistic application context. Here is what reviewers at STOTEN, Environmental Pollution, and Water Research expect.
Chemistry manuscripts face specific scrutiny on characterization completeness, novelty assessment, and benchmarking against existing methods. Here is what JACS and Angewandte Chemie reviewers look for.
Cell biology manuscripts need multi-system validation, mechanistic depth beyond observation, and publication-quality imaging. Here is what reviewers at top cell biology journals expect.
Genetics manuscripts face increasing scrutiny on ancestry diversity, functional follow-up of association signals, and statistical genetics methodology. What reviewers at top genetics journals expect.
Microbiology manuscripts need proper controls, multi-strain validation, and clinical or ecological relevance. Here is what reviewers at top microbiology journals expect.
Physics manuscripts face specific scrutiny on computational reproducibility, error analysis, and whether the result provides genuine physical insight beyond the numbers.
Ecology and evolution manuscripts need robust field data, proper sampling design, and conclusions that scale appropriately from the study system to broader principles.
Pharmacology manuscripts need dose-response data, proper controls, in vivo validation, and clear therapeutic relevance. Here is what reviewers at top pharmacology journals expect.
Engineering manuscripts face specific scrutiny on practical validation, real-world benchmarking, and scalability. Here is what reviewers at top engineering journals expect.
Cardiovascular manuscripts face specific scrutiny on clinical endpoints, statistical rigor, and Clinical Perspective sections. Here is what Circulation, JACC, and European Heart Journal reviewers expect.
Research Square is a preprint platform, not a pre-submission review service. This guide walks through every alternative category and helps you choose the right one for your manuscript.
A practical guide to the International Journal of Biological Macromolecules submission process, covering what editors screen for first and what to fix before upload.
A practical guide to the Journal of Alloys and Compounds submission process, covering what editors screen for first and what to fix before upload.
A practical Cell submission process guide covering what happens after upload, what editors screen for first, and what to fix before you submit.
A serious buyer's guide to pre-submission review services: who each service is best for, where Manusights actually wins, and when editing-heavy alternatives may be the better buy.
A workflow-focused Nature submission process guide covering what happens after upload, what triage is testing, and where papers lose time.
A practical Nature Medicine submission process guide covering what happens after upload, what editors screen first, and how to interpret silence or delay.
Major revision vs resubmit - understand the difference, what editors expect, and how to respond to each decision. Plus when to switch journals.
How to disagree with reviewer comments professionally, with evidence, templates, and strategies that protect the paper without sounding defensive.
Rebuttal letter template for major revision with examples, point-by-point structure, and practical guidance for answering reviewers clearly.
Is pre-submission peer review worth it? A cost-benefit guide to when to buy AI review, editing, expert review, and when to skip it.
A practical system for responding to reviewer comments without sounding defensive, skipping key points, or making the editor work harder than necessary.
Journals can sometimes spot AI-assisted writing, but the bigger risk is not the detector. It is the manuscript errors, citation problems, and disclosure mistakes that AI leaves behind.
AI screening is no longer hypothetical. Major publishers are using it before peer review, which changes what authors need to catch before they submit.
Advanced Energy Materials can move quickly on obvious fit questions, but the real timing depends on whether the paper proves a field-level energy consequence.
This Angewandte Chemie submission guide helps authors decide whether the manuscript has the breadth, urgency, and cross-field chemistry appeal editors screen for first.
Annals of Oncology moves quickly on low-priority papers, but manuscripts that clear triage still face a selective multi-week oncology review path.
Applied Energy has a quick editorial front end, but the real path still depends on whether the paper is systems-level enough to survive review.
Bioinformatics is usually fast enough to desk-reject weak method papers early, but reviewed papers still depend on validation and tool trust.
Bioresource Technology publishes unusually clear timing metrics, but the main issue is still whether the paper is genuinely a bioresource-technology paper.
BMC Medicine editors need a cover letter that does more than summarize the abstract. It has to explain why the paper belongs in a broad general-medicine journal and why the package is ready now.
BMC Medicine formatting problems are usually package problems: abstract structure, reporting checklists, reviewer suggestions, declarations, and clean file setup all have to line up.
BMC Medicine is fast at the editorial front end, but reviewed papers still take months because the journal asks for broad clinical relevance.
BMJ formatting is not mainly visual style. It is a disciplined general-medical package with structured reporting, patient involvement, and clean transparency.
This BMJ submission guide helps authors decide whether the paper is broad enough, mature enough, and clear enough for a flagship general-medical screen.
Brain cover letters work when they explain the neurological question, the mechanistic advance, and why broad neurology readers should care now.
Brain formatting is mostly about clean manuscript architecture: editable files, title limits, structured section order, declarations, thumbnails, and a package that does not rely on the supplement to explain itself.
Brain reports strikingly fast headline decision metrics, but that number mostly reflects a very hard editorial front end.
Cancer Research can make an early decision quickly, but the useful issue is whether the paper is mechanistic enough for AACR's flagship biology audience.
Carbohydrate Polymers formatting problems are usually package problems: named polymer focus, glycan characterization, a 200-word abstract, a required graphical abstract, and a clean Elsevier file stack.
Cell Host & Microbe formatting problems are usually package problems: a 150-word abstract, a tight interaction-first manuscript format, and methods, figures, and data language that all support one host-microbe claim.
Cell Host & Microbe has one of the clearest timing splits in this set: the desk signal is extremely fast, but the real reviewed path depends on how complete the host-microbe mechanism already is.
Cell Stem Cell cover letters work when they show function first, keep the mechanism claim disciplined, and explain why the story is complete enough for review now.
Cell Stem Cell formatting is really article-shaping: article type, 150-word summary, figure count, graphical abstract, STAR Methods, and reviewer-ready data access all need to support the same claim.
Cell Stem Cell is quick to make the first editorial call, but the meaningful number is the full path from submission to acceptance. The journal moves fast when the story is wrong for it and much more slowly when the paper survives.
Ceramics International formatting problems are usually package-discipline problems: a concise abstract, category-coded keywords, reproducible methods, and artwork files that support one ceramics story.
Chemical Communications is a rapid-communication journal, so the clock matters, but the real first question is whether the result is urgent enough to deserve the format.
Circulation Research cover letters work when they make the mechanistic cardiovascular case quickly and avoid sounding like a generic cardiology pitch.
Circulation Research formatting problems are usually mechanism-package problems: the abstract, figure order, supplement, and disclosure layer all have to support one mechanistic cardiovascular claim.
Circulation Research is not a casual cardiovascular venue. The review clock mainly reflects how fast the editors can tell whether the paper is mechanistic enough.
Clinical Cancer Research can reject weak translational packages early, but manuscripts that survive review still move on a multi-week oncology timeline.
CID now publishes unusually clear timing data, and the gap between desk-reject medians and reviewed-paper medians is the key thing authors need to understand.
Current Biology cover letters work when they state one biological point clearly, explain the broad readership case, and avoid sounding like a redirected specialist manuscript.
Current Biology formatting problems are usually package problems: concise story shape, a 150-word abstract, a clean Cell Press manuscript file, and methods/data language that all point to the same biological claim.
Developmental Cell cover letters work when they explain the developmental process, the causal mechanism, and why the package is shaped correctly for the journal.
Developmental Cell formatting is really mechanism formatting: article type, 150-word summary, STAR Methods, graphical abstract, and dynamic evidence all have to support one developmental claim.
Developmental Cell is not usually slow because the editors are indecisive. It is slow because the journal asks for mechanistic completeness and that stretches the full revision path.
Diabetes Care can reject quickly at the desk, but the longer editorial review stage is what most authors underestimate.
EMBO Journal often decides quickly at the editorial stage, but mechanistic papers that clear triage still face a hard multi-round review path.
A practical FEMS Microbiology Reviews submission guide for authors deciding whether a review idea is broad enough, authoritative enough, and timely enough to pitch.
This Gastroenterology submission guide helps authors decide whether a GI manuscript has enough clinical or translational significance for the AGA flagship.
A practical Genome Research submission guide for authors deciding whether the manuscript is biologically consequential enough, data-ready enough, and complete enough for the journal.
Applied Sciences desk rejections usually happen when the paper claims practical relevance without proving it. This guide shows the editorial screens to fix before submission.
A practical guide to the proposal and article ideas Trends in Molecular Medicine screens out before review, and what a viable pitch needs instead.
A practical RBME submission guide for authors deciding whether their review is broad enough, critical enough, and complete enough for editorial screening.
A practical International Journal of Oral Science submission guide for authors deciding whether the paper is strong enough, broad enough, and complete enough for this selective oral-science journal.
A practical International Journal of Plasticity submission guide for authors deciding whether the manuscript is rigorous enough, mechanistic enough, and plasticity-centered enough for editorial screening.
A practical JACC: CardioOncology submission guide for authors deciding whether the manuscript really changes the cardiovascular care conversation for patients with cancer.
JACC cover letters work when they explain the broad cardiovascular consequence, the flagship readership case, and why the manuscript belongs in JACC specifically.
JACC formatting is really clinical-package formatting: title discipline, structured abstract, central illustration, perspectives, disclosures, and a manuscript that looks ready for a fast editorial read.
JACC's own public messaging is speed-first, but the real point is that the journal forms a view quickly on whether the manuscript deserves the flagship audience.
This JACS submission guide helps authors decide whether the chemistry feels broad, mechanistically complete, and strong enough for editorial screening at the ACS flagship.
JAMA Cardiology cover letters work when they show a broad cardiology consequence quickly and avoid sounding like a prestige pitch for a narrower paper.
JAMA Cardiology formatting is not mainly stylistic. It is a disciplined JAMA Network package: 3000-word research paper, structured abstract, Key Points, reporting checklist, data sharing, and clean display-item limits.
JAMA Cardiology is unusually transparent about how quickly it triages papers. The real question is whether the manuscript is broad and practice-relevant enough to survive that screen.
A practical JCI Insight submission guide for authors deciding whether the manuscript is broad enough, disease-relevant enough, and complete enough for the journal's editorial screen.
This JAFC submission guide helps authors decide whether the chemistry is genuinely food-relevant, analytically validated, and strong enough for editorial screening.
This Journal of Applied Physics submission guide helps authors decide whether the work has enough applied relevance, measurement depth, and physical insight for JAP.
A practical Journal of Biomedical Science submission guide for authors deciding whether the paper is broad enough, molecular enough, and biomedical enough for the journal's editorial screen.
A practical Journal of Cell Biology submission guide for authors deciding whether the manuscript is mechanistic enough, visually convincing enough, and complete enough for JCB.
This Journal of Colloid and Interface Science submission guide helps authors decide whether interface science is truly the story and whether the characterization package is strong enough.
A practical JECCR submission guide for authors deciding whether the manuscript has the translational cancer relevance, mechanistic depth, and package discipline this journal screens for.
Journal of Immunology formatting problems are usually package-discipline problems: a clean immunology manuscript, a concise abstract, complete back matter, and figures that prove mechanism early.
The Journal of Immunology is less mysterious than many journals in its tier. It publishes a real turnaround number, and that makes the main planning issue less about uncertainty and more about whether the paper is mechanistic enough for JI rather than better suited to a softer immunology lane.
This Journal of Immunology submission guide helps authors decide whether a manuscript is truly mechanistic immunology and strong enough for the society journal's editorial screen.
A practical Journal of Nanobiotechnology submission guide for authors deciding whether the manuscript is truly nano-bio enough, biomedical enough, and complete enough for editorial screening.
Journal of Neuroscience cover letters work when they explain the broad neuroscience question, the conceptual advance, and why the story belongs in a field journal.
Journal of Neuroscience formatting problems are usually package-order problems: the manuscript, figures, statistics, and supplement all have to make one broad-neuroscience argument visible fast.
JNeurosci is not mostly a prestige journal anymore, but it is still a broad-neuroscience gatekeeper. Its timing makes more sense when you realize the editors are screening for breadth and mechanistic coherence at the same time.
This Journal of Physical Chemistry C submission guide helps authors decide whether the manuscript is truly JPC C work rather than a materials or device paper in disguise.
Journal of Power Sources formatting problems are usually validation-package problems: article type, word limits, figure count, good-practice alignment, data statements, and file discipline all have to support one serious electrochemical claim.
Journal of Power Sources is one of the clearer examples of a journal where official timing metrics are helpful, but only if the paper already looks device-ready.
This Journal of Power Sources submission guide helps authors decide whether the manuscript is complete enough, rigorous enough, and practical enough for JPS.
A practical Kidney International submission guide for authors deciding whether the paper is strong enough, clinically relevant enough, and complete enough for this flagship nephrology journal.
Lancet Infectious Diseases cover letters work when they show why the result matters beyond one local setting and why a global infectious-disease readership should care now.
Lancet Infectious Diseases formatting is really editorial packaging: abstract discipline, selective figures and references, reporting files, and a package that proves the paper travels beyond one local setting.
Lancet Infectious Diseases is a good example of a journal where timing is mostly a function of consequence. Papers with obvious mismatch can move fast. Papers that are plausible but not clearly world-leading can spend more time in editorial sorting.
Lancet Neurology cover letters work when they explain what changes for neurologists, why the manuscript is broad enough, and why the paper belongs here specifically.
Lancet Neurology formatting is really editorial packaging: word limits, exact abstract headings, figure and reference caps, reporting checklists, and a data-sharing statement all have to line up.
Lancet Neurology is a journal where the first useful timing question is not how fast peer review runs, but how quickly the editors decide whether the paper has enough broad clinical-neurology consequence to deserve review at all.
Materials formatting problems are usually package-discipline problems: the front matter, section structure, highlights, abstract, and data-availability layer all need to support one clear materials-science paper.
This Materials submission guide helps authors decide whether the manuscript is truly a Materials paper and whether the package is complete enough for MDPI's fast workflow.
A practical Microbiome submission guide for authors deciding whether the paper is mechanistic enough, data-ready enough, and broad enough for this journal.
Molecular Psychiatry cover letters work when they explain the psychiatric consequence clearly, keep translational claims disciplined, and prove the paper belongs in this journal.
Molecular Psychiatry formatting problems are usually package-identity problems: an unstructured abstract, a 5,000-word article shape, no keywords, and a manuscript that still has to prove real psychiatric relevance.
Molecular Psychiatry is faster than many authors fear at the first editorial pass, but the right way to read the journal is as a selective psychiatry-neuroscience filter with a materially longer full cycle than its first-decision number implies.
A practical Molecular Therapy submission guide for authors deciding whether the manuscript is strong enough, translational enough, and field-defining enough for this ASGCT flagship journal.
Nano Letters is unusually transparent about timing. The journal publishes current median review metrics, which means the real planning question is less about uncertainty and more about whether the manuscript is truly sharp enough for a short, high-visibility nano journal.
Nature Chemical Biology cover letters work when they show that chemistry unlocks biology, biology justifies the chemistry, and the paper belongs in an integrated journal.
Nature Chemical Biology formatting problems are usually package problems: a review-ready manuscript file, a concise abstract, chemistry-grade characterization, biology-grade controls, and one integrated chemical biology story.
Nature Chemical Biology is quick to decide whether a paper is truly chemical biology, then much slower to carry an accepted manuscript through the full path. That split matters more than the headline first-decision number.
A practical Nature Microbiology submission guide for authors deciding whether the manuscript is broad enough, important enough, and complete enough for Nature Microbiology.
Nature Neuroscience cover letters work when they explain the causal advance, the broad field consequence, and why the package is already complete enough.
Nature Neuroscience formatting is really a submission-readiness test: one editorially readable manuscript file, clear figures and methods, broad-neuroscience writing, and source-data discipline.
NSMB cover letters work when they explain the mechanistic question, the structure-function payoff, and why the evidence already solves the right problem.
NSMB formatting problems are usually structure-function package problems: a review-ready manuscript, a concise argument, structural validation support, and supporting files that reinforce one mechanistic story.
Nature Structural & Molecular Biology is quick to decide whether a manuscript has true structure-to-mechanism payoff, but the full acceptance path is much longer than the first editorial number suggests.
This Nutrients submission guide helps authors decide whether the manuscript is genuinely a nutrition paper and whether the package is ready for a fast editorial screen.
A practical Pharmacology & Therapeutics submission guide for authors deciding whether the journal is even an available target for their review idea.
A practical PLOS Biology submission guide for authors deciding whether the manuscript is broad enough, important enough, and complete enough for the journal's editorial screen.
PLOS Medicine cover letters work when they explain why the study belongs in a global clinical and public-health journal, not just in a local medical context.
PLOS Medicine formatting problems are usually package-stage problems: understanding the format-free initial submission, preparing the full submission later, and keeping abstract, cover letter, and reporting files aligned.
PLOS Medicine is a journal where the first useful timing question is whether the editors think the paper matters beyond one health system, not just how quickly reviewers reply.
A practical Protein & Cell submission guide for authors deciding whether the manuscript is broad enough, mechanistically strong enough, and complete enough for editorial screening.
This Renewable & Sustainable Energy Reviews submission guide helps authors decide whether the manuscript is really an RSER paper and whether the literature contribution is strong enough.
A practical Science Immunology submission guide for authors deciding whether the paper is broad enough, strong enough, and mechanistically sharp enough for this AAAS journal.
A Science Translational Medicine cover letter works when it proves the manuscript already bridges mechanism and human relevance in the main data.
Science Translational Medicine formatting is really translational-package discipline: title length, concise abstract, article limits, figure economy, and a submission stack that proves the human bridge is already in the data.
Science Translational Medicine is one of the clearest examples of a translational journal with a sharp desk filter. The journal can reject quickly, but the files that survive often enter a longer and more revision-heavy process.
Small is not a generic nanomaterials journal. This guide shows what the journal actually wants, what makes a paper feel incremental, and what to fix before you submit.
A practical Trends in Endocrinology & Metabolism submission guide for authors deciding whether the journal is the right editorial home for their review or opinion idea.
Trends in Molecular Medicine is a review and opinion journal, so the first timing question is whether the editor wants the thesis at all, not how fast reviewers answer.
Trends in Molecular Medicine is not a default outlet for standard primary research. This guide explains what to pitch, what article types actually work, and how to avoid mis-targeting the journal.
Water Research formatting problems are usually package-discipline problems: a concise abstract, clean title page, required highlights, sensible keywords, and a manuscript that looks broader than one local study.
Most manuscript improvement advice is too generic to act on. This guide maps improvement to the six dimensions editors actually use during triage, with named failure patterns and a one-pass fix protocol for each.
Thesify gives rubric-based feedback on argument structure and writing quality. Manusights evaluates whether the science is ready to submit: citations verified, figures analyzed, journal fit scored. They solve different problems at different stages, and the order you run them in matters.
Writefull fixes how your manuscript reads. Manusights evaluates whether the science is ready to submit. They solve different problems at different stages, and the order you run them in matters.
Most researchers do not need both services at the same time. They need the right one first. Here's how to tell whether your manuscript needs editing, scientific review, or a diagnostic step before either.
Pre-submission review and editing are often sold next to each other, but they are not the same purchase. Here's what each actually does, where each one earns its keep, and when to start with AI diagnosis instead.
Many buyers do not know how to judge a pre-submission review report before paying for one. This page shows what a useful report should contain, what weak reports look like, and how to tell whether the feedback is actionable.
ACS Catalysis editors are screening for mechanistic insight, not just strong catalytic performance data. A strong cover letter makes that depth obvious fast.
ACS Nano editors are screening for real nanoscale science, not just nanoscale ingredients. A strong cover letter makes that distinction obvious fast.
Advanced Materials editors are screening for broad materials consequence fast. A strong cover letter makes that flagship case without hype.
Angewandte Chemie requires broad appeal. Your cover letter must explain why a chemist outside your subfield would care about this paper, not just why specialists will.
Cell Reports editors are screening for genuine biological insight, not just competent execution. A strong cover letter makes that fit argument obvious fast.
ChemComm editors are screening for novelty and urgency in short-format chemistry. A strong cover letter makes the case for a rapid communication obvious fast.
Food Chemistry editors are screening for real food-chemistry relevance, not generic analytical competence. A strong cover letter makes that obvious fast.
IEEE Access evaluates technical correctness, not novelty or impact. A cover letter that argues for significance is written for a Transactions journal, not for this one.
JACS editors are screening for broad chemical consequence, not just good chemistry. A strong cover letter makes the flagship case without sounding inflated.
JAFC editors are screening for chemistry-first papers. A strong cover letter makes the molecular or analytical chemistry contribution obvious fast.
JCP often spends more time on papers that are technically serious but borderline on chemistry-physics integration. The useful submission question is fit.
JCP editors screen for a direct connection to cleaner production processes. A cover letter that frames the work as environmental science without a production angle gets desk-rejected fast.
JCO editors are screening for evidence that could change what oncologists do in clinic. A strong cover letter makes that practice consequence obvious fast.
Journal of Hazardous Materials editors are screening for hazard relevance and realism fast. A strong cover letter makes that obvious in the first paragraph.
Molecules editors are usually screening for scope clarity and submission completeness faster than for prestige claims. A strong cover letter respects that.
Neuron editors are screening for papers that connect across levels of neuroscience - from molecules to circuits to behavior. A strong cover letter makes that multi-level case fast.
NAR has a resubmission disclosure rule that trips up returning authors. If you previously submitted any version of this manuscript to NAR and it was rejected, you must disclose the prior manuscript number and explain what changed.
RSER editors screen first for article type and contribution to the literature. Your cover letter must explain what gap this review, analysis, or research article with a review element actually fills.
RSC Advances is broad chemistry, not chemistry-themed overflow. A strong cover letter explains the chemistry contribution, the importance of the work, and the journal fit plainly.
STOTEN editors apply an environmental relevance test at triage. Your cover letter must show that the findings matter for real environmental systems, not just report analytical results.
Sensors editors screen for sensor relevance and section fit before anything else. A cover letter that names the section and states a clear sensing result moves through triage fastest.
Small publishes micro and nanoscience where the small length scale drives the science. Your cover letter must prove the work is nano-driven, not just that it happens at the nanoscale.
Sustainability publishes across an enormous range of topics. A cover letter that names the right section and states a concrete sustainability finding is the fastest way through triage.
A workflow-first Nature Communications process page focused on what happens after upload, what early status changes mean, and where papers lose time.
Is Enago worth it for manuscript review? It depends on which Enago review tier you mean, what problem you are trying to solve, and whether you need broad support or a narrower submission-readiness answer.
Nature desk-rejects roughly 93% of submissions. The best pre-submission review for Nature tells you whether your paper passes the real editorial gate before the editors decide for you.
AJE's presubmission review is strongest when you need structure, consistency, and impact framing, not a hard scientific go or no-go call.
Enago's Lite and Full review tiers solve different problems. This page breaks down what changes when you move from AI-plus-human validation to the broader human-review workflow.
Reviewer3 is one of the more serious AI review products in this category, but it is still best used as first-pass triage rather than final submission judgment.
q.e.d is one of the more differentiated AI tools in this space because it focuses on claim structure and evidence logic, but its manuscript-rights language deserves close reading.
Paperpal is a strong AI writing and research-assistance product for researchers, but it is not a substitute for scientific go or no-go review before submission.
PaperReview.ai is one of the more interesting free AI review tools because it shows its workflow and limits clearly, but it is still a first-pass triage product.
Rigorous is interesting because it is explicit about being an ETH Zurich project exploring AI-supported review, but the terms make clear it is not formal peer review.
Trinka is a serious academic writing assistant with stronger compliance and confidentiality messaging than most grammar tools, but it is still not scientific review.
ScholarsReview is appealing as an all-in-one academic AI workflow, but the public site is thinner on pricing and policy detail than stronger competitors.
A practical Construction and Building Materials submission process guide covering the Elsevier Editorial Manager workflow, desk screening, review stages, and what to expect.
A practical Advanced Materials submission process guide covering the Wiley submission portal, editorial screening, review stages, and what to expect at each step.
A practical IJMS submission process guide covering the MDPI portal workflow, academic editor assignment, review stages, and what to expect at each step.
Reviewer3 reviews methodology in 10 minutes. Paperpal fixes grammar in real time. They solve completely different problems. Here is when to use each.
A practical Science of the Total Environment submission process guide covering the Elsevier Editorial Manager workflow, editorial screening, review stages, and what to expect.
Not sure what pre-submission review actually involves? Here is the step-by-step process from upload to revision, what you receive at each stage, and how long it takes.
A practical PLOS Medicine submission process guide covering the two-stage submission workflow, editorial screening, peer review stages, and what each decision means.
A practical Chemical Engineering Journal submission process guide covering the Elsevier Editorial Manager workflow, desk screening, review stages, and what to expect after upload.
Clinical trial manuscripts face the toughest editorial scrutiny in academic publishing. Here is what editors and reviewers check first, why CONSORT 2025 changes the requirements, and how to prepare before submission.
A practical JACC submission process guide focused on what happens after upload, what editors screen first, and what to tighten before submission.
A practical memo on why JACC desk-rejects papers and what authors need to make obvious before the first editorial read.
A practical guide to avoiding desk rejection at Brain by strengthening mechanistic depth, broad neurology relevance, and the first editorial read.
Sensors submission process. Practical guidance for Sensors, plus what authors should do next. See the full timeline from upload to decision.
A practical Developmental Cell submission process guide covering what happens after upload, what editors screen for first, and what to tighten before you submit.
Nucleic Acids Research submission process. Practical guidance for Nucleic Acids Research, plus what authors should do next. See the full timeline.
A practical memo on why Genes & Development desk-rejects manuscripts and what authors need to make obvious before the first editor finishes the abstract and opening figures.
A practical International Journal of Hydrogen Energy submission process guide covering editorial screening, reviewer routing, and what to fix.
A practical Journal of Materials Chemistry A submission process guide covering editorial screening, reviewer routing, and what to fix before upload.
A practical BMJ Open desk-rejection guide covering reporting discipline, study-design fit, and the common mistakes that stop papers before review.
A practical guide to the first-pass editorial screen at Nature Neuroscience and what needs to be true before you submit.
A practical memo on why Cell Systems desk-rejects papers and what authors need to make obvious before the first editor finishes the abstract and opening figures.
A practical memo on why Science Translational Medicine desk-rejects papers and what authors need to make obvious before the first editor finishes the abstract and opening figures.
A practical guide to what the RSC Advances submission process usually looks like, what editors judge early, and what slows a chemistry paper down.
A practical guide to what the Molecules submission process usually looks like, what editors judge early, and what slows a chemistry paper down.
A workflow-focused Remote Sensing submission process guide covering what happens after upload, what triage is testing, and where papers lose time.
A practical BMJ submission process guide: what the portal asks for, what editors decide first, and what authors should expect after upload.
A practical Gut submission process guide: how the portal works, what editors are deciding early, and what usually weakens a submission before review.
A practical Hepatology submission process guide: how the portal works, what editors are deciding early, and what usually weakens a liver-paper submission.
A practical guide to the Frontiers in Immunology submission process, including section routing, collaborative review, and common slowdowns.
A practical guide to the Frontiers in Microbiology submission process, including section routing, collaborative review, and common delays.
A practical JCO submission process guide covering what happens after upload, what editors screen first, and where papers lose momentum.
A practical European Heart Journal process guide covering what happens after upload, what editors test first, and where papers lose momentum.
A practical Food Chemistry submission process guide covering editorial screening, review routing, common delays, and what to tighten before upload.
A practical Cancer Research submission process guide covering what happens after upload, what editors test first, and where oncology papers usually lose momentum.
Genome Biology submission process guide covering editorial triage, reviewer assignment, timelines, and common causes of delay.
A practical guide to the Fuel submission process, including editorial screening, reviewer routing, common delays, and what to tighten before upload.
A practical Applied Energy submission process guide covering editorial screening, reviewer routing, and what to tighten before upload.
Blood submission process guide covering editorial triage, reviewer assignment, first-decision timing, and common causes of delay.
A practical Current Biology submission process guide covering what happens after upload, what editors test first, and where papers usually lose momentum.
A workflow-focused BMJ Open submission process guide covering what happens after upload, how open review changes the process, and where papers stall.
A workflow-focused Cell Reports submission process guide covering what happens after upload, what triage is testing, and where papers lose time.
A practical Carbohydrate Polymers submission process guide covering editorial screening, reviewer routing, and what to tighten.
EMBO Journal submission process guide covering editorial screening, reviewer assignment, first-decision timing, and common causes of delay.
A practical guide to the Chemical Society Reviews submission process, including editorial screening, proposal fit, common delays, and what to tighten.
A practical guide to the Energy submission process, including editorial screening, reviewer routing, common delays, and what to tighten before upload.
A workflow-focused IEEE Access submission process guide covering what happens after upload, how editors route papers, and where the process slows.
Journal of Cleaner Production submission process guide covering editorial screening, reviewer routing, common delays, and draft fixes.
q.e.d Science decomposes your paper into a claim tree and stress-tests the logical chain. Manusights verifies citations against 500M+ papers, analyzes figures, and scores journal-specific readiness. They catch different failure modes - and the ones Manusights catches cause more rejections.
A buyer's guide to pre-submission manuscript review services, with a cleaner split between scientific review, editing support, and AI-first tools.
A direct Manusights vs Reviewer3 comparison for researchers deciding which AI review tool to use before submission. The real split is fast triage versus final submission-readiness judgment.
The best alternative to Reviewer3 depends on the gap you're trying to close: deeper scientific judgment, citation verification, figure analysis, or just a free first pass.
AI catches structural problems fast and cheap. Human experts catch the scientific and strategic problems that actually cause rejection. The best approach uses both - Manusights provides both in one platform.
Most PhD students learn what reviewers want by getting rejected first. Pre-submission review compresses that learning curve from months to minutes - starting free.
Pre-submission review grant applications: check timeline risk, journal fit, and manuscript readiness before funding deadlines.
Pre-submission review career-critical papers: protect tenure, fellowship, and job-market timelines from avoidable rejection.
Trinka is a $7/month academic grammar checker owned by Enago's parent company. Manusights verifies citations against 500M+ papers, analyzes figures, and scores journal readiness - starting free. One fixes your writing. The other tells you whether your paper survives review.
For postdocs, one avoidable rejection cycle can cost a faculty search season, a fellowship deadline, or months of career momentum. Here is how to reduce that risk before you submit.
First high-impact submissions fail for recognizable reasons: wrong journal, weak significance framing, missing experiments, and citation gaps. Here is how to catch these before the editor does.
Enago is stronger as a broad publication-support vendor with a clearer multi-reviewer lane. Manusights is stronger as a lower-cost readiness diagnosis before submission.
Paperpal is a $25/month AI writing assistant for grammar and academic English. Manusights is a pre-submission review platform that verifies citations, analyzes figures, and scores journal readiness. They solve completely different problems.
AJE's $289 presubmission review adds margin comments about structure and consistency. Manusights' $29 diagnostic verifies citations against 500M+ papers, analyzes every figure, and scores journal-specific readiness. We researched both services to show you exactly what you get.
Editage is stronger for editing-led publication support. Manusights is stronger for diagnosing whether the manuscript is actually ready for the target journal.
Reviewer3 provides fast AI triage in under 10 minutes. q.e.d Science decomposes your paper into a claim tree and stress-tests the logic. Neither verifies citations, analyzes figures, or scores journal fit - for that, you need Manusights.
Rigorous AI Review is a free ETH Zurich research project that sends manuscripts to OpenAI for processing. Manusights is a production platform with SOC 2 Type II certification and Anthropic zero-retention. Here is what each delivers - and the privacy difference that matters.
ScholarsReview is an all-in-one AI academic assistant with peer review, literature review, journal finding, and grammar checking. Manusights is a focused pre-submission platform that verifies citations against 500M+ papers and scores journal-specific readiness. Breadth vs depth.
The useful way to compare AI pre-submission tools is not by hype but by job: triage, logic analysis, writing support, or workflow convenience.
PaperReview.ai is free but reads only 15 pages and is strongest in CS/ML. Manusights covers full manuscripts across all fields with citation verification and figure analysis.
Editage is strongest when you want a large publication-support vendor with editing, submission help, and a technical pre-submission review lane.
Journal of Chemical Physics submission process guide covering editorial screening, reviewer assignment, timelines, and common early weaknesses.
A practical Lancet Oncology submission process guide covering what happens after upload, what editors screen first, and where papers lose momentum.
Manusights and ManuscriptsReviewer both offer pre-submission peer review, but they differ in reviewer credentials, pricing model, and what the review actually covers. Here's the direct comparison.
AI peer review is genuinely useful. It's also genuinely limited in ways that matter for specific manuscripts. Here's the clear line between when AI feedback is sufficient and when you need a human scientist who's published at your target journal's tier.
Infectious disease publishing spans clinical journals, microbiology journals, and translational hybrid venues. Each has specific reviewer expectations. Here's how to prepare a manuscript that's positioned correctly for the journal you're targeting.
Editage is a legitimate service backed by Springer Nature. Whether it's worth the investment depends entirely on what's actually holding your manuscript back. Here's the honest breakdown.
The price range for pre-submission manuscript services is enormous - from free reciprocal peer review to $1,800 expert review. Here's exactly what each tier delivers and when it's worth the investment.
Reviewer3 is a real AI peer review service used by thousands of researchers. Whether it's worth paying for depends on what your manuscript actually needs. Here's the honest breakdown.
PLOS Medicine desk rejects roughly half of initial submissions within 2 weeks. Here is what editors actually screen for and how to avoid the most common triage failures.
Nature Chemical Biology desk rejects roughly half of all submissions. Here is what editors actually screen for and how to avoid the most common triage failures.
A practical memo on why Cell Host & Microbe desk-rejects papers and what authors need to make obvious before the first editor finishes the abstract and opening figures.
Practical guidance on how to avoid desk rejection at JAMA Cardiology, including what editors screen for first and where strong papers usually fail.
How to avoid desk rejection at Circulation Research: what editors want in mechanistic cardiovascular biology before peer review.
A practical memo on why Cell Discovery desk-rejects manuscripts and what authors need to make obvious before the first editor finishes the abstract and opening figures.
A practical memo on why Developmental Cell desk-rejects manuscripts and what authors need to make obvious before the first editor finishes the abstract and opening figures.
How to avoid desk rejection at Current Biology. Practical guidance for Current Biology, plus what authors should do next. See how to avoid it.
A practical memo on why Nature Cell Biology desk-rejects manuscripts and what authors need to make obvious before the first editor finishes the abstract and opening figures.
how to avoid desk rejection at BMC Medicine. Practical guidance for BMC Medicine, plus what authors should do next. See how to avoid it.
how to avoid desk rejection at JAMA Oncology. Practical guidance for JAMA Oncology, plus what authors should do next. See how to avoid it.
Avoid desk rejection at Cell Stem Cell by proving functional stem-cell claims, mechanistic depth, and field-level significance.
A practical memo on why Nature Structural & Molecular Biology desk-rejects manuscripts and what authors need to make obvious before the first editor finishes the abstract and opening figures.
How to avoid desk rejection at Lancet Infectious Diseases. Editorial screens, triggers, and what to fix before submission.
How to avoid desk rejection at Molecular Psychiatry. Practical guidance on editorial screens, common triggers, and what to fix before submission.
How to avoid desk rejection at Journal of Neuroscience. Practical guidance on what editors screen for before peer review. See how to avoid it.
Avoid desk rejection at Nature Methods: editorial filters, common trigger points, and what a methods paper must demonstrate to survive triage.
Avoid desk rejection at Nature Immunology with broader field consequence, stronger mechanism, and a decisive package.
Avoid desk rejection at Cancer Cell with broader consequence, translational weight, and a fully integrated package.
How to avoid desk rejection at Cell Metabolism. Practical guidance for Cell Metabolism, plus what authors should do next. See how to avoid it.
Avoid desk rejection at Nature Genetics with enough scale, stronger interpretation, and defensible population design.
Avoid desk rejection at Journal of Physical Chemistry C by showing mechanistic surface chemistry, experiment-theory integration, and clear fit.
How to avoid desk rejection at Molecular Cell: mechanistic completeness, multi-system validation, and causal clarity.
Avoid desk rejection at Journal of Materials Chemistry A with real energy performance, stability, and hard benchmarking.
Avoid desk rejection at Journal of Power Sources by showing full-system electrochemical performance, realistic cycling data, and practical viability.
How to avoid desk rejection at Materials by proving functional novelty, complete characterization, and realistic application validation.
Avoid desk rejection at Molecules by proving structural novelty, complete characterization, and biological claims backed by real controls.
How to avoid desk rejection at Nature Biotechnology: biotech-first framing, platform innovation, and therapeutic relevance.
How to avoid desk rejection at Nature Medicine: disease mechanism, human relevance, and clinical consequence.
Avoid desk rejection at Neuron by proving circuit-level mechanism, meaningful behavioral relevance, and complementary evidence.
Avoid desk rejection at Nucleic Acids Research by proving community utility, rigorous benchmarking, and reusable field value.
Avoid desk rejection at Nutrients by proving health relevance, stronger study design, and a credible biological nutrition story.
How to avoid desk rejection at Nature Reviews Cancer: commissioned-level synthesis, timing, and field authority.
How to avoid desk rejection at Nature Reviews Molecular Cell Biology: synthesis, timing, and author credibility.
Physical Review D editors look for theoretical rigor, clear physical interpretation, and real experimental relevance.
How to avoid desk rejection at RSC Advances: stronger novelty, complete characterization, and defensible mechanism.
How to avoid desk rejection at Remote Sensing: environmental context, real validation, and methods that transfer beyond one site.
How to avoid desk rejection at Science Advances: what editors screen first on breadth, rigor, and cross-disciplinary significance.
Small editors look for functional nanomaterials with real application evidence, strong benchmarking, and a credible structure-function story.
How to avoid desk rejection at Renewable and Sustainable Energy Reviews by proving complete coverage and analytical synthesis.
How to avoid desk rejection at Sensors by proving real-sample testing, full characterization, and practical performance outside the lab.
How to avoid desk rejection at Sustainability by proving systems thinking, solution pathways, and real implementation logic.
How to avoid desk rejection at Water Research: real-water validation, treatment relevance, and operational viability.
eLife uses a reviewed-preprint model, so desk rejection is about scientific fit, rigor, and readiness for open review rather than traditional journal.
Avoid desk rejection at Immunity with broad mechanistic significance, multi-level evidence, and cross-field relevance.
How to avoid desk rejection at IJBM: characterization depth, biological relevance, and structure-function novelty.
How to avoid desk rejection at Nano Letters by proving clear nanoscale novelty, mechanism, and application significance.
How to avoid desk rejection at MNRAS: observational rigor, computational validation, and astrophysical significance.
How to avoid desk rejection at Journal of Hazardous Materials: remediation relevance, real-matrix validation, and the editorial screen that matters.
How to avoid desk rejection at Applied Catalysis B: what editors screen for in environmental fit, catalyst proof, and realistic conditions.
What ACS Catalysis editors screen for before peer review, and the missing pieces that make a catalysis paper look premature.
What ACS Nano editors look for before peer review, and the gaps that make a nanomaterials paper feel impressive but still unready.
What Advanced Energy Materials editors screen for before peer review, and the missing evidence that makes an energy materials paper feel premature.
How to avoid desk rejection at Analytical Chemistry: method validation, benchmarking, matrix testing, and real analytical scope.
What Annals of Oncology editors screen for before peer review, and the missing pieces that make an oncology paper look promising but still too early.
How to avoid desk rejection at Applied Physics Letters: device relevance, physical insight, and letter-level proof.
How to avoid desk rejection at Applied Sciences: what editors screen for first, and how to frame an applied paper so it looks broader than a narrow.
Avoid desk rejection at Applied Surface Science with real surface logic, stronger characterization, and clearer scope fit.
How to avoid desk rejection at Bioinformatics by proving real biological utility, credible benchmarking, and usable computation.
How to avoid desk rejection at Blood: what editors screen first on hematology fit, mechanistic depth, and clinical relevance.
How to avoid desk rejection at Cancer Research: mechanism, oncology consequence, and stronger translational grounding.
How to avoid desk rejection at Cell Reports: mechanistic completeness, stronger controls, and Cell Press reporting discipline.
How to avoid desk rejection at Chemical Society Reviews: what editors expect in scope, synthesis, and author authority.
How to avoid desk rejection at Circulation: what editors screen for and how to make the clinical consequence obvious.
How to avoid desk rejection at Construction and Building Materials: what editors expect in construction relevance, durability evidence, and real.
How to avoid desk rejection at Diabetes Care: what ADA editors screen for first, and how to position a clinically relevant diabetes paper for review.
How to avoid desk rejection at Applied Energy: system relevance, techno-economic context, deployment realism, and data rigor.
Avoid desk rejection at Astronomy & Astrophysics with clearer inference, stronger uncertainty treatment, and field-level consequence.
How to avoid desk rejection at Clinical Infectious Diseases: what editors screen for and how to make the clinical consequence obvious.
Avoid desk rejection at Bioresource Technology with process realism, scale logic, and benchmarked conversion performance.
How to avoid desk rejection at Carbohydrate Polymers: what editors screen for in carbohydrate-based materials papers.
How to avoid desk rejection at Ceramics International: ceramic novelty, property validation, and application relevance that holds up.
How to avoid desk rejection at Clinical Cancer Research: translational depth, stronger models, and patient-facing logic.
How to avoid desk rejection at EMBO Journal: deeper mechanism, direct proof, and broader biological consequence.
How to avoid desk rejection at Environmental Science & Technology: what editors expect in environmental consequence and real-world relevance.
Avoid desk rejection at European Heart Journal with broad cardiology relevance, clinical consequence, and design strength.
How to avoid desk rejection at Food Chemistry: what editors expect in food relevance, method validation, and practical chemical insight.
How to avoid desk rejection at Chemical Communications: what editors expect in novelty, mechanistic support, and concise impact.
How to avoid desk rejection at Chemical Reviews: what invitation-led commissioning means and how to judge fit realistically.
How to avoid desk rejection at Energy: show system-level relevance, techno-economic support, and deployment realism before submission.
How to avoid desk rejection at Frontiers in Immunology: section fit, translational context, and reporting discipline.
How to avoid desk rejection at Frontiers in Microbiology: microbial function, biological consequence, and real-world validation.
Avoid desk rejection at Fuel with clear combustion relevance, stronger validation, and real fuel-use consequence.
How to avoid desk rejection at Genome Biology: what editors screen for and how to make the biological consequence obvious.
Avoid desk rejection at Frontiers in Plant Science with clear section fit, plant-science consequence, and review-ready framing.
How to avoid desk rejection at Gut: what editors screen first on translational GI relevance, mechanism, and clinical consequence.
How to avoid desk rejection at Hepatology: what editors screen for and how to make the liver-specific consequence obvious.
How to avoid desk rejection at International Journal of Hydrogen Energy: energy relevance, benchmarking, and durability.
How to avoid desk rejection at Journal of Applied Physics: the measurement depth, physical insight, and theory link editors expect.
How to avoid desk rejection at Journal of Agricultural and Food Chemistry: food relevance, method validation, and real application fit.
Avoid desk rejection at Journal of Alloys and Compounds with stronger functional proof, complete characterization, and real application fit.
How to avoid desk rejection at Journal of Biological Chemistry: mechanistic depth, kinetic proof, structural evidence, and JBC's editorial bar.
How to avoid desk rejection at Journal of Clinical Oncology: practice-changing evidence, definitive methods, and clinical consequence.
How to avoid desk rejection at Journal of Chemical Physics: computational rigor, validation, and the chemical insight editors expect before review.
How to avoid desk rejection at Journal of Immunology: mechanistic novelty, functional validation, and the editorial bar AAI applies before review.
Avoid desk rejection at JCIS with real interface science, complete characterization, and clear phase-boundary relevance.
Submitting to IEEE Access? Learn what triggers desk rejections, how editors evaluate scope fit, and how to position papers to pass initial screening.
IJMS is broad, but not careless. The fast rejection usually hits papers that say 'molecular' in the title while offering only thin mechanism, weak validation, or routine assay packages.
How to avoid desk rejection at Lancet: global clinical relevance, study authority, and broad medical consequence.
How to avoid desk rejection at JCI: human relevance, mechanistic depth, disease fit, and translational strength.
How to avoid desk rejection at Nature Communications by proving real advance, stronger completeness, and broader field consequence.
How to avoid desk rejection at PLOS ONE: sound methods, transparent reporting, ethics, and a reviewable paper.
How to avoid desk rejection at Science: breadth, consequence, completeness, and top-journal review fit.
How to avoid desk rejection at Advanced Functional Materials: stronger function, mechanism, and device-level proof.
How to avoid desk rejection at Cell: breadth, mechanism, evidence depth, and editorial fit before review.
How to avoid desk rejection at Nature: breadth, conceptual force, claim discipline, and cross-field consequence.
Research Square is a preprint server, not a pre-submission review service. If you need manuscript feedback before going public, here are the alternatives that actually review your science.
How to avoid desk rejection at PNAS: scientific significance, breadth, completeness, and a significance statement that works.
Physical Review Letters desk-rejects papers that are good physics but do not yet look like genuinely significant Letters for a broad physics audience.
Chemical Engineering Journal desk rejects papers that look scientifically sound but still read like materials or chemistry papers instead of chemical engineering papers.
At STOTEN, the fast rejection usually isn't about grammar or formatting. It's about whether your paper teaches anything beyond a local monitoring exercise.
At Advanced Materials, good data isn't the standard. That's the entry fee. The real question is whether the paper feels field-shifting enough to deserve reviewer time.
PRB isn't a home for any competent condensed matter paper. Editors reject quickly when the manuscript is really materials characterization, routine DFT, or device work with a thin physics wrapper.
Avoid desk rejection at ACS Applied Materials & Interfaces with applied proof, strong benchmarking, and complete characterization.
How to avoid desk rejection at Journal of Cleaner Production: system fit, quantified trade-offs, and decision-useful sustainability evidence.
Avoid desk rejection at Astrophysical Journal with clean journal fit, honest uncertainty treatment, and complete astrophysical inference.
Avoid desk rejection at Lancet Oncology with practice-changing evidence, global relevance, and defensible trial design.
Systematic reviews and meta-analyses face unique rejection triggers that differ from original research. Here is what editors check first, what PRISMA 2020 requires, and how to prepare.
AJE is still a credible editing service, but many researchers looking for alternatives do not actually need another editor. They need a better pre-submission decision tool.
AuthorONE gives you modular technical reports. If you want a unified readiness answer instead, the best alternative depends on whether formatting or science is the real risk.
Grammarly is useful, but most researchers outgrow it when the problem shifts from grammar to discipline-specific language, citation hygiene, and submission risk.
Paperpal is useful when you want one recurring writing assistant for academic work. It becomes less convincing when your main question is scientific readiness, not wording.
Penelope.ai checks journal formatting requirements. If that is your problem, the alternatives are other compliance tools. If the problem is deeper, you need a different category.
Research Square is useful when you want visibility and In Review workflow support. The best alternative depends on whether you want public exposure or private pre-submission judgment.
Trinka is the cheapest academic grammar tool at $7/month. The best alternative depends on whether you need better writing help or a completely different category of manuscript support.
Writefull is trained on published papers and has the best Overleaf integration. The best alternative depends on whether you need a different writing tool or a different kind of manuscript help.
Conflicting reviewer comments are not a special failure state. They are a normal part of peer review, and what matters is whether you can show the editor that you saw the conflict and made a defensible tradeoff.
How to avoid desk rejection at Scientific Reports: fix scope, reporting, ethics, and submission-readiness problems before upload.
A revision-extension request is not a confession of weakness. It is a communication problem. If you ask early, explain the real constraint, and propose a credible date, editors usually read it differently from a last-minute scramble.
A good reviewer-response document is not polite theater. It is a technical argument map that makes it easy for the editor and reviewers to see that you understood the critique and acted proportionately.
A rebuttal letter is not where you vent, grandstand, or try to outwrite the reviewers. It is where you make the editor's next decision easier.
AuthorONE is worth it if you need automated journal-template formatting and reference management. It's not worth it if you think you're buying a pre-submission review.
Editage is one of the largest academic services companies. Its editing is reliable. Its $289 pre-submission review provides structural comments but no citation verification or figure analysis. Worth it for language, but not for scientific readiness.
Enago is attractive because the service menu is unusually transparent. This support page focuses on when that broader workflow is actually worth paying for.
Grammarly is useful for cleanup, tone, and sentence-level polish. It is not a serious substitute for manuscript review, journal-fit judgment, or field-specific scientific critique.
Paperpal is one of the better academic writing assistants on the market. It is not a pre-submission review tool, and it should not be asked to do that job.
Penelope.ai checks whether manuscripts meet journal formatting requirements. It is strong for compliance. It does not evaluate whether the science is good enough.
Research Square is a preprint platform with Springer Nature journal partnerships, not a manuscript review service. It offers visibility and DOIs. It does not tell you if your paper is ready.
Trinka is the cheapest dedicated academic writing tool at $7/month with strong medical and technical English support. It is not a scientific review product.
Writefull is trained on published research papers, not generic prose. That makes it one of the more credible academic writing tools. It is still a writing assistant, not a manuscript review.
Peer review feels opaque because journals show you status labels, not the actual decision logic beneath them. This guide makes the process legible from submission through revision and acceptance.
Peer review in 2026 is not broken in one single way. It is being pulled in several directions at once: toward transparency, toward automation, toward stronger integrity screening, and toward new pressure around reviewer labor. The result is a system that is still recognizable, but no longer static.
Most researchers do not know what a serious pre-submission review report should contain until they have already paid for one. Here are the six core components, what a strong deliverable looks like, and how to tell a real working report from a shallow one.
Finding a pre-submission reviewer sounds simple until you try. Your closest colleagues have conflicts. Your lab mates are too polite. And not everyone who reads manuscripts can give you the feedback that actually prevents desk rejection.
A Pangram Labs study found 21% of ICLR reviews were fully AI-generated: not AI-assisted, fully written by an LLM. In 2026, the structural incentives driving this are stronger, not weaker. Here's the problem and what researchers can do about it.
Major revision doesn't mean your paper is in trouble. Minor revision doesn't mean you're home free. Here's what each decision actually signals.
A workflow-focused Science Advances submission process guide covering what happens after upload, what triage is testing, and where papers lose time.
What 'Reviewer Invited', 'Under Review', 'Reviews Complete', and 'Decision Pending' actually mean for your Scientific Reports manuscript, and what each transition signals about your paper.
If your Nature Neuroscience submission shows Under Consideration, here is what each status means, the timeline, and what passing the desk signals.
What Under Review, Awaiting Decision, and every other JAMA status means, plus what the independent statistical reviewer is actually evaluating when your paper is in review.
If your Circulation submission shows Under Review, here is what each status means, what the statistical review involves, and when to expect decisions.
If your Nature Medicine submission shows Under Consideration, here is what each status means, how long each stage typically takes, and when a follow-up is reasonable.
What Awaiting PRM Assignment, Under Review, and every other BMJ status means, including what the independent statistical reviewer is evaluating when your paper is in review.
If your Nature submission shows Under Consideration, here is what each status means, how long each stage typically takes, and when to follow up.
If your PLOS ONE submission shows Under Review or another editorial status, here is what each stage means, how long it typically takes, and when to contact the editorial office.
If your Angewandte Chemie manuscript is under review, here is what each status means, the typical 2-4 week timeline for Communications, and when to follow up.
If your JACS manuscript is under review, here is what each status means, the typical 4-8 week timeline, and how the ACS transfer system works if the paper is declined.
If your Nature Biotechnology submission shows Under Consideration, here is what each status means, the typical timeline, and what passing the desk screen signals about your paper.
If your Advanced Materials submission is under review, here is what each status means, the typical 4-8 week timeline, and how the Wiley transfer to sister journals works.
If your Nature Genetics submission shows Under Consideration, here is what each status means, the typical timeline, and what it signals about your paper.
What 'With Divisional Editor', 'Under Review', 'Decision Pending', and every other APS status code means for your Physical Review Letters submission.
PNAS 'Under Review' means your paper is with reviewers. Desk decisions take ~14 days, full review 30-45 days. Here's what each PNAS status means.
BMJ Open 'Under Review' means your paper is with peer reviewers. First decisions take 8-16 weeks. Status meanings and when to follow up.
Science Advances shows 'Under Evaluation' not 'Under Review.' What it means, how long each phase lasts, and when to follow up.
If your Cancer Cell submission shows Under Review, here's what's happening behind the scenes, how long each stage takes, and what to expect next.
Pre-submission guide for JCO covering the guideline-changing evidence bar, Phase 3 requirements, clinical impact, and ASCO editorial fit.
Nature Communications (15.7) and a ~$7,350 APC. This guide covers editorial expectations, the Nature cascade system, and when Nat Comms is the right target.
If your Nature Biotechnology submission shows Under Consideration, here's what's happening, how long each stage takes, and what outcomes to expect.
If your Nature Medicine submission shows Under Consideration, here's what each status label means, how long each stage typically takes, and when it's appropriate to follow up.
If your Nature Methods submission shows Under Consideration, here's what each status means, typical timelines, and what to expect at each stage.
After rejection from ACS Applied Materials & Interfaces, the best alternative journals include Journal of Materials Chemistry A/B/C, Applied Surface Science, and ACS Applied Nano Materials, depending on your materials system and application area.
After rejection from Advanced Functional Materials, consider ACS Nano for nanomaterials, Small within the Wiley family, ACS Applied Materials & Interfaces for applied work, or Chemistry of Materials for fundamental studies.
After rejection from Advanced Materials, your best next journals include Advanced Functional Materials, ACS Nano, Advanced Energy Materials, and Chemistry of Materials, depending on your subfield and rejection reason.
After rejection from Angewandte Chemie, JACS is the most natural lateral move. Chemical Science, Chemistry A European Journal, and subdiscipline-specific journals like ACS Nano or JOC are also strong alternatives.
After rejection from Blood, the best alternative journals include Leukemia for malignant hematology, Haematologica for European research, Blood Advances as the ASH companion, and JCO for clinical hematology-oncology.
After rejection from BMJ Open, consider PLOS ONE for methodologically sound work, BMC Public Health for epidemiology, JMIR for digital health, or BMC Medicine if your paper is stronger than you think.
Paper rejected from The BMJ? 7 alternative journals ranked by fit, with IF, acceptance rates, and scope comparison. Your best next steps.
Paper rejected from Cancer Cell? 7 alternative journals ranked by fit, with IF, acceptance rates, and scope comparison. Your best next steps.
Paper rejected from Cell Metabolism? 7 alternative journals ranked by fit, with IF, acceptance rates, and scope comparison. Your best next steps.
Paper rejected from Cell Reports? 7 alternative journals ranked by fit, with IF, acceptance rates, and scope comparison. Your best next steps.
Paper rejected from Cell? 7 alternative journals ranked by fit, with IF, acceptance rates, and scope comparison. Your best next steps.
After rejection from Chemical Engineering Journal, the best alternatives include Journal of Hazardous Materials and Water Research for environmental work, Applied Catalysis B for catalysis, and Separation and Purification Technology for separation science.
After rejection from Chemical Reviews, the strongest alternatives are Chemical Society Reviews for broad chemistry, Coordination Chemistry Reviews for inorganic work, and Accounts of Chemical Research for shorter personal accounts.
Paper rejected from Circulation? 7 alternative journals ranked by fit, with IF, acceptance rates, and scope comparison. Your best next steps.
After rejection from eLife, consider PLOS Biology for open-access biology, EMBO Journal for molecular and cell biology, Nature Communications for broad scope, or PNAS for cross-disciplinary work.
After rejection from European Heart Journal, consider Circulation or JACC as direct competitors, EHJ sister journals for subspecialty work, or Heart and JAHA for solid mid-tier cardiovascular research.
After rejection from Frontiers in Immunology, strong alternatives include Journal of Immunology for core immunology, Clinical Immunology for clinical work, and International Journal of Molecular Sciences for broader molecular studies.
After rejection from Gastroenterology, consider Gut for translational GI research, American Journal of Gastroenterology for clinical work, or Clinical Gastroenterology and Hepatology as the AGA companion cascade.
Paper rejected from Gut? 7 alternative journals ranked by fit, with IF, acceptance rates, and scope comparison. Your best next steps.
After rejection from Hepatology, Journal of Hepatology is the direct European counterpart with a higher IF. Gastroenterology and Gut cover GI-liver overlap, and Hepatology Communications provides a natural AASLD cascade.
Paper rejected from Immunity? 7 alternative journals ranked by fit, with IF, acceptance rates, and scope comparison. Your best next steps.
Rejected from IJMS? Explore 6 strong alternative journals ranked by scope fit, impact factor, and acceptance rate to find the best home for your molecular sciences paper.
Rejected from JACS? Here are 7 alternative chemistry journals ranked by scope, impact factor, and acceptance rate, from Angewandte Chemie to Chemical Science.
Rejected from JAMA Oncology? Discover 7 alternative oncology journals, from JCO and Annals of Oncology to JAMA Network Open, ranked by fit for your study type.
Paper rejected from JAMA? 7 alternative journals ranked by fit, with IF, acceptance rates, and scope comparison. Your best next steps.
Paper rejected from JCI? 7 alternative journals ranked by fit, with IF, acceptance rates, and scope comparison. Your best next steps.
Rejected from Journal of Cleaner Production? 7 alternative sustainability journals ranked by scope, from Resources Conservation and Recycling to ES&T.
Rejected from JCO? 7 alternative clinical oncology journals ranked by fit, including Annals of Oncology, JAMA Oncology, and Clinical Cancer Research.
Rejected from The Lancet Oncology? 7 top alternative journals including JCO, Annals of Oncology, and Nature Medicine, ranked by scope and study type.
Paper rejected from The Lancet? 7 alternative journals ranked by fit, with IF, acceptance rates, and scope comparison. Your best next steps.
Paper rejected from Molecular Cell? 7 alternative journals ranked by fit, with IF, acceptance rates, and scope comparison. Your best next steps.
Paper rejected from Nature Biotechnology? 7 alternative journals ranked by fit, with IF, acceptance rates, and scope comparison. Your best next steps.
Paper rejected from Nature Communications? 7 alternative journals ranked by fit, with IF, acceptance rates, and scope comparison.
Paper rejected from Nature Genetics? 7 alternative journals ranked by fit, with IF, acceptance rates, and scope comparison. Your best next steps.
Paper rejected from Nature Immunology? 7 alternative journals ranked by fit, with IF, acceptance rates, and scope comparison. Your best next steps.
Paper rejected from Nature Medicine? 7 alternative journals ranked by fit, with IF, acceptance rates, and scope comparison. Your best next steps.
Paper rejected from Nature Methods? 7 alternative journals ranked by fit, with IF, acceptance rates, and scope comparison. Your best next steps.
Paper rejected from Nature? 7 alternative journals ranked by fit, with IF, acceptance rates, and scope comparison. Your best next steps.
Paper rejected from NEJM? 7 alternative journals ranked by fit, with IF, acceptance rates, and scope comparison. Your best next steps.
Paper rejected from Neuron? 7 alternative journals ranked by fit, with IF, acceptance rates, and scope comparison. Your best next steps.
Rejected from Nucleic Acids Research? 7 alternative journals for genomics, RNA biology, and bioinformatics papers, from Genome Biology to Bioinformatics.
Rejected from Physical Review B? 6 alternative condensed matter and materials physics journals, from JPCM to Physical Review Materials and PRR.
Rejected from Physical Review Letters? 7 alternative physics journals ranked by subfield, from Physical Review X and Nature Physics to PRB and PRD.
Paper rejected from PLOS ONE? 7 alternative journals ranked by fit, with acceptance rates and scope. Your best next steps.
Paper rejected from PNAS? 7 alternative journals ranked by fit, with IF, acceptance rates, and scope comparison. Your best next steps.
Paper rejected from Science Advances? 7 alternative journals ranked by fit, with IF, acceptance rates, and scope comparison. Your best next steps.
Rejected from STOTEN? 7 alternative environmental science journals including Environmental Pollution, Chemosphere, and ES&T, ranked by scope and study type.
Paper rejected from Science? 7 alternative journals ranked by fit, with IF, acceptance rates, and scope comparison. Your best next steps.
Rejected from Scientific Reports? 7 alternative broad-scope journals including PLOS ONE, PeerJ, and BMC-series titles, with advice on fixing common issues first.
If your Science submission shows Under Review, you've already beaten tough odds. Here's what's actually happening at each stage and how long to expect.
If your Lancet submission is under review, the real question is what the timing now signals and what you should do while the manuscript is in external review.
Nature Biotechnology (IF 41.7) publishes platform technologies that change what entire fields can do. Here's the editorial test, what gets desk-rejected in 4 days, and when Nature Methods or Nature is the better target.
A practical fit verdict for authors deciding whether their disease-mechanism manuscript is realistically strong enough for Journal of Clinical Investigation.
A practical Nature Medicine fit verdict for authors deciding whether the manuscript is translationally strong, clinically meaningful, and mature enough.
PNAS is prestigious and genuinely selective, but the two-track submission system and the Significance Statement format create specific opportunities and traps. Here's what actually matters for your submission decision.
If your NEJM submission is under review, the immediate question is not prestige. It is what the clock now means and what you should do while the decision is pending.
Cell is one of the hardest journals to publish in. If your paper shows Under Review, here's what's actually happening and how long each stage takes.
CA has the highest IF of any journal in the world, driven by the annual cancer statistics report. It is a solicited review journal. Unsolicited original research is not accepted.
Kidney International Supplements operates on a supplement model, not a standard open-submission research journal. Before submitting, understand how the KDIGO process and ISN-organized issues work.
There are five tools that offer free manuscript review. They do very different things. This page explains what each one actually catches, where each one stops, and how to decide whether free is enough before you submit.
Most manuscript quality checks focus on grammar and formatting. Editors triage on six different dimensions: journal fit, claim calibration, methods completeness, figure quality, citation integrity, and reporting compliance. Here is how to self-assess each one before you submit.
Thesify is a well-built academic writing tool for students and graduate researchers. It handles argument structure, rubric-based feedback, and literature search. For journal-submission readiness at selective journals, it has real gaps.
Peer reviewers don't read your manuscript cover to cover. They form a provisional accept-or-reject judgment in the first 10 minutes, and the rest of the review largely confirms that initial read. The sequence differs by journal tier, and understanding it changes how you should structure your manuscript.
Peer review criteria aren't the same across journals. At Nature and Cell, reviewers are gatekeeping significance. At PLOS ONE, they're checking soundness only. Here's what your target journal's reviewers are actually evaluating.
BMJ Open is not mainly a speed journal. The useful submission question is whether the open-review, broad-medicine model fits your paper better than a tighter specialty venue.
Frontiers in Immunology is not just a standard wait-for-decision journal. The useful submission question is whether the interactive review model and open-access tradeoff fit your goals.
IJHE is often faster at filtering weak hydrogen-fit papers than at giving a final answer on borderline submissions. The useful submission question is fit.
Chemical Reviews does not accept unsolicited primary research. Here is what the invitation model means, who gets invited, and where your chemistry research paper actually belongs.
Chemical Society Reviews does not accept unsolicited primary research. Here is what the review-proposal model means, who gets invited, and where your chemistry research paper belongs.
Nature Reviews Drug Discovery does not accept unsolicited primary research. Here is what the commissioned model means and where drug discovery research papers actually belong.
Nature Reviews Microbiology does not accept unsolicited primary research. Here is what the commissioned model means and where microbiology research papers actually belong.
JCO usually tells authors relatively quickly whether a paper belongs in flagship clinical oncology, but the real submission question is practice-changing consequence, not just speed.
Nature Genetics often tells authors relatively quickly whether a paper belongs in flagship genetics, but the real submission question is field-level genetic consequence, not just speed.
Nature Immunology often tells authors relatively quickly whether the paper belongs in flagship immunology review, but the real submission question is mechanistic depth, not just speed.
A practical guide to the ACS Applied Materials and Interfaces submission process, covering editorial screening, reviewer routing, and common slowdowns.
How to submit to Diabetes Care, what the portal asks for, what slows papers down, and what editors usually notice before review starts.
How to submit to Bioresource Technology, what Elsevier's workflow asks for, and what editors usually screen before the paper reaches review.
Nature Medicine desk-rejects 70-80% of submissions. The gate is not scientific rigor - it is translational importance. Here is how to test whether your paper clears it before the editor decides.
Biotech and pharma teams lose months not because the data are weak, but because the first submission overstates translational consequence or targets the wrong journal. Here is how to prevent both.
A practical PNAS submission process guide covering what happens after upload, how editorial triage works, and what to expect before first decision.
Aging Cell submission guide covering scope, aging-specific fit, reviewer expectations, and the mistakes that weaken a submission.
Cell Reports publishes high-quality cell biology with meaningful selectivity. Here is what editors actually look for at desk review and in peer evaluation, and where the common traps are.
Progress in Materials Science does not accept unsolicited primary research. Here is what the invitation model means for materials researchers and where to submit primary research instead.
Molecular Systems Biology is highly selective and wants quantitative models integrated with experimental validation. Single-gene studies and pure computation consistently fail at desk review.
Journal of Hematology and Oncology publishes roughly 1,000 papers per year at IF 40.4. Here is what editors actually screen for, what gets desk-rejected, and how to assess your manuscript's fit.
Nature Reviews Nephrology does not accept unsolicited primary research. Here is what the invitation model means for nephrology researchers and where primary research papers belong.
Nature Reviews Molecular Cell Biology does not accept unsolicited primary research. Here is what the commissioned model means for cell biologists and where primary research papers belong.
A practical The Lancet fit verdict for authors deciding whether their paper is globally important enough, broad enough, and mature enough for the journal.
Construction and Building Materials acceptance rate is ~30-35%. Desk rejection is ~35-40%. The key filter is construction application relevance.
A practical IJMS fit verdict for authors deciding whether the paper has a real molecular-science contribution, complete evidence, and a reason to want.
BMJ accepts about 7% of submissions. Here's what the number means, where the real filter sits, and when BMJ is a better fit than JAMA or The Lancet.
Journal of the American Chemical Society (JIF 15.6) vs Nature (JIF 48.5). Both elite. JACS is chemistry-specific. Nature is multidisciplinary.
Lancet Oncology accepts roughly 8-10% of submissions. 70-80% desk-rejected. What the numbers mean for clinical oncology authors.
Selective OA vs soundness-only megajournal. NComms (~8% accepted) vs Scientific Reports (~57% accepted). How to pick the right tier.
eLife editors are screening for papers worth sending into public review, not for prestige theater. A strong cover letter makes the question and evidence quality obvious fast.
ACS Catalysis demands mechanistic depth beyond activity data. Understand the editorial bar, IF 13.1, 20-25% acceptance rate, and how it compares to Journal of Catalysis.
PLOS ONE charges $1,695 for gold open access. Full waivers for low-income countries, institutional All-In deals eliminate fees.
Scientific Reports formatting guide. Word limits, figure specs, reference format, LaTeX vs Word, and journal-specific formatting quirks you need to know.
The BMJ is for oncology papers with broad clinical, policy, or systems consequences. JAMA Oncology is for top-tier oncology work whose real audience is still cancer medicine.
European Heart Journal is stronger for broad cardiovascular papers. Blood is stronger for hematology papers with real field-wide consequence across blood biology and disorders.
European Heart Journal is the better first target for broad cardiovascular papers. BMJ Open is stronger for sound, publishable work that values methodological credibility over flagship selectivity.
European Heart Journal is for top-tier cardiovascular papers. Journal of Clinical Oncology is for broad clinical-oncology papers with strong field-level consequence.
European Heart Journal is for top-tier cardiovascular papers. Lancet Oncology is for practice-changing oncology work with global relevance.
JAMA is for liver papers with broad clinical or policy consequence across medicine. Hepatology is for top-tier liver papers whose deepest value still belongs inside the field.
The Lancet is for rare hematology papers that become broad clinical events. Blood is for major hematology papers whose real audience is still the hematology field.
The Lancet is for infectious-disease papers that become broad clinical or global-health events. CID is for strong clinician-facing ID papers that still belong primarily to infectious disease.
The Lancet is for rare diabetes papers that become broad clinical events. Diabetes Care is for strong clinical diabetes papers with direct management and outcomes relevance.
The Lancet is for GI papers that become broad medical or global-health events. Gut is for top-tier gastroenterology papers with strong translational or clinical consequence.
The Lancet is for oncology papers that become broad medical events. JAMA Oncology is for high-rigor oncology papers with strong clinical or population-level cancer consequence.
The Lancet is for oncology papers that become broad medical events. The Lancet Oncology is for major oncology papers that belong with oncology readers from the start.
This isn't really a prestige contest. It's a fit contest. NEJM is for cardiovascular papers that change practice across medicine. European Heart Journal is for top-tier cardiology papers that speak directly to the field.
A practical JACS submission process guide covering the ACS Paragon Plus workflow, editorial triage, review stages, and what to expect after uploading your manuscript.
A workflow-focused eLife submission process guide covering what happens after submission, how public review works, and the key stages.
A practical Circulation submission process guide covering the AHA portal workflow, format-free initial submission, the Clinical Perspective box, and what to expect at each review stage.
A practical Brain submission guide for authors deciding whether the paper is mechanistic enough, clinically relevant enough, and mature enough for this neurology journal.
Sustainability submission process. Practical guidance for Sustainability, plus what authors should do next. See the full timeline from upload.
A practical Nature Methods submission guide for authors deciding whether the method is broad, validated, and editor-ready enough before submission.
A practical Journal of Clinical Investigation submission guide focused on translational fit, disease-mechanism strength, and what must already be obvious before you submit.
A package-readiness guide to JAMA Oncology covering Key Points, structured abstract discipline, endpoint logic, and what must be stable before submission.
A practical Journal of Neuroscience submission guide focused on package readiness, broad-neuroscience framing, and what should already be true before upload.
Applied Energy accepts system-level energy research only. Component-level studies get desk-rejected. How to frame your paper and what editors screen.
Bioinformatics submission guide covering computational fit, biological value, submission setup, and what editors screen before review.
A practical Water Research submission guide for authors deciding whether the manuscript is broad enough, rigorous enough, and complete enough for editorial review.
Chemical Reviews submission guide covering invitations, proposal positioning, scope, and how editors evaluate review submissions.
How Chemical Society Reviews submissions work: unsolicited reviews, editorial fit, scope expectations, and what makes a strong chemistry review.
Practical Energy submission guide: what the journal publishes, what editors screen for, and how to prepare a stronger systems-focused energy.
Practical Food Chemistry submission guide: what the journal publishes, what editors screen for, and how to prepare a stronger food-science submission.
Practical Diabetes Care submission guide: what the journal publishes, what editors screen for, and how to frame a clinically useful diabetes paper.
A package-readiness guide to Cell Reports: choose the right format, shape the story, stabilize STAR Methods, and avoid desk rejection.
A package-readiness guide to IEEE Access covering article type, validation strength, reproducibility, and what must be stable before submission.
ACS Applied Materials & Interfaces submission guide with manuscript limits, formatting rules, cover letter tips.
How to submit to Physical Review B in 2026. Scope, article types, reviewer expectations, formatting mistakes, and the final checks that save time.
A practical Nature Medicine submission guide for authors deciding whether the manuscript is translationally strong enough, clinically relevant enough, and complete enough for the journal.
A practical NEJM submission guide for authors deciding whether the manuscript has the clinical consequence, breadth, and package quality NEJM expects.
A practical Cell submission guide for authors deciding whether the manuscript has the mechanistic depth, breadth, and package quality Cell expects.
JAMA impact factor is 55.7 (JCR 2024), CiteScore 30.8, SJR 5.352. Five-year JIF 64.7, Q1, rank 3/332.
Nature Communications impact factor is 15.7. Five-year JIF is 17.2. Quartile: Q1. Category rank: 10/135.
Physical Review Letters doesn't publish an official acceptance rate, but estimates put it around 25-30% of papers that survive initial screening. Here's what that means and how PRL's selectivity actually works.
Sustainability accepts around 35-45% of submissions - accessible but not a rubber stamp. Here's what the review process looks like and what editors actually screen for.
Physical Review Letters has strict formatting rules and a high desk rejection rate. Here's everything you need to know about submitting to PRL.
Developmental Cell fit verdict: IF 8.7, Cell Press. Here is when it fits and when Development or Nature Cell Biology is the smarter move.
A practical Nature Cell Biology fit verdict for authors deciding whether their paper is mechanistic, conceptually strong, and broad enough.
Applied Catalysis B fit verdict with key metrics, comparison to ACS Catalysis and Journal of Catalysis, and practical guidance for environmental and energy catalysis authors.
Frontiers in Plant Science is a high-volume OA plant biology journal with IF 4.8. Here's when it fits, the Frontiers perception issue, and how it compares to Plant Cell, New Phytologist, and Plant Physiology.
A practical Scientific Reports submission process guide covering what happens after upload, what editors look at first, and what to fix before submission.
Advanced Energy Materials (IF 26.0, Wiley, Q1) publishes energy materials where the energy consequence is central. Here is who should submit and how it compares to Joule, EES, and ACS Energy Letters.
Frontiers in Microbiology is a broad OA microbiology journal with IF 4.5. Here's when it fits, the Frontiers perception issue, and how it compares to mBio, AEM, and ISME Journal.
Immunity (JIF 26.3, Cell Press) uses academic editors who are working immunologists. This guide covers how that model differs from Nature Immunology, the Cell Press transfer system, and when Immunity is the right target.
Applied Energy (IF 11.0, CiteScore 19.0) is the mid-tier workhorse of energy research. This guide covers its scope, how it compares to Energy, Renewable Energy, and Joule, and when it is the right target.
Genome Biology is the BMC flagship for genomics and computational biology with IF 9.4. Here's when your paper fits, what editors want, and how it compares to Nature Genetics, Nucleic Acids Research, and Bioinformatics.
Applied Physics Letters (IF 3.7, AIP) is the standard physics communication journal for concise results. Here is who should submit and how it compares to PRL, Nano Letters, and Optics Express.
Bioinformatics fit verdict with key metrics, comparison to Nature Methods and Genome Biology, and practical guidance for computational biology tool and method authors.
Blood (IF 23.1) is hematology's flagship journal with $0 APC. This guide covers its community model, editorial pathways for thrombosis through malignancy, and how it compares to Nature Medicine, Leukemia, and Haematologica.
EMBO Journal fit verdict: IF 8.3, EMBO Press. Transparent peer review, double-blind option. Here is when it fits and when Molecular Cell or Cell Reports is smarter.
Bioresource Technology (IF 9.0, Elsevier) is a top-tier journal for biomass conversion, bioenergy, and bioprocessing. Here's who fits and who doesn't.
Ceramics International (IF 5.6, Elsevier) is the leading broad-scope ceramics journal. Here's how it compares to J. European Ceramic Society, J. American Ceramic Society, and Acta Materialia.
Chemical Communications fit verdict with key metrics, comparison to JACS and Angewandte, and practical guidance for concise chemistry results.
The Astrophysical Journal (IF 5.4, AAS/IOP) is the flagship US astronomy journal, running since 1895. Here's how it compares to MNRAS, A&A, and Nature Astronomy.
Chemical Reviews fit verdict with key metrics, comparison to Chemical Society Reviews and Nature Reviews Chemistry, and practical guidance for review authors.
J. Alloys Compd. (IF 6.3) is Elsevier's high-volume venue for alloy and intermetallic research. Here's when your paper fits, what editors expect, and how it compares to Acta Materialia, Scripta Materialia, and J. Materials Science.
Molecules (IF 4.2, MDPI) is a high-volume OA chemistry journal. Honest comparison with RSC Advances, ACS Omega, and ChemistrySelect, plus the MDPI reputation question.
Clinical Infectious Diseases (IF 8.2, IDSA) is the flagship clinical infectious disease journal. Here's how it compares to Lancet ID, JID, and Clinical Microbiology Reviews.
IJHE (IF 8.1) is the primary journal for hydrogen energy research, production, storage, fuel cells, safety. Here's when your paper fits, what editors reject, and how it compares to Applied Energy and J. Power Sources.
RSC Advances is a legitimate gold open-access chemistry journal with IF 4.6. This guide covers its sound-methodology review model, how it compares to PLOS ONE and Scientific Reports, and when it is the right call.
Energy (Elsevier) fit verdict: IF 9.4, systems-level energy research. Here is when it fits and when Applied Energy or Renewable Energy is smarter.
Brain (IF 11.7, Oxford Academic) occupies a unique position bridging bench neuroscience and clinical neurology. This guide covers its editorial identity, comparisons with Lancet Neurology and Nature Neuroscience, and when it fits.
Cell Stem Cell (IF 20.4, Cell Press) is the Cell family's stem cell flagship. Here is who should submit and how it compares to Cell, Nature Cell Biology, and Cell Reports.
BMC Medicine (IF 8.3) is the strongest open-access general medicine journal below the Big 4. Here's when it's the right target and when to aim higher or narrower.
A practical JAMA Oncology fit verdict for authors deciding whether the manuscript can change physician practice in oncology broadly enough for the JAMA Network.
Molecular Psychiatry (IF 10.1, Nature Portfolio) publishes the biological basis of psychiatric disorders. Comparison with Biological Psychiatry, American J. Psychiatry, and Nature Neuroscience.
Lancet Infectious Diseases (IF 31.0) is the top-ranked infectious disease journal. COVID changed its profile permanently. Comparison with Clinical Infectious Diseases, J. Infectious Diseases, and NEJM for ID trials.
ACS Catalysis JIF 13.1 is the top dedicated catalysis journal from ACS. Here's when your paper fits, what the editors reject for, and when JACS, Nature Catalysis, or Journal of Catalysis is the better target.
Analytical Chemistry is the ACS measurement science flagship with IF 6.7. Here's when your paper fits, what gets desk-rejected, and how it compares to Analyst, TrAC, and ACS Sensors.
Cell journal fit verdict with key metrics, comparison to Nature and Science, and practical submit-or-skip guidance for authors.
JBC (IF 4.0, ASBMB) has been the workhorse of biochemistry since 1905. Here's what the IF drop means, when JBC is still the right venue, and how it compares to Molecular Cell, EMBO Journal, and Biochemistry.
ACS Nano IF 16.0 (JCR 2024), 5-yr JIF 16.4. Q1, rank 28/460. Stable in the 14-16 band for 8 years. Named failure patterns for nano submissions.
A practical Physical Review Letters fit verdict for authors deciding whether their result is broad and concise enough for a flagship physics letters journal.
A practical Science fit verdict for authors who need to decide whether their paper is truly broad enough, important enough, and concise enough for the journal.
Advanced Materials (IF 26.8, Wiley, Q1) is the top interdisciplinary materials journal. Here is who should submit, what the editors want, and how it stacks up against Nature Materials and ACS Nano.
The Lancet (IF 88.5) is the highest-impact general medical journal. Here's what the Research in Context panel actually tests, why global framing matters, and when NEJM, JAMA, or BMJ is the better target.
Nature is arguably the most prestigious scientific journal in the world. Here's what the data says about when your paper actually belongs here, what the 7-day desk rejection actually evaluates, and when Nature Communications or a field journal is the smarter target.
Circulation (IF 38.6, AHA) is the flagship cardiovascular journal. With ~8% acceptance and a 17-day median first decision, here's who belongs and who doesn't.
Nature Communications and PNAS are both elite multidisciplinary journals, but they serve different papers. The IF gap matters less than field fit, editorial model, and cost.
NEJM accepts 5-6% of manuscripts and desk-rejects over 90%. The numbers matter, but the more useful question is whether your paper is broad and practice-changing enough to clear the desk.
The Lancet accepts roughly 4-5% of submitted manuscripts, with over 80% desk-rejected in 1-2 weeks. Here's what the stage-by-stage data looks like and what determines whether your paper clears each stage.
NEJM and The Lancet are both elite, but they are not interchangeable. The real question is which one fits your study type, audience, and geography.
eLife changed its entire model in 2022. All submissions get published, then reviewed publicly. Here's what that means for your paper and whether the IF 6.4 is a fair reflection of the journal's quality.
A practical Nature Communications fit verdict for authors deciding whether their paper is broad, complete, and credible enough for a selective Nature-branded audience.
PLOS ONE does not judge novelty, but it absolutely does judge methods, reporting, and data availability. Here is what the submission process actually looks like.
Most cover letters fail because researchers write summaries instead of pitches. Here are 5 complete, filled-in templates for different journal tiers and fields: copy, adapt, submit.
Nature Communications charges £5490 / $7350 / €6150. Fee, funding options, and when the journal is worth the cost.
Science Advances impact factor is 12.5 in 2024. Here is the trend, the current Q1 context, and how it compares with Nature Communications and PNAS before you submit.
A fit-first IEEE Access verdict: IF 3.6, 27% acceptance, $1,850 APC. Is it predatory? No. Is it the right venue for your paper? That depends on what you're trading.
Science journal accepts ~7% of submissions. 80%+ desk rejected without review. Review time, what editors want, and how to improve your odds.
A practical The Lancet submission process guide covering what happens after upload, what editors screen for first, and what to fix before you submit.
Cell accepts about 8% of submissions. 70-80% desk rejected. Papers reaching reviewers have 25-35% odds. Here's how Cell's editorial process works.
Cell Reports is the Cell Press journal for focused biological insights. Here's when it's the right target and when to aim at Cell, Molecular Cell, eLife, or a specialty journal instead.
A workflow-focused JAMA submission process guide covering what happens after upload, how triage works, and where papers get redirected or delayed.
A practical Science Advances fit verdict for authors deciding whether their paper is broad, complete, and persuasive enough for a selective cross-field audience.
A practical Scientific Reports submission guide focused on scope fit, technical soundness, and what needs to be true before you upload the manuscript.
Remote Sensing is not predatory. It has a 4.1 Impact Factor and Q1 rankings in geosciences - but MDPI's special issue model and review speed are the real concerns.
Sustainability is not predatory by standard definitions. It has a 3.3 Impact Factor and dual SCIE/SSCI indexing - but Norway removed it from approved lists and Finland downgraded it to Level 0.
Nature charges $11,390 for open access. Hybrid model, Read & Publish deals cover many institutions. Full cost breakdown and how to avoid paying.
BMC Medicine submission guide. Practical guidance for BMC Medicine, plus what authors should do next. See what editors expect before you submit.
A practical Science submission guide focused on editorial fit, breadth, and what must be obvious before a manuscript goes to Science.
30 to 70% of manuscripts are desk rejected without ever reaching peer review. Here is how to avoid it at any journal, from PLOS ONE to Nature.
A practical European Heart Journal submission guide covering package readiness, broad-cardiology fit, and what to tighten before upload.
A practical PRD fit verdict for authors deciding whether their paper is significant, authoritative, and genuinely interesting to particle physics, gravitation, or cosmology readers.
A practical PLOS Medicine fit verdict for authors deciding whether their paper has the global, policy-facing medical consequence the journal expects.
The Nature Communications cover letter is what editors read before they read your paper. Here is what it actually needs to say, what to avoid, and how to decide whether your letter is doing its job.
Scientific Reports and PLOS ONE are both megajournals with technical-soundness-only peer review. The differences come down to field community, publisher brand, and APC structure. Here's how to choose.
Most researchers don't know there are three reliable free ways to look up any journal's impact factor. Here's the fastest method and what to do when IF isn't listed.
A practical Scientific Reports fit verdict for authors deciding whether a broad, soundness-led open-access journal is the right home for their paper.
A practical PNAS submission guide focused on significance, broad-reader fit, and what must already be obvious before a manuscript goes to PNAS.
If your Nature Communications submission shows Under Consideration, your paper is somewhere between desk review and peer review. Here's what that actually means and when to expect a decision.
How long does Cell Reports take? Here's the real desk-review timeline, acceptance-rate context, and what usually triggers reviewer pushback.
BMJ Open fits sound clinical work, protocols, and negative results. When a selective specialty journal is the better call.
Nature accepts 7% for breakthroughs. Nature Communications takes strong disciplinary advances at 15%. Here's which one your manuscript belongs in.
A practical PLOS ONE verdict for authors deciding whether the journal is legitimate, what its editorial model actually means, and when it is the right fit.
A practical Water Research fit verdict for authors deciding whether their paper is water-first, realistic, and broad enough for a flagship audience.
Science Advances uses 'Under Evaluation' as a broad status. The label matters less than the timing, so authors should read the wait in context instead of trying to decode a hidden message.
ACS AMI editors are screening for the materials-to-application bridge fast. A strong cover letter makes that bridge obvious in the first paragraph.
Advanced Energy Materials editors are screening for field-level energy consequence fast. A strong cover letter makes that case without drifting into hype.
Advanced Functional Materials editors are screening for demonstrated function fast. A strong cover letter makes the function case concrete in the first paragraph.
Analytical Chemistry editors are screening for method-level advances, not just applications of known techniques. A strong cover letter makes the analytical innovation obvious fast.
Annals of Oncology editors are screening for practice-relevant oncology evidence, not just interesting cancer data. A strong cover letter makes the treatment consequence obvious fast.
Applied Catalysis B (renamed to Environment and Energy in 2024) requires applied relevance. Your cover letter must connect the catalysis to a real environmental or energy problem, not just report incremental catalyst optimization.
Applied Energy rejects papers that read like pure science with an energy label. The cover letter must prove the research has a path from lab bench to real-world deployment.
APL gives you four printed pages. That constraint shapes the cover letter too. State the applied significance fast and keep the letter short.
Applied Sciences editors screen for section fit and applied focus before anything else. A clear cover letter that names the right section and states a practical result moves fastest through triage.
Applied Surface Science rejects papers that treat surfaces as a backdrop rather than the subject. If the surface is not the central scientific focus, expect a desk rejection.
A&A is organized by numbered sections. Name the section, state the result, and respect the journal's emphasis on reproducible science.
ApJ accepts most of what it receives. The cover letter is for routing, not persuasion.
Bioinformatics wants the method you built, not the biological finding it produced. If the cover letter leads with biology, the editor will route the paper elsewhere.
Bioresource Technology does not publish basic biology. The cover letter must prove the work moves biomass, biowaste, or bioprocessing closer to application.
Blood editors are screening for real hematology consequence, not just technically solid blood research. A strong cover letter makes that field-level case obvious fast.
BMJ Open uses open peer review and mandatory reporting checklists. Missing a checklist is the single most common trigger for desk rejection, and it is entirely preventable.
Cancer Cell editors are screening for the bridge between mechanism and oncology consequence. A strong cover letter makes that bridge obvious fast.
Cancer Research editors are screening for mechanistic insight into cancer biology, not just strong tumor data. A strong cover letter makes that depth obvious fast.
Carbohydrate Polymers desk-rejects papers where the polymer is a supporting character. The cover letter must prove the carbohydrate polymer chemistry is central.
Cell editors are screening for conceptual advance, not just strong data. A strong cover letter makes that flagship case obvious fast.
Ceramics International publishes over 6,000 articles per year. The cover letter must quickly prove scope fit and a real advance over existing ceramic materials.
Chemical Engineering Journal editors are usually screening for engineering consequence and mechanistic value fast. A strong cover letter makes that obvious.
Chemical Reviews is primarily invitation-only. If you have not been invited, the path in is a proposal letter, not a traditional cover letter. Here is what editors need to see.
Chemical Society Reviews is primarily invitation-based. If you have not been invited, the path in is a proposal that identifies a coverage gap and makes the case for your team.
Circulation editors are screening for cardiovascular findings that matter beyond a narrow subspecialty lane. A strong cover letter makes that flagship case obvious fast.
Clinical Cancer Research editors are screening for a real bench-to-bedside or bedside-to-bench bridge. A strong cover letter makes that translational logic obvious fast.
Diabetes Care editors are screening for findings that change clinical practice, not just strong diabetes data. A strong cover letter makes the practice consequence obvious fast.
ES&T editors are practicing environmental scientists who can spot the difference between a paper that addresses a real environmental problem and one that borrowed an environmental keyword.
At Frontiers in Immunology, the cover letter's main job is routing. Name the specialty section, state the finding, and suggest reviewers who will engage constructively with the collaborative review model.
Frontiers in Microbiology has 25+ specialty sections. The cover letter's main job is getting the paper to the right section editor with enough context for a fast triage decision.
Gastroenterology editors are screening for practice-changing GI findings, not just solid clinical data. A strong cover letter makes the AGA-flagship case obvious fast.
Genome Biology does not want your data. It wants what your data means for biology. A cover letter that reads like a methods summary will be desk-rejected before it reaches a reviewer.
Hepatology editors are screening for real liver-disease consequence and a properly handled study-origin disclosure. A strong cover letter makes both clear fast.
JCI editors are screening for a real translational arc - mechanism connected to human disease. A strong cover letter makes that bench-to-bedside case obvious fast.
JBC is fully open access with no publication fees. The editors are working biochemists who screen for mechanistic depth and molecular-level detail, not impact narratives.
The best JCP cover letters do not oversell impact. They show why the paper belongs at the chemistry-physics boundary and what physical insight it adds.
Materials editors screen for scope clarity and section fit across a broad materials-science platform. A cover letter that names the section and states a clear materials result moves fastest.
Nature Reviews Cancer does not accept unsolicited manuscripts. Most content is commissioned by in-house editors. If you want to publish here, you need a proposal, not a traditional cover letter.
Nutrients editors screen for nutritional relevance and section fit before anything else. A cover letter that states the dietary or nutritional finding clearly moves through triage fastest.
PRL editors are screening for broad physics interest, not just technically correct results. A strong cover letter proves that a physicist outside your subfield would care.
PLOS ONE does not evaluate novelty or significance. It evaluates scientific soundness. A strong cover letter proves methodological rigor instead of overselling impact.
Remote Sensing editors screen for geospatial relevance and section fit before anything else. A cover letter that names the section and states a clear remote-sensing result moves through triage fastest.
Scientific Reports evaluates technical merit, not perceived impact. A cover letter that argues for novelty is written for the wrong journal. Argue for rigor instead.
Trends in Molecular Medicine publishes mostly invited content. You submit a one-page proposal, not a finished manuscript. The editors want a forward-looking argument, not a literature catalog.
Science Advances desk-rejects about 75% of submissions. Your cover letter is the first thing editors read. Here is how to write one that actually works.
A manuscript review service comparison is only useful if the reader can see how the judgment was made. This page explains our methodology, evidence standard, and what we do and do not claim to know firsthand.
PLOS Biology impact factor is 7.2 (JCR 2024). Q1, rank 6/107 in Biology. 10% acceptance, $5,500 APC. What 7.2 means for submission.
Nature Reviews Molecular Cell Biology impact factor is 90.2 with a 5-year JIF of 128.7. Q1, rank 1/204. An invited review journal.
Genome Biology IF 9.4, 5-year JIF 16.3, CiteScore 20, APC $5,490. Year-by-year trend, peer comparisons, and the submission bar explained.
BMJ IF 42.7 (JCR 2024), Q1, rank 5/332. Five-year JIF 76.1 is pandemic-inflated; 42.7 is the real baseline. Under 7% acceptance. What BMJ actually publishes.
BMC Medicine IF dropped from 12.5 to 8.3 after COVID normalization. Five-year JIF 9.4 is the real baseline. Q1, $3,054 APC, PubMed-indexed OA.
Genes & Development impact factor is 7.7 (JCR 2024). Q1, rank 3/39 in Dev Bio. Five-year JIF 10.2. See the trend and what editors want.
PLOS Medicine impact factor is 9.9 (JCR 2024). Q1, rank 13/332 in Medicine. APC $5,300 with waivers. See the trend and submission guidance.
JCI Insight impact factor is 6.1 (2024 JCR). Q1. Comparisons to JCI, what it publishes, acceptance rate, and submission guidance.
PNAS Nexus received its first JCR impact factor of 3.8 in 2024. Here's what that means, how it compares to PNAS, and whether you should submit there.
Science Advances charges $5K APC and accepts ~10%. PNAS has a free track and accepts ~15%. Which one fits and why it is not just about cost.
Molecules has a 2024 JIF of 4.6 (Q2, rank 82/319 in Chemistry). What the impact factor means for chemistry and materials authors deciding where to submit.
RSC Advances IF 4.6 in 2024. Q2, rank 75/239. 45-55% acceptance. What it means for your submission.
Analytical Chemistry IF 6.7 (JCR 2024). Q1, rank 10/111. ACS flagship. 20-25% acceptance. Named failure patterns from ACS editorial guidelines.
Applied Physics Letters (APL) impact factor is 3.6 (JCR 2024). Q2 in Physics. h-index 556 with 6M+ citations. The most-cited applied physics journal.
Angewandte Chemie International Edition impact factor is 16.9 (2024 JCR). Q1, ranked 15th out of 239 chemistry journals.
Advanced Materials impact factor is 26.8. CiteScore 27.78, SJR 8.851. Q1, rank 10/460 in Materials Science.
Advanced Functional Materials impact factor is 19.0. CiteScore 19.96, SJR 5.439. Q1, rank 9/187 in Physics, Applied.
IEEE Access impact factor is 3.6. Five-year JIF is 3.9. Quartile: Q2. Category rank: 128/366.
JCO has a JIF of 41.9 and CiteScore of 38.9. Here's what those numbers mean for selectivity and realistic submission expectations.
Circulation impact factor is 38.6. Five-year JIF is 35.9. Quartile: Q1. Category rank: 1/98.
ACS Catalysis impact factor is 13.1 with a 5-year JIF of 13.3. Q1, rank 21/185. Comparisons, trend, and submission guidance.
Annals of Oncology impact factor is 65.4. Five-year JIF 46.8, Q1, rank 4/326. See trend, comparisons, and submission guidance.
Cancer Research impact factor is 16.6. Five-year JIF is 13.4. Q1, rank 16/326. See the trend and what it means for authors.
Chemical Communications impact factor is 4.2. Five-year JIF 4.1, Q2, rank 84/239. See trend, comparisons, and what it means.
Chemical Reviews impact factor is 55.8. Five-year JIF 67.5, Q1, rank 1/239. See what the number means for chemistry authors.
Chemical Society Reviews impact factor is 39.0. Five-year JIF 50.1, Q1, rank 3/239. See what it means for chemistry authors.
Diabetes Care impact factor is 16.6. Five-year JIF 14.5, Q1, rank 6/191. See comparisons and what it means for authors.
Genes & Development impact factor is 7.7 with a 5-year JIF of 10.2. See rank, quartile, and what it means before you submit.
Journal of Immunology impact factor is 3.4 with a 5-year JIF of 3.9. See rank, quartile, and what it means for authors.
Molecular Systems Biology impact factor is 7.7 with a 5-year JIF of 10.0. See rank, quartile, and what it means for authors.
Nano Letters impact factor is 9.1 with a 5-year JIF of 9.9. See rank, quartile, and what it means for nanoscience authors.
Nature Chemical Biology impact factor is 13.7 with a 5-year JIF of 15.7. See rank, quartile, and what it means for authors.
Nature Protocols impact factor is 16.0 with a 5-year JIF of 19.4. Q1, rank 2/86. Comparisons, trend, and submission guidance.
Nature Reviews Cancer impact factor is 66.8 with a 5-year JIF of 81.0. Q1, rank 3/326. An invited review journal with elite citation performance.
RNA impact factor is 5.0 with a 5-year JIF of 4.7. Q1, rank 70/319. Comparisons, trend, and what it means for RNA biology authors.
Small impact factor is 12.1 with a 5-year JIF of 12.5. Q1, rank 14/187. Comparisons, trend, and submission guidance.
Trends in Molecular Medicine impact factor is 13.8 with a 5-year JIF of 14.4. Q1, rank 4/195. Comparisons and what it means.
Physical Review Letters (PRL) impact factor is 9.0 (JCR 2024). Q1, rank 9/114 in Physics. 25% acceptance rate. Review time, comparisons, and what editors want.
NAR impact factor is 13.1 (JCR 2024), CiteScore 18.2, SJR 4.472. Five-year JIF 16.8, ranked 13/319 in Molecular Biology.
Science has a JIF of 45.8 and CiteScore of 48.4. Here's how to interpret those numbers and decide if your paper should target Science.
eLife impact factor is approximately 6.4 (estimated). Q1 in Biology. APC $2,500, no desk rejections for reviewed papers. The journal redefining peer review.
Cell Reports IF 6.9 (JCR 2024), CiteScore 12.9, ~14% acceptance, $5,200 APC. Year-by-year trend, what editors look for, and how it compares to Cell.
American Journal of Human Genetics impact factor is 8.1. Five-year JIF 9.6, Q1, rank 12/191. See comparisons and guidance.
Blood impact factor is 19.4 (2024 JCR). Five-year JIF 18.1. Q1 in hematology. See trend, comparisons, and what it means.
Cell Host & Microbe impact factor is 18.7. Five-year JIF 20.5, Q1, rank 1/47. See comparisons and what it means for authors.
Cell Metabolism impact factor is 30.9. Five-year JIF 33.4, Q1, rank 3/191. See comparisons and what it means for authors.
Clinical Infectious Diseases impact factor is 7.3. Five-year JIF 7.2, Q1, rank 8/137. See comparisons and submission guidance.
Developmental Cell impact factor is 8.7 (JCR 2024). Q1, rank 2/39 in Developmental Biology. Five-year JIF 11.4. APC $9,080.
Genome Research impact factor is 5.5 (JCR 2024). Q1, rank 20/191. Five-year JIF 7.3. h-index 409. See trend, comparisons, and what editors want.
JCB impact factor is 6.4 with a 5-year JIF of 7.2. See rank, quartile, comparisons, and what it means for cell biology authors.
JEM impact factor is 10.6 with a 5-year JIF of 13.5. See rank, quartile, and what it means for immunology authors.
Molecular Cell impact factor is 16.6 with a 5-year JIF of 17.7. See rank, quartile, and what it means for molecular biology.
Nature Cell Biology impact factor is 19.1 with a 5-year JIF of 22.6. See rank, quartile, and what it means for authors.
Nature Metabolism impact factor is 20.8 with a 5-year JIF of 23.2. Q1, rank 5/191. Comparisons, trend, and submission guidance.
JCO's impact factor of 41.9 makes it the highest-IF journal in clinical oncology. The editorial test is specific: does your study answer a question oncologists face in clinic every day? If not, JCO probably isn't the right venue.
The Lancet's impact factor is 88.5 in the internal JCR 2024 reference table, but the useful submission question is fit. The number signals top-tier reach, not automatic fit for every strong clinical paper.
JCI impact factor is 13.6 in 2024. Here is the trend, what the number signals in translational medicine, and when JCI is still the right shortlist journal.
ACS Applied Materials & Interfaces impact factor is 8.2 (JCR 2024). Q1 in Materials Science. h-index 367. Review time, acceptance rate, and what editors want.
Cell impact factor is 42.5 (JCR 2024). CiteScore 74.8, SJR 22.612, Q1. Rank 3/319 in Biology. What the metrics mean for authors.
Citation errors get papers retracted and careers damaged. Here is what live citation verification actually catches, why most review services skip it, and how to check your manuscript before submission.
Most pre-submission review services ignore figures entirely. Here is what figure-level feedback actually catches, why reviewers form their first impression from your figures, and how to get this feedback before submission.
Before you submit to PNAS, use this checklist to verify significance, data requirements, and the specific items editors evaluate after the 2022 editorial reforms.
Thesify is an AI tool for thesis and dissertation feedback with rubric-based evaluation and semantic search. It is best for graduate students, not for journal submission readiness.
There are now a dozen AI tools that claim to review manuscripts. We compared what each actually does, what each misses, and which ones are worth your time.
A practical Cell Discovery submission process guide focused on what happens after upload, what editors screen first, and what to tighten before you submit.
A practical JAMA Cardiology process guide covering what happens after upload, early editorial triage, and where papers get redirected.
A practical Brain submission process guide covering what happens after upload, what editors screen for first, and what to fix before you submit.
A practical Genes & Development submission process guide covering what happens after upload, what editors screen first, and what to fix before submission.
A practical Neuron submission process guide covering what happens after upload, what editors screen for first, and what to fix before you submit.
A practical guide to the Physical Review D submission process, covering what editors screen for first and what to fix before upload.
A practical guide to the Applied Catalysis B submission process, covering what editors screen for first and what to fix before upload.
A practical Nature Neuroscience submission process guide covering what happens after upload, what editors screen first, and how to interpret silence or delay.
A practical Journal of Clinical Investigation submission process guide covering what happens after upload, what editors screen first, and what to fix before you submit.
A practical Cell Systems submission process guide covering what happens after upload, what editors screen for first, and what to fix before you submit.
Compare Circulation vs European Heart Journal: JIF 9.9 vs 7.0 (2024 JCR), scope differences, acceptance rates, and which journal fits your cardiovascular.
Cross-disciplinary breakthrough vs rigorous disciplinary advance. How to choose between Nature and PNAS.
Compare Neuron vs Molecular Cell: JIF 12.8 vs 19.5 (2024 JCR), scope differences, acceptance rates, and which journal fits your cell biology or.
A practical NEJM submission process guide covering what happens after upload, what editors screen for first, and what to fix before you submit.
A practical Molecular Cell submission process guide covering what happens after upload, what editors screen for first, and what to fix before you submit.
A practical verdict on whether Nano Letters is the right journal for your nanoscience paper, who should submit, and who should aim elsewhere.
Compare BMJ vs The Lancet on scope, selectivity, global significance, article types, and submission strategy. Use this guide to decide where your paper fits.
A practical Nature Biotechnology submission process guide covering what happens after upload, what editors screen for first, and what to fix before you submit.
Stuck between two journals? Use this practical framework to compare fit, readership, evidence bar, turnaround, and strategic downside before you submit.
BMJ vs JAMA: choose BMJ for clinically useful, policy-relevant work with practical transparency, and choose JAMA for broad clinical, public-health.
Respond to reviewers example scenarios for hostile comments, contradictory feedback, statistical concerns, and more, with usable templates.
Get our proven revision response matrix template. Track reviewer comments, your responses, and manuscript changes in one organized document.
Journal of Chemical Physics has a 2024 JIF of 3.1 (Q2, rank 10/39 in Physics, Atomic/Molecular & Chemical). Learn what the JIF means and whether to submit.
Use this journal fit checklist before you submit. It helps you test scope, audience, claim level, evidence bar, and likely desk-reject risk.
Compare Nature vs Science: JIF 48.5 vs 45.8, scope differences, acceptance rates, and which journal is the right fit for your research.
Physical Review D has a 2024 JIF of 5.3. See its Q1 rank, five-year IF, and what that means for particle physics, cosmology, and gravitation authors.
PNAS (IF 9.1, 15% acceptance) vs Scientific Reports (IF 3.9, 57% acceptance). Both are broad-scope. Here's what separates them and which one matches your.
Applied Catalysis B impact factor is 21.1 (2024 JCR). #1 ranked in catalysis. 18-22% acceptance, $3,500 APC.
A practical PRB fit verdict for authors deciding whether the paper makes a significant, substantive condensed matter or materials physics contribution.
Science of The Total Environment has an impact factor of 8.0 (JCR 2024). Q1, ranked 39th out of 374 environmental journals. What the number means for your paper.
Physical Review B impact factor is 3.7. Five-year JIF is 3.6. Quartile: Q2. Category rank: 66/187.
Astrophysical Journal impact factor is 5.4. Five-year JIF is 5.2. Quartile: Q1. Category rank: 17/84.
Advanced Functional Materials returns most first decisions in 4-8 weeks. Here's what the full timeline looks like, what slows review, and faster.
PLOS ONE is not predatory. It's a legitimate, nonprofit, PubMed-indexed journal with real peer review. Here's why the question keeps coming up.
PNAS and Nature Communications fit different goals. Compare selectivity, audience signal, review flow, and when each is better.
Angewandte Chemie International Edition impact factor is 16.9. Five-year JIF 16.4, Q1, rank 15/239. See trend and guidance.
Angewandte Chemie vs Nature: acceptance rates, timelines, and editorial standards for chemistry breakthroughs versus paradigm-shifting discoveries.
Compare Angewandte Chemie vs Scientific Reports: JIF 16.9 vs 3.9 (2024 JCR), acceptance rates, scope, and which journal matches your research impact level.
Carbohydrate Polymers impact factor is 12.5. Five-year JIF 11.9, Q1, rank 1/57. See comparisons and what it means for authors.
Food Chemistry impact factor is 9.8 (JCR 2024). Q1, rank 4/112 in Food Science. h-index 392. APC $4,300. See trend, comparisons, and what editors want.
Fuel impact factor is 7.5 with a 5-year JIF of 7.1. See rank, quartile, peer comparisons, and what it means for your submission.
Journal of Alloys and Compounds impact factor is 6.3 with a 5-year JIF of 5.9. See rank, quartile, and what it means.
Journal of Applied Physics impact factor is 2.5 with a 5-year JIF of 2.7. See rank, quartile, and what it means for authors.
JCIS impact factor is 9.7 with a 5-year JIF of 8.9. See rank, quartile, and what it means for colloid science authors.
JPC C impact factor is 3.2 with a 5-year JIF of 3.5. See rank, quartile, and what it means for physical chemistry authors.
JACS (IF 15.6) vs Scientific Reports (IF 3.9): acceptance rates, scope, and which journal matches your chemistry work.
MNRAS impact factor is 4.8 with a 5-year JIF of 4.7. See rank, quartile, and what it means for astronomy authors.
Nature Genetics impact factor is 29.0 (JCR 2024). Q1, rank 2/191 in Genetics. Five-year JIF 37.4. Acceptance rate, review time, and what editors want.
Nature Neuroscience impact factor is 20.0 with a 5-year JIF of 24.8. Q1, rank 2/314. Comparisons, trend, and submission guidance.
NSMB impact factor is 10.1 with a 5-year JIF of 12.1. Q1, rank 4/79 in Biophysics. Comparisons and submission guidance.
Neuron impact factor is 15.0. CiteScore 22.1, SJR 6.755, SNIP 2.952. Q1, rank 9/314 in Neurosciences.
Physical Review Letters (JIF 9.0) vs Physical Review B (JIF 3.7). Both APS journals. When to choose each based on article type, selectivity, and scope.
Physical Review Letters (JIF 9.0) vs Physical Review D (JIF 5.3). Both APS journals. When to choose each for particle physics, fields, cosmology.
ACS Catalysis charges ~$5,000 for open access. ACS hybrid model, Read & Publish deals, member discounts, and comparison with top catalysis journal alternatives.
ACS Catalysis has no strict word limit for Research Articles (5,000-9,000 words typical), while Letters cap at ~3,000 words. A TOC graphic is required, references use ACS superscript numbered style, and both Word and LaTeX are accepted.
Advanced Energy Materials charges ~$5,500-$6,000 for open access. Wiley-VCH hybrid, IF ~25, DEAL coverage.
Advanced Energy Materials limits Full Papers to ~10 printed pages and Communications to ~5 pages. A TOC image (5.5 x 5.0 cm) is required, references use Wiley numbered style with square brackets, and Word is the preferred submission format.
Advanced Materials charges ~$5,500-$6,000 for open access. Hybrid Wiley journal, DEAL agreements, IF ~27. Full cost breakdown and how it compares to ACS Nano.
Analytical Chemistry has no strict word limit for Articles (4,000-7,000 words typical), while Letters are limited to ~4 printed pages. A TOC graphic (3.25 x 1.75 inches) is required, and references use ACS superscript numbered style.
Angewandte Chemie charges $5,500-$6,000 for open access (hybrid). Free subscription route available. Wiley DEAL agreements, waivers, and cost comparisons.
Annals of Oncology does not publish a strong official acceptance rate. The better submission question is whether the paper is broad and mature enough to matter at ESMO-flagship level.
Annals of Oncology limits Original Articles to 3,000 words with a 250-word structured abstract and up to 6 figures/tables combined. References use Vancouver numbered style with square brackets, and CONSORT compliance is required for clinical trials.
Applied Catalysis B recommends an 8,000-word limit for research articles. Highlights (3-5 bullets) and a graphical abstract are both required. References use Elsevier numbered style with square brackets, and both Word and LaTeX are accepted.
Applied Energy formatting guide. Word limits, figure specs, reference format, LaTeX vs Word, and journal-specific formatting quirks you need to know.
Applied Physics Letters charges ~$2,500-$3,500 for open access via AIP Publishing. Hybrid model with free subscription-track. Full comparison inside.
Applied Physics Letters formatting guide. Word limits, figure specs, reference format, LaTeX vs Word, and journal-specific formatting quirks you need to know.
Applied Sciences (MDPI) charges CHF 2,400 (~$2,600) for open access. Gold OA megajournal with 30K+ papers/year. Comparison with PLOS ONE, Sensors, IEEE Access.
Applied Sciences has no strict word limit (4,000-8,000 words typical) and requires the MDPI template for all submissions. The abstract is ~200 words, references use MDPI numbered style with square brackets, and both Word and LaTeX are accepted.
Applied Surface Science limits Research Articles to 8,000 words (including tables, excluding abstract and references). Highlights (3-5 bullets, 85 characters each) are required, references use Elsevier numbered format, and figures must meet strict resolution requirements.
Astronomy & Astrophysics charges ~$500-$800 in page charges. Most authors pay nothing due to ESO agreements. How A&A compares to ApJ and MNRAS.
Astronomy & Astrophysics has no strict word limit (most papers run 6,000-12,000 words) but charges page fees beyond 16 printed pages. LaTeX with the aa.cls class is effectively required, and references use an author-year style without article titles.
Astrophysical Journal charges $2,300-$3,500+ based on article length. Gold OA since 2022. AAS page charge model explained. How it compares to MNRAS and A&A.
Ranked list of the top 14 agricultural science journals by impact factor, acceptance rate, APC, and review speed, with guidance on choosing the right venue for your crop science, agroecology, or food systems manuscript.
Ranked list of the top 13 analytical chemistry journals by impact factor, acceptance rate, APC, and review speed, with guidance on matching your methods paper, sensor study, or separation science work to the right outlet.
Ranked list of the top 12 astrophysics and astronomy journals by impact factor, acceptance rate, page charges, and review speed, with advice on choosing between ApJ, MNRAS, A&A, and the Nature portfolio.
Ranked list of the top 12 biochemistry journals by impact factor, acceptance rate, APC, and review speed, with guidance on placing protein, enzyme, nucleic acid, and chemical biology manuscripts.
Ranked list of the top 12 cardiology journals by impact factor, acceptance rate, APC, and review speed, covering EHJ, JACC, Circulation and specialty venues for imaging, electrophysiology, and heart failure research.
Ranked list of the top 13 cell biology journals by impact factor, acceptance rate, APC, and review speed, from Cell and Nature Cell Biology to accessible society journals and OA options.
Ranked list of the top 14 chemical engineering journals by impact factor, acceptance rate, APC, and review speed, with guidance on placing reaction engineering, separation, and sustainable process research.
Ranked list of the top 14 civil engineering journals by impact factor, acceptance rate, APC, and review speed, covering structural, geotechnical, construction materials, and digital construction venues.
Ranked list of the top 14 computer science journals by impact factor, acceptance rate, APC, and review speed, with guidance on when to target a journal versus a top conference in ML, systems, and theory.
Ranked list of the top 12 condensed matter physics journals by impact factor, acceptance rate, APC, and review speed, from Nature Physics and PRL to PRB and accessible IOP options.
Ranked list of the top 12 dermatology journals by impact factor, acceptance rate, APC, and review speed, covering clinical, investigative, surgical, and open-access dermatology outlets.
Ranked list of the top 13 ecology and evolution journals by impact factor, acceptance rate, APC, and review speed, with guidance on placing field studies, phylogenetics, and global-change research.
Ranked list of the top 14 electrical engineering journals by impact factor, acceptance rate, APC, and review speed, spanning power electronics, circuits, communications, and smart-grid research.
Ranked list of the top 12 endocrinology and diabetes journals by impact factor, acceptance rate, APC, and review speed, with guidance on placing diabetes trials, thyroid research, and obesity studies.
Ranked list of the top 14 energy research journals by impact factor, acceptance rate, APC, and review speed, covering batteries, solar cells, energy systems, and policy-oriented venues.
Ranked list of the top 14 environmental science journals by impact factor, acceptance rate, APC, and review speed, covering water, air, soil, contaminants, and sustainability research.
Ranked list of the top 14 food science journals by impact factor, acceptance rate, APC, and review speed, covering food chemistry, hydrocolloids, safety, engineering, and microbiology outlets.
Ranked list of the top 12 gastroenterology journals by impact factor, acceptance rate, APC, and review speed, covering Gut, Gastroenterology, hepatology companions, and endoscopy outlets.
Ranked list of the top 13 genetics and genomics journals by impact factor, acceptance rate, APC, and review speed, with guidance on placing GWAS, functional genomics, and computational tool papers.
Ranked list of the top 14 global health journals by impact factor, acceptance rate, APC, and review speed, with guidance on placing clinical trials, health-systems research, and policy analyses for LMIC settings.
Ranked list of the top 12 hematology journals by impact factor, acceptance rate, APC, and review speed, covering malignant and non-malignant hematology, hemostasis, and transfusion medicine.
Ranked list of the top 11 hepatology journals by impact factor, acceptance rate, APC, and review speed, covering viral hepatitis, MASLD, HCC, liver transplantation, and cholestatic disease research.
Ranked list of the top 12 immunology journals by impact factor, acceptance rate, APC, and review speed, covering innate and adaptive immunity, clinical allergy, mucosal immunology, and translational venues.
Ranked list of the top 12 infectious disease journals by impact factor, acceptance rate, APC, and review speed, covering clinical trials, antimicrobial resistance, surveillance, and emerging-pathogen research.
Ranked list of the top 13 inorganic chemistry journals by impact factor, acceptance rate, APC, and review speed, with guidance on placing coordination, organometallic, bioinorganic, and catalysis manuscripts.
A ranked guide to the top 14 machine learning and AI journals by impact factor, acceptance rate, APC, and review time - plus why conferences often matter more than journals in ML.
A ranked guide to the top 15 materials science journals by impact factor, acceptance rate, APC, and review speed, with practical advice on choosing the right venue for your manuscript.
A ranked guide to the top 14 mechanical engineering journals by impact factor, acceptance rate, APC, and review time, covering manufacturing, dynamics, solid mechanics, and thermal engineering.
A ranked guide to the top 13 medical education journals by impact factor, acceptance rate, APC, and review time - from Academic Medicine and Medical Education to accessible open-access options.
A ranked guide to the top 13 microbiology journals by impact factor, acceptance rate, APC, and review time, including the ASM portfolio and microbial ecology venues.
A ranked guide to the top 12 molecular biology journals by impact factor, acceptance rate, APC, and review time, from Molecular Cell and NAR to accessible society journals.
A ranked guide to the top 14 nanotechnology journals by impact factor, acceptance rate, APC, and review time - covering synthesis, devices, biomedicine, and 2D materials.
A ranked guide to the top 12 nephrology journals by impact factor, acceptance rate, APC, and review time, from JASN and Kidney International to accessible open-access options.
A ranked guide to the top 12 neuroscience journals by impact factor, acceptance rate, APC, and review time, spanning molecular, systems, and clinical neuroscience.
A ranked guide to the top 14 nursing research journals by impact factor, acceptance rate, APC, and review time, from IJNS and JAN to accessible open-access options.
A ranked guide to the top 12 oncology journals by impact factor, acceptance rate, APC, and review time, from JCO and Lancet Oncology to accessible open-access venues.
A ranked guide to the top 12 ophthalmology journals by impact factor, acceptance rate, APC, and review time, covering clinical, surgical, and basic science venues.
A ranked guide to the top 13 organic chemistry journals by impact factor, acceptance rate, APC, and review time, from JACS and Organic Letters to accessible society journals.
A ranked guide to the top 12 particle physics journals by impact factor, acceptance rate, APC, and review time - including free SCOAP3-funded options for HEP researchers.
A ranked guide to the top 14 pharmacology journals by impact factor, acceptance rate, APC, and review time, spanning drug discovery, clinical pharmacology, and basic receptor biology.
A ranked guide to the top 13 physical chemistry journals by impact factor, acceptance rate, APC, and review time, covering spectroscopy, thermodynamics, kinetics, and computational chemistry.
A ranked guide to the top 12 plant science journals by impact factor, acceptance rate, APC, and review time, from Nature Plants and Plant Cell to accessible open-access options.
A ranked guide to the top 13 psychiatry journals by impact factor, acceptance rate, APC, and review time, from JAMA Psychiatry and Lancet Psychiatry to accessible open-access options.
A ranked guide to the top 13 public health and epidemiology journals by impact factor, acceptance rate, APC, and review time - from policy-focused Lancet Public Health to accessible OA options.
A ranked guide to the top 12 pulmonology journals by impact factor, acceptance rate, APC, and review time, from AJRCCM and ERJ to accessible open-access options.
A ranked guide to the top 12 rheumatology journals by impact factor, acceptance rate, APC, and review time, from Annals of the Rheumatic Diseases and Arthritis & Rheumatology to accessible options.
A ranked guide to the top 11 structural biology journals by impact factor, acceptance rate, APC, and review time, covering cryo-EM, crystallography, and NMR venues.
A ranked guide to the top 15 surgery journals by impact factor, acceptance rate, APC, and review time, from Annals of Surgery and JAMA Surgery to subspecialty and open-access options.
A ranked guide to the top 13 toxicology journals by impact factor, acceptance rate, APC, and review time, covering environmental, clinical, regulatory, and mechanistic toxicology.
A ranked guide to the top 12 virology journals by impact factor, acceptance rate, APC, and review time - from Nature Microbiology to accessible OA options for fundamental and clinical virology.
Bioinformatics formatting guide. Word limits, figure specs, reference format, LaTeX vs Word, and journal-specific formatting quirks you need to know.
Bioresource Technology formatting guide. Word limits, figure specs, reference format, LaTeX vs Word, and journal-specific formatting quirks you need to know.
Blood charges $5,850 for open access and $85/page for ALL articles. Brief Reports cost $2,925. Full cost breakdown, waivers, and comparisons.
Blood formatting guide. Word limits, figure specs, reference format, LaTeX vs Word, and journal-specific formatting quirks you need to know.
BMJ charges ~$5,450 for open access. BMJ Open is $2,850 gold OA. Institutional deals, waivers for low-income countries, and full cost breakdown.
BMJ doesn't just send your paper to academic experts. It also sends it to patient and public reviewers who read your work with completely different eyes. Your cover letter needs to speak to both audiences, and that changes how you frame everything.
Cancer Cell follows the Cell Press AI policy: disclosure goes in STAR Methods, AI cannot be an author, and AI-generated images are banned across all Cell Press journals.
Cancer Cell formatting guide. Word limits, figure specs, reference format, LaTeX vs Word, and journal-specific formatting quirks you need to know.
Cancer Research limits Articles to 5,000 words with a 250-word structured abstract and up to 7 figures. References use AACR numbered style with parenthetical citations, and a Significance statement is mandatory for all research articles.
Carbohydrate Polymers does not disclose an official acceptance rate. The editorial filter that matters is whether your polysaccharide paper delivers structural characterization depth tied to a clear structure-property relationship.
Carbohydrate Polymers charges ~$4,200 for open access. Elsevier hybrid model, Read & Publish deals, waivers, and comparison with polysaccharide journal.
Cell Press limits AI to readability improvements only, requires disclosure in a dedicated section before References using a provided template, and bans AI-generated images across all Cell Press journals.
Cell charges $11,400 for open access. Hybrid model, excluded from most Elsevier Read & Publish deals. Full cost breakdown, waivers, and alternatives.
Cell Metabolism follows the Cell Press AI policy: disclosure goes in STAR Methods, AI cannot be an author, and AI-generated images are prohibited across all Cell Press titles.
Cell Reports follows the Cell Press AI policy: disclosure goes in STAR Methods, AI cannot be an author, and the same rules apply across Cell Reports Medicine and all Cell Press titles.
Ceramics International (Elsevier) charges ~$3,800-$4,200 for open access. Hybrid journal, IF ~5, core Elsevier R&P.
Chemical Communications (ChemComm) charges ~$2,000-$2,500 for open access. Hybrid model, RSC Gold for Gold deals, and comparison to Angewandte and JACS.
Chemical Communications limits Communications to 4 journal pages (~2,500-3,000 words). A TOC graphic (8.5 x 4.5 cm) is mandatory, references use RSC numbered style without article titles, and Electronic Supplementary Information is expected.
Chemical Society Reviews does not publish a strong official acceptance rate. The better submission question is whether the topic and author team are realistic for a field-level review.
Chemical Society Reviews charges ~$2,500-$3,000 for open access. RSC hybrid model, invitation-only publishing, and how it compares to Chemical Reviews (ACS).
Circulation requires dual AI disclosure in both Methods and cover letter under AHA rules, prohibits AI authorship and AI-generated images, and bans clinical data processing through external AI tools.
Clinical Cancer Research (AACR) charges $4,200-$5,000 for open access. Hybrid model, AACR member discounts, page charges, and peer journal comparison.
Clinical Cancer Research limits Articles to 5,000 words with a 250-word structured abstract and up to 7 figures. A mandatory 150-word Translational Relevance statement is unique to this journal, and references use AACR numbered style with parenthetical citations.
Clinical Infectious Diseases limits Major Articles to 3,500 words with a 200-word structured abstract and up to 6 figures/tables combined. References use Vancouver numbered style with superscript citations, and Word is the standard submission format.
Diabetes Care limits Original Articles to 4,000 words with a 250-word structured abstract using ADA-specific headings (OBJECTIVE, RESEARCH DESIGN AND METHODS, RESULTS, CONCLUSIONS). References use ADA numbered style, and up to 4 figures and 3 tables are allowed.
eLife requires AI disclosure in Methods and amplifies accountability through its public peer review model, where reviewer concerns about AI use become permanently visible alongside the published paper.
The EMBO Journal charges ~$5,450 for open access. Fully gold OA since 2023, Springer Nature partnership, IF ~9. Waivers, deals, and peer comparison.
EMBO Journal editors are screening for mechanistic molecular biology with real biological consequence. A strong cover letter makes that balance obvious fast.
The EMBO Journal allows up to 10,000 words for Research Articles with a 175-word unstructured abstract. References use EMBO author-date (Harvard-type) style, source data for key experiments is mandatory, and both Word and LaTeX are accepted.
Energy (Elsevier) caps Research Articles at 8,000 words including tables, requires 3-5 Highlights of 85 characters each, and uses Elsevier numbered references with square-bracket citations.
European Heart Journal requires AI disclosure in Methods under combined ESC and Oxford University Press rules, prohibits AI authorship and AI-generated images, and applies the policy across all ESC journals.
European Heart Journal allows 5,000 words for Clinical Research articles with a four-heading structured abstract (Background and Aims, Methods, Results, Conclusions). Vancouver-style superscript references and a mandatory Structured Graphical Abstract.
European Heart Journal often tells authors relatively quickly whether a paper belongs in flagship cardiology, but the real submission question is cardiovascular consequence across practice, not just speed.
Frontiers in Immunology follows the Frontiers publisher-wide AI policy requiring disclosure, prohibiting AI authorship, and banning AI-generated images across all 200+ Frontiers journals.
Frontiers in Microbiology charges CHF 2,950 (~$3,200) for gold open access. Fee tiers, waivers, institutional deals, and comparison to ASM, mBio, and ISME.
Frontiers in Microbiology formatting guide. Word limits, figure specs, reference format, LaTeX vs Word, and journal-specific formatting quirks you need to know.
Frontiers in Plant Science does not publish a strong official acceptance rate. The better submission question is whether the paper is section-ready, review-ready, and suited to the Frontiers model.
Frontiers in Plant Science charges CHF 2,950 (~$3,200) for open access. Gold OA model, waivers, institutional discounts, and how it compares to Plant Cell.
Frontiers in Plant Science formatting guide. Word limits, figure specs, reference format, LaTeX vs Word, and journal-specific formatting quirks you need to know.
Fuel does not disclose an official acceptance rate. The editorial filter that matters is whether your combustion or fuel science paper presents original work with systematic data and practical relevance.
Fuel formatting guide. Word limits, figure specs, reference format, LaTeX vs Word, and journal-specific formatting quirks you need to know.
Gastroenterology formatting guide. Word limits, figure specs, reference format, LaTeX vs Word, and journal-specific formatting quirks you need to know.
Genome Biology has no strict word limit for Research articles. Structured abstracts use Background/Results/Conclusions headings, BMC numbered references, and strict data/code public availability is mandatory.
Gut follows BMJ Publishing Group's AI policy requiring disclosure in Methods, prohibiting AI authorship and AI-generated images, and applying the same rules as The BMJ across all BMJ specialty journals.
Gut charges ~£2,700 ($3,500) for open access. Hybrid model with strong Jisc coverage. Full cost breakdown, waivers, and comparison to Gastroenterology.
Hepatology requires AI disclosure in Methods under dual AASLD and Wolters Kluwer rules, prohibits AI authorship and AI-generated images, and applies heightened scrutiny to AASLD practice guideline papers.
Hepatology formatting guide. Word limits, figure specs, reference format, LaTeX vs Word, and journal-specific formatting quirks you need to know.
Immunity follows the Cell Press AI policy: disclosure goes in STAR Methods under Method Details, AI cannot be an author, and AI-generated images are banned across all Cell Press journals.
Immunity charges $9,350 for open access. Cell Press hybrid excluded from most Elsevier R&P deals. Full cost breakdown, waivers, and peer journal comparison.
International Journal of Biological Macromolecules formatting guide. Word limits, figure specs, reference format, LaTeX vs Word, and journal-specific.
International Journal of Hydrogen Energy formatting guide. Word limits, figure specs, reference format, LaTeX vs Word, and journal-specific formatting.
Frontiers in Immunology is not predatory. It carries a 5.9 Impact Factor, Q1 ranking, and IUIS backing - but Frontiers' publisher model and Finland's downgrade are worth understanding before you submit.
Frontiers in Microbiology is not predatory. It has a 4.5 Impact Factor, Q1 ranking, and PubMed indexing - but the Frontiers review model and institutional downgrades are worth understanding.
Frontiers in Plant Science is not predatory. It has a 4.8 Impact Factor, Q1 status, and PubMed indexing - but the Frontiers review model and Finland's downgrade are worth understanding.
Frontiers is not a fake publisher, but its role in pressuring Beall's list offline, its 2025 mass retraction, and Finland's downgrade of 78 journals mean the answer requires journal-level judgment.
Hindawi was not predatory by standard definitions during its independent years, but after Wiley's acquisition, systematic fraud led to 11,300+ retractions and the brand's complete shutdown by 2024.
IEEE Access is a legitimate IEEE journal, not a predatory one. The real decision is whether its broad, fast, society-backed model is the right fit for your work.
IJMS is not predatory. It has a 4.9 Impact Factor, Q1 status, and MEDLINE indexing - but its 17,000-paper annual output means quality consistency is the real question.
Materials (MDPI) is not predatory. It has a 3.2 Impact Factor and SCIE indexing - but its ~65% acceptance rate and extraordinary special issue volume are the real concerns.
Molecules is not predatory. It has a 4.6 Impact Factor, Scopus Q1 ranking, and PubMed indexing - but MDPI's special issue model and 38-day publication speed are the real concerns.
Angewandte Chemie International Edition desk-rejects about 50% of submissions. Master the 2,500-word Communication format, VIP designation, and what GDCh editors screen for.
Angewandte Chemie values novelty and concise Communication format. Understand the 20-25% acceptance rate, editorial screen, and how to frame your chemistry for GDCh editors.
Applied Energy demands engineering-grade energy research with real-world validation data. Understand the 15-20% acceptance rate and how it differs from Energy.
The Astrophysical Journal accepts 60-70% of submissions and charges page fees. Learn the AASTeX requirements, arXiv norms, and how ApJ compares to ApJ Letters and ApJ Supplement.
The BMJ accepts 7% of submissions with open peer review and patient reviewers. Understand the editorial bar, how BMJ compares to NEJM and The Lancet, and what editors prioritize.
Cancer Cell requires systems-level cancer biology with clinical relevance and STAR Methods. Learn the 8-10% acceptance rate, desk rejection triggers, and pre-submission inquiry process.
Cell Metabolism requires mechanistically complete metabolism stories with in vivo relevance. Understand the 10-12% acceptance rate, STAR Methods requirement, and scope boundaries.
Cell requires mechanistically complete stories validated across multiple systems. Understand the 8% acceptance rate, 85% desk rejection, STAR Methods, and pre-submission inquiry process.
Chemical Engineering Journal requires mechanistic insight alongside engineering applications. Understand the IF 13.3, 22-30% acceptance rate, scope boundaries, and what editors screen for.
Circulation desk-rejects 70% of submissions and requires clinical consequence data. Understand the AHA editorial bar, clinical implications boxes, and how it compares to European Heart Journal.
Construction and Building Materials requires practical construction testing with standards compliance. Learn the 25-30% acceptance rate, durability evidence expectations, and scope boundaries.
eLife charges $3,000 at review commitment and publishes reviewer reports publicly. Understand the assessed preprint model, 15% acceptance rate, and when eLife is the right strategic choice.
Pre-submission guide for Frontiers in Immunology covering section selection strategy, the collaborative review model, and editorial screening criteria.
Pre-submission guide for IEEE Access covering scope boundaries, the open-access APC model, review speed, and when the journal is the right fit.
Pre-submission guide for Immunity covering mechanistic depth requirements, STAR Methods formatting, human relevance, and the Cell Press editorial bar.
Pre-submission guide for IJBM covering editorial screening criteria for proteins, polysaccharides, and biopolymer research.
Pre-submission guide for JAMA covering Original Investigations, Research Letters, submission logistics, and statistical review requirements.
Pre-submission guide for JAMA Oncology covering the 48-hour desk screen, oncology scope requirements, and what editors actually prioritize.
Pre-submission guide for JAMA covering general-medicine fit, structured abstract rules, and how the journal differs from NEJM.
Pre-submission guide for JCI covering translational depth expectations, data-display rules, sex-as-variable analysis, and title constraints.
Pre-submission guide for Journal of Chemical Physics covering chemical-physics fit, theory-experiment rigor, and scope decisions.
Pre-submission guide for JPC C covering surface science scope, APC details, comparison with Langmuir and PCCP, and editorial screening criteria.
Pre-submission guide for Lancet Oncology covering global-trial relevance, policy impact requirements, and the bar for practice-changing evidence.
Pre-submission guide for The Lancet covering global clinical significance, structured abstract requirements, and the bar for practice-changing evidence.
Nature Biotechnology accepts 7-10% of submissions and desk-rejects ~70%. The journal publishes new tools and technologies, not biological discoveries made with existing tools.
Nature accepts ~8% of submissions and desk-rejects 75-80%. This guide covers what editors screen for in the first 48 hours, common rejection triggers, and the pre-submission enquiry system.
NEJM accepts ~5% of submissions and desk-rejects ~90%. This guide covers the clinical practice test, statistical review requirements, and what editors screen for during triage.
NEJM accepts 5-7% of submissions and desk-rejects over 90%. This practical guide covers submission requirements, statistical review, cover letter strategy, and article type selection.
Physical Review Letters accepts ~7% of submissions and desk-rejects ~35%. This guide covers the 4-page format, editorial expectations for broad significance, and self-assessment before submission.
Science of The Total Environment publishes 15,000+ papers yearly with an IF of ~8.0 and 25-30% acceptance. This guide covers what editors screen for and how to avoid desk rejection.
Scientific Reports accepts ~48% of submissions based on technical soundness, not novelty. This guide covers the Nature Portfolio cascade, how it compares to PLOS ONE, and what editors check.
Nutrients is not predatory. It has a 5.0 Impact Factor and MEDLINE indexing - but the 2018 mass resignation of editors over alleged pressure to accept weaker papers makes it MDPI's most complicated case.
RSC Advances is not predatory. It is published by the Royal Society of Chemistry, a learned society with a Royal Charter dating to 1841. The real question is whether it is the right strategic fit for your paper.
JACS charges $5,000-$6,000 for open access (hybrid). Default subscription route is free. ACS Read & Publish deals, waivers, and competitor cost comparison.
JACS formatting guide. Word limits, figure specs, reference format, LaTeX vs Word, and journal-specific formatting quirks you need to know.
JAMA charges ~$5,500 for open access. JAMA Network Open is $3,000 gold OA. AMA institutional deals, waivers, and full cost breakdown.
JAMA formatting guide. Word limits, figure specs, reference format, LaTeX vs Word, and journal-specific formatting quirks you need to know.
JAMA Oncology formatting guide. Word limits, figure specs, reference format, LaTeX vs Word, and journal-specific formatting quirks you need to know.
The JCI requires AI disclosure in Methods, prohibits AI authorship, and sets its own editorial policy through the ASCI rather than inheriting rules from a commercial publisher.
JCI charges $5,300-$5,700 for gold open access. Subscription track is free. Full breakdown of ASCI publishing costs, waivers, and funder compliance.
J Agricultural and Food Chemistry (ACS) charges ~$5,450-$5,500 for open access. Hybrid, IF ~5, ACS R&P deals. Comparison with Food Chemistry, LWT, J Food Sci.
JAFC limits Articles to 7,000 words with a mandatory TOC graphic (3.25 x 1.75 inches). ACS numbered reference style with superscript citations and CASSI journal abbreviations.
Journal of Alloys and Compounds does not disclose an official acceptance rate. The editorial filter that matters is whether your materials paper demonstrates functional properties, not just structural characterization.
Journal of Alloys and Compounds charges ~$3,800-$4,200 for gold open access. Elsevier hybrid model, R&P deals, waivers. Compared to Materials Letters and more.
Journal of Applied Physics formatting guide. Word limits, figure specs, reference format, LaTeX vs Word, and journal-specific formatting quirks you need to know.
Journal of Chemical Physics charges $2,500-$3,500 for open access. AIP hybrid model, institutional deals, waivers, and comparisons with PRB, CPL, and PCCP.
Journal of Chemical Physics formatting guide. Word limits, figure specs, reference format, LaTeX vs Word, and journal-specific formatting quirks you need.
JCO requires AI disclosure in Methods under ASCO rules, prohibits AI authorship and AI-generated images, and expects clinical trial interpretations and treatment recommendations to be entirely human-generated.
JCIS formatting guide. Word limits, figure specs, reference format, LaTeX vs Word, and journal-specific formatting quirks you need to know.
Journal of Materials Chemistry A formatting guide. Word limits, figure specs, reference format, LaTeX vs Word, and journal-specific formatting quirks you.
J Phys Chem C formatting guide. Word limits, figure specs, reference format, LaTeX vs Word, and journal-specific formatting quirks you need to know.
The Lancet restricts AI to readability and language improvements only, requires disclosure in acknowledgments, and prohibits AI-generated images across all Lancet family journals.
The Lancet charges ~$6,500 for open access. Hybrid model, excluded from most Elsevier deals. Full breakdown of costs, waivers, and Lancet family APCs.
Lancet Oncology restricts AI to readability and language improvements only, stricter than JCO and JAMA Oncology, with disclosure required in the acknowledgments section.
Lancet Oncology charges ~$5,450-$6,500 for open access. IF ~42. Excluded from most Elsevier R&P deals. Full cost breakdown and oncology journal comparisons.
Lancet Oncology formatting guide. Word limits, figure specs, reference format, LaTeX vs Word, and journal-specific formatting quirks you need to know.
Materials (MDPI) charges CHF 2,600 (~$2,800) for open access. Gold OA only, no subscription track. Discounts, waivers, and comparison with competing journals.
Molecular Cell follows Cell Press AI rules requiring disclosure in STAR Methods, prohibiting AI authorship and AI-generated images, with specific guidance for AlphaFold and cryo-EM workflows.
Molecules formatting guide. Word limits, figure specs, reference format, LaTeX vs Word, and journal-specific formatting quirks you need to know.
Monthly Notices of the Royal Astronomical Society is free to publish in. Subscription model, optional OA from ~$2,800. How MNRAS compares to ApJ and A&A.
Nano Letters charges ~$5,450-$5,500 for open access (hybrid). Default subscription route is free. ACS R&P deals, waivers, and comparison to ACS Nano and more.
Nano Letters limits papers to ~4,000 words with a mandatory TOC graphic (3.25 x 1.75 inches). ACS numbered reference style with superscript citations, and substantial Supporting Information is expected.
Nature requires AI disclosure in Methods, prohibits AI authorship and AI-generated images across all Springer Nature journals, with a copy editing exemption.
Nature Biotechnology follows Springer Nature's AI policy with Methods disclosure required, and provides guidance on separating research AI from writing AI in biotech manuscripts.
Nature Biotechnology formatting guide. Word limits, figure specs, reference format, LaTeX vs Word, and journal-specific formatting quirks you need to know.
Nature Communications follows Springer Nature's AI policy requiring Methods disclosure, with enforcement dynamics shaped by its scale of 6,000+ open-access articles per year.
Nature Genetics follows Springer Nature's AI policy with Methods disclosure required, plus special considerations for genetic data privacy, GWAS pipelines, and variant interpretation.
Nature Genetics charges $12,850 for open access. Springer Nature hybrid model with Read & Publish deals. Comparison with AJHG, Genome Biology, and more.
Nature Genetics is scale-dependent in a way most journals aren't. A 500-person GWAS that would be competitive at a specialty genetics journal won't survive desk review here. Your cover letter has to communicate sample size, effect size, and replication before the editor even opens the manuscript.
Nature Immunology follows Springer Nature's AI policy with Methods disclosure required, plus guidance on single-cell analysis pipelines, immune repertoire data, and clinical immunology considerations.
Nature Medicine follows Springer Nature's AI policy with Methods disclosure required, but clinical content raises the stakes due to patient safety implications and IRB considerations.
Nature Medicine formatting guide. Word limits, figure specs, reference format, LaTeX vs Word, and journal-specific formatting quirks you need to know.
Nature Methods follows Springer Nature's AI policy with Methods disclosure required, with unique considerations for papers describing AI methods, benchmarking studies, and code availability.
Nature Methods editors are screening for a method other labs will actually use, not just a biological result enabled by one clever tool. A strong cover letter makes that obvious fast.
Nature Reviews Cancer charges $12,850 for open access. Primarily invited reviews, IF ~66. Hybrid model, Read & Publish deals, and peer journal comparison.
Nature Reviews Cancer publishes primarily invited Reviews of 8,000-12,000 words. All figures are professionally redrawn by the in-house art team. Nature numbered reference style with 150-300 citations typical.
Nature Reviews Molecular Cell Biology does not publish a strong official acceptance rate. The better submission question is whether the topic and author team are realistic for a commissioned review.
Nature Reviews Molecular Cell Biology charges $12,850 for open access. Invitation-only model, Springer Nature deals, IF ~80+, and how it compares to NRRC.
Nature Reviews Molecular Cell Biology formatting guide. Word limits, figure specs, reference format, LaTeX vs Word, and journal-specific formatting quirks.
NEJM requires AI disclosure in both the cover letter and manuscript, follows ICMJE guidelines prohibiting AI authorship, and its sister journal NEJM AI actively encourages LLM use.
NEJM charges ~$10,000 for open access. Subscription publishing is free. Limited institutional deals. Full breakdown of costs, compliance, and alternatives.
NEJM formatting guide. Word limits, figure specs, reference format, LaTeX vs Word, and journal-specific formatting quirks you need to know.
Neuron follows Cell Press AI rules requiring disclosure in STAR Methods, with guidance on separating computational neuroscience research tools from manuscript preparation AI use.
Nucleic Acids Research formatting guide. Word limits, figure specs, reference format, LaTeX vs Word, and journal-specific formatting quirks you need to know.
Nutrients is one of the highest-volume nutrition journals, with Q1 ranking and a fast review cycle. Here is what the acceptance data actually tells you.
Nutrients (MDPI) charges CHF 2,900 (~$3,150) for open access. Gold OA, IF ~5. How it compares to Journal of Nutrition, AJCN, and alternatives.
Nutrients formatting guide. Word limits, figure specs, reference format, LaTeX vs Word, and journal-specific formatting quirks you need to know.
Physical Review B charges ~$2,100-$2,700 for open access depending on article length. Hybrid APS journal, SCOAP3 may cover some fees. Full cost comparison.
Physical Review D charges $2,100-$2,700 for open access. SCOAP3 covers most HEP articles for free. APS member discounts and funder compliance guide.
PLOS ONE requires AI disclosure in Methods and during submission, prohibits AI authorship, and enforces compliance across 15,000+ articles per year through author attestation and community scrutiny.
PNAS requires AI disclosure in both Methods and Author Contributions, prohibits AI authorship, and applies the same rules across all submission tracks including the NAS contributed track.
PNAS charges $4,975 for immediate OA with site license, $5,475 without. Delayed OA costs $2,575. Full pricing tiers, institutional deals, and funder compliance.
PNAS dropped the contributed track that let NAS members fast-track papers. Every submission now goes through standard peer review. Your cover letter has to do more work than it used to, and most researchers haven't adjusted.
Remote Sensing (MDPI) has no strict word limit for research articles but enforces a 200-word abstract cap. MDPI numbered references with full journal names and mandatory MDPI template usage.
RSER allows ~15,000 words for review articles with mandatory Highlights (85 characters each). Elsevier numbered references, and systematic review methodology with PRISMA documentation is increasingly expected.
RSC Advances has no strict word limit (Papers typically 4,000-8,000 words) but requires a mandatory TOC graphic. RSC reference style with superscript numbers and no article titles in journal references.
Science Advances follows the AAAS AI policy requiring disclosure in Acknowledgments and Methods, with editors particularly vigilant due to the organization's earlier AI text ban.
Science Advances charges $5,450 for gold open access. AAAS member discounts, institutional deals, and full waivers for developing nations. Complete cost guide.
Science requires AI disclosure in three locations (cover letter, acknowledgments, methods), classifies violations as scientific misconduct, and prohibits AI-generated images without editor permission.
Science magazine has no standard APC. It's subscription-only for the flagship. Science Advances charges $5,450 OA. Full breakdown of AAAS publishing costs.
Science has 20+ PhD-level in-house editors who desk-reject 75% of submissions. Your cover letter isn't a formality. It's the document that determines whether anyone reads page two of your manuscript.
Science of The Total Environment charges ~$4,200 for open access. Hybrid model, covered by Elsevier R&P deals, waivers exist. Compare with ES&T, Water Research.
Scientific Reports follows Springer Nature's AI policy with Methods disclosure required, enforcing the same rules as Nature across 20,000+ articles per year with reliance on author self-reporting.
Sensors (MDPI) has no strict word limit but enforces a 200-word abstract cap. MDPI numbered references with full journal names (not abbreviations), mandatory MDPI template, and performance comparison tables are expected.
Small (Wiley) charges ~$5,000-$5,500 for open access. Hybrid model, Wiley DEAL agreements, waivers, and comparison to ACS Nano, Nano Letters, and Nanoscale.
Small formatting guide. Word limits, figure specs, reference format, LaTeX vs Word, and journal-specific formatting quirks you need to know.
Sustainability (MDPI) charges CHF 2,600 (~$2,800) for gold open access. MDPI discount schemes, vouchers, and how it compares to J. Cleaner Production.
Trends in Molecular Medicine charges $6,000-$7,000 for open access. Cell Press hybrid, invited reviews, IF ~12. Deals, waivers, and peer comparison.
Trends in Molecular Medicine formatting guide. Word limits, figure specs, reference format, LaTeX vs Word, and journal-specific formatting quirks you need to know.
Journal of Cleaner Production impact factor is 10.0 (JCR 2024). CiteScore 11.55, SJR 2.174. Q1, rank 23/374 in Environmental Science.
Lancet Oncology impact factor is 35.9 (JCR 2024). Q1, rank 8/326 in Oncology. h-index 511. APC $6,300. Trend, acceptance rate, and what editors want.
Annals of Oncology is stronger for high-end clinical and translational oncology with a European feel. JCO is stronger for broad clinical oncology papers with practice-changing intent.
Annals of Oncology is stronger for top-tier clinical and translational oncology with a European perspective. Lancet Oncology is stronger for papers with clearer global practice-changing force.
Applied Surface Science impact factor is 6.9 (JCR 2024). Q1, rank 3/23 in Materials Science. h-index 272. APC $3,670. Trend and submission guidance.
Bioinformatics impact factor is 5.4 (JCR 2024). Q1, rank 8/86. h-index 564. The most-cited computational biology journal. Trend and submission tips.
The BMJ is for oncology papers with broad clinical, policy, or systems consequences. Annals of Oncology is for top-tier oncology work whose real audience is still cancer medicine.
The BMJ is for hematology papers with broad clinical, policy, or systems consequences. Blood is for flagship hematology work whose real audience is still the field.
The BMJ is for broad clinical or policy papers with strong general-medical consequences. BMJ Open is for methodologically sound medical research that wins on transparency, not prestige filtering.
BMJ is for oncology papers with broad clinical or policy consequences. Clinical Cancer Research is for translational oncology work whose main audience is still cancer medicine.
The BMJ is for infectious-disease papers with broad clinical, policy, or systems consequences. Clinical Infectious Diseases is for clinician-facing ID papers.
The BMJ is for diabetes papers with broad clinical, policy, or systems consequences. Diabetes Care is for diabetes research whose real audience is still diabetes practice.
BMJ is for cardiovascular papers with broad clinical, policy, or systems consequences. European Heart Journal is for flagship cardiology work whose real audience is the cardiovascular field.
The BMJ is for GI papers with broad clinical, policy, or systems consequences. Gastroenterology is for flagship digestive-disease work whose real audience is still GI.
The BMJ is for GI papers with broad clinical, policy, or systems consequences. Gut is for top-tier gastroenterology papers whose real audience is still digestive disease.
The BMJ is for liver papers with broad clinical, policy, or systems consequences. Hepatology is for flagship liver-disease work whose real audience is still hepatology.
The BMJ is for cancer papers with broad clinical, policy, or systems consequences. Journal of Clinical Oncology is for top-tier oncology work whose real audience is clinical oncology.
The BMJ is for oncology papers with broad clinical, policy, or systems consequences. Lancet Oncology is for practice-changing oncology work with global relevance.
Current Biology impact factor is 7.5 (JCR 2024). Q1, rank 5/107 in Biology. APC $6,830. See the trend, comparisons, and what editors want.
European Heart Journal is for top-tier cardiovascular papers. Annals of Oncology is for top-tier oncology work with broad clinical or translational consequence.
European Heart Journal is stronger for broad cardiology papers. Clinical Cancer Research is stronger for translational oncology papers with real patient-facing consequence.
European Heart Journal is the better first target for cardiovascular papers with broad cardiology consequence. Clinical Infectious Diseases is stronger for clinically actionable ID papers.
European Heart Journal is the better first target for broad cardiovascular papers. Diabetes Care is stronger for diabetes-practice papers with clear clinical consequence.
European Heart Journal is the better first target for broad cardiovascular papers. Gastroenterology is stronger for flagship GI work that still lives inside digestive disease.
European Heart Journal is the better first target for cardiovascular papers with broad cardiology consequence. Gut is stronger for GI and hepatology work with translational depth.
European Heart Journal is the better first target for broad cardiovascular papers. Hepatology is stronger for liver-disease work with real mechanistic, translational, or clinical hepatology consequence.
European Heart Journal is for top-tier cardiovascular papers. JAMA Oncology is for broad oncology papers with strong clinical consequences.
JAMA is for oncology papers with broad clinical or policy consequence across medicine. Annals of Oncology is for elite oncology papers that are strongest inside the cancer field.
JAMA is for hematology papers with broad clinical or policy relevance across medicine. Blood is for flagship hematology work whose real audience is the field itself.
JAMA is for broad clinical papers with strong general-medical consequences. BMJ Open is for medically relevant, transparently reported studies that win on soundness rather than prestige filtering.
JAMA is for oncology papers with broad clinical or policy consequences across medicine. Clinical Cancer Research is for translational oncology work whose real audience is still cancer medicine.
JAMA is for infectious-disease papers with broad clinical or policy consequences across medicine. CID is for strong clinician-facing ID papers whose real audience is still infectious disease.
JAMA is for diabetes papers with broad clinical or public-health consequence across medicine. Diabetes Care is for papers that are strongest inside diabetes management.
JAMA is for cardiovascular papers with broad clinical or public-health consequence. European Heart Journal is for top-tier cardiology papers whose real audience is the field itself.
JAMA is for GI papers with broad clinical or policy consequence across medicine. Gastroenterology is for flagship digestive-disease papers that still belong inside the field.
JAMA is for GI papers with broad clinical or policy consequence across medicine. Gut is for top-tier gastroenterology papers with strong translational or clinical consequence.
JAMA is for oncology papers with broad clinical or public-health consequence. Journal of Clinical Oncology is for practice-changing papers aimed squarely at oncologists.
JAMA is for oncology papers with broad clinical or policy consequence across medicine. The Lancet Oncology is for flagship oncology papers with international practice consequence.
The Lancet is for oncology papers that become broad medical or global-health events. Annals of Oncology is for top-tier oncology papers that mainly need the oncology field.
The Lancet is for papers that become broad medical or global-health events. BMJ Open is for methodologically sound medical research that wins on transparency, not prestige filtering.
The Lancet is for rare oncology papers that become broad medical events. Clinical Cancer Research is for translational oncology papers whose force still depends on oncology readers.
The Lancet is for cardiology papers that become broad medical or global-health events. European Heart Journal is for top-tier cardiovascular papers whose natural readership is the cardiology field.
The Lancet is for digestive-disease papers that break into broad medicine. Gastroenterology is for elite GI papers whose real value still depends on specialist readership.
The Lancet is for liver papers that become broad clinical or global-health events. Hepatology is for top-tier liver papers whose deepest value still belongs inside hepatology.
The Lancet is for oncology papers that become broad medical events. JCO is for oncology papers that change practice for oncologists and cancer-care teams.
If the paper is a cancer study with medicine-wide consequence, NEJM is in play. If it's an elite oncology paper that still lives inside oncology, Annals of Oncology is often the sharper target.
NEJM is for rare hematology papers that become broad clinical events. Blood is the flagship first target for many high-impact hematology papers that still belong primarily to the field.
NEJM and BMJ are both elite general medical journals, but they aren't interchangeable. NEJM wants definitive practice-changing evidence. BMJ is more receptive to policy, systems, and population-health relevance.
These journals aren't close substitutes. NEJM is for rare practice-changing medicine. BMJ Open is for sound clinical and public-health research reviewed under a more inclusive open-access model.
NEJM is for the rare oncology paper that becomes broad clinical medicine. Clinical Cancer Research is for translational oncology work where the bridge from mechanism to patient consequence is the real story.
NEJM is for infectious-disease papers that change broad clinical medicine. Clinical Infectious Diseases is for strong, clinician-facing ID work that changes diagnosis, treatment, prevention, or stewardship.
NEJM is for rare diabetes papers that become broad clinical events. Diabetes Care is the stronger first target for many high-quality clinical diabetes papers with direct practice relevance.
NEJM is the play for GI papers that become broad medical events. Gastroenterology is the better first target for many top digestive-disease papers, especially when mechanistic depth and GI-specific context matter.
NEJM is for gastroenterology papers that change medicine broadly. Gut is for top-tier GI work with strong translational or clinical consequence, especially in microbiome, IBD, liver, and GI oncology.
NEJM is for liver papers that change broad clinical medicine. Hepatology is the stronger first target for many serious liver studies that are field-defining but still liver-specific.
NEJM is the play for rare oncology papers that become broad medical events. JAMA Oncology is the better first target for high-rigor oncology work with strong clinical or population-level cancer relevance.
For oncology authors, this is often a breadth question. NEJM is for the rare oncology paper that changes medicine broadly. JCO is for oncology papers that change how oncologists treat patients.
NEJM is for oncology studies that become broad medical events. Lancet Oncology is for high-consequence oncology papers with global clinical relevance, especially when the story is still best told inside oncology.
A practical Angewandte Chemie International Edition submission process guide covering the Editorial Manager workflow, editor triage, review stages, and what each decision means.
Your paper was rejected. Before resubmitting unchanged to the next journal, here is how to identify the real rejection cause, fix it, and avoid losing another 3 to 6 months in a preventable rejection cycle.
A practical Nature Chemical Biology submission process guide covering the Nature portfolio portal workflow, editorial triage, dual-discipline review, and what to expect.
A practical Cell Host & Microbe submission process guide covering what happens after upload, what editors screen for first, and where strong packages still lose momentum.
A practical JACC submission guide on what editors screen first, how to judge fit, and how to prepare a package that looks review-ready.
A practical JAMA Cardiology submission guide focused on clinical importance, broad-readership fit, and package readiness before upload.
A practical Cell Metabolism submission process guide covering what happens after upload, what editors screen first, and where strong packages still lose momentum.
A practical Nature Reviews Cancer process guide covering what happens after a pitch, what editors judge first, and how to read silence or delay.
A practical Nature Reviews MCB process guide covering what happens after a pitch, what editors judge first, and how to read silence or delay.
A practical Nature Cell Biology submission process guide covering what happens after upload, what editors screen for first, and what to tighten before you submit.
A practical Nature Structural & Molecular Biology submission process guide covering what happens after upload, what editors screen first, and what to tighten before you submit.
A practical Genes & Development submission guide focused on mechanistic fit, editorial screen risk, and what should already be true before you upload.
A practical Nature Immunology submission guide for authors deciding whether the manuscript is important, mechanistically strong, and complete enough before submission.
A workflow-focused Nature Methods submission process guide covering what happens after upload, what editors screen for first, and where method papers usually lose momentum.
A practical Nature Immunology submission process guide focused on what happens after upload, what editors test first, and how to interpret early movement.
A practical guide to the Frontiers in Plant Science submission process, from section choice and editorial screening to review timing and common delay points.
A practical Nature Neuroscience submission guide focused on editorial fit, causal evidence, and what must already be obvious before a manuscript goes to Nature Neuroscience.
A practical Nature Genetics submission process guide focused on what happens after upload, what editors test first, and how to interpret early movement.
A practical Cancer Cell submission process guide covering portal steps, cover letter framing, and editorial screening. See the full timeline.
A practical Science Translational Medicine submission process guide covering what happens after upload, what editors judge first, and what to fix before you submit.
A practical Cell Systems submission guide focused on systems-biology fit, editorial readiness, and what must already be obvious before the paper goes in.
A practical guide to what the Journal of Hazardous Materials submission process usually looks like, what editors screen first, and what slows strong papers down.
A practical guide to the Nano Letters submission process for authors trying to understand what editors screen first and where the route to review usually gets harder.
A practical guide to the Water Research submission process for authors trying to understand how editors screen problem importance, evidence quality, and broader field relevance.
A practical ACS Catalysis submission process guide: what the portal does, what editors decide first, and what usually weakens a catalysis submission before review.
ACS Nano submission process guide covering editorial screening, reviewer assignment, first-decision timing, and common causes of delay.
A practical guide to the Analytical Chemistry submission process, including editorial triage, reviewer routing, and what to tighten before upload.
A practical guide to the Astrophysical Journal submission process, including editorial screening, reviewer routing, common delays, and what to tighten.
A practical guide to the Advanced Energy Materials submission process, including editorial screening, reviewer routing, common slowdowns, and what to.
A practical guide to the Applied Surface Science submission process, including editorial screening, reviewer routing, common slowdowns, and what to tighten.
A practical guide to the Bioinformatics submission process, including editorial screening, reviewer routing, common slowdowns, and what to tighten before upload.
A practical guide to the Advanced Functional Materials submission process, including editorial triage, reviewer routing, common delays, and what to tighten.
BMC Medicine submission process. Practical guidance for BMC Medicine, plus what authors should do next. See the full timeline from upload to decision.
Lancet Infectious Diseases submission process. Practical guidance for Lancet Infectious Diseases, plus what authors should do next.
A practical Molecular Psychiatry submission process guide covering what happens after upload, what editors judge first, and how to interpret silence or delay.
A practical Clinical Cancer Research submission process guide focused on what happens after upload, what editors test first, and how to interpret early movement.
How to submit to Environmental Science & Technology, what ACS Paragon Plus asks for, and what editors usually screen before external review.
How to submit to Applied Physics Letters, what the letter format demands, and what editors usually screen before the paper reaches review.
A practical Astronomy & Astrophysics submission process guide covering file structure, editorial screening, and what editors notice before review.
Non-native English speakers often spend $200-$400 on language editing before learning the paper has scientific problems. The better sequence: free readiness scan first, science review second, language editing last.
Communications Biology (IF 5.1) reviews for significance. Scientific Reports (IF 3.9) reviews for soundness only. Here's how to pick the right one.
A practical guide to the MNRAS submission process, including editorial screening, reviewer routing, and what to fix before upload.
A practical Science Translational Medicine submission guide focused on translational fit, editorial readiness, and what must already be obvious before the paper goes in.
A practical Nature Chemical Biology submission guide covering the interdisciplinary framing requirement, cover letter strategy, and what must be true before your paper enters review.
A practical PLOS Medicine submission guide covering the initial submission process, global health framing, reporting requirements, and what must be true before your paper enters review.
A practical Cell Host & Microbe submission guide focused on interaction fit, mechanistic depth, and what editors need to see before a paper reaches review.
A practical Circulation Research submission guide covering scope, mechanistic depth, cover-letter framing, and common submission mistakes.
Sensors submission guide. Practical guidance for Sensors, plus what authors should do next. See what editors expect before you submit.
A practical Developmental Cell submission guide focused on mechanistic fit, live-imaging expectations, and what the package should already prove before submission.
A practical Nature Cell Biology submission guide focused on mechanistic fit, conceptual breadth, and what the package should already prove before submission.
A practical Nature Structural & Molecular Biology submission guide focused on structure-function fit, mechanistic validation, and what the package should already prove before submission.
Lancet Neurology submission guide covering clinical fit, submission setup, editorial screening, and what to fix before review.
A practical Molecular Psychiatry submission guide focused on package readiness, psychiatric fit, and what should already be true before upload.
Lancet Infectious Diseases submission guide. Practical guidance for Lancet Infectious Diseases, plus what authors should do next.
Journal of Chemical Physics submission guide. Practical guidance for Journal of Chemical Physics, plus what authors should do next.
Monthly Notices of the Royal Astronomical Society submission guide. Practical guidance for MNRAS, plus what authors should do next.
A practical Journal of Materials Chemistry A submission guide covering scope, package readiness, editorial fit, and how to submit cleanly.
A practical International Journal of Hydrogen Energy submission guide covering scope, editorial fit, and how to package a hydrogen-energy paper.
A practical IJBM submission guide for authors deciding whether the paper is complete, biologically relevant, and editorially credible enough before submission.
A practical JAC submission guide for authors deciding whether the alloy story is complete, competitive, and applied enough for editorial screening.
A practical PRD submission guide for authors deciding whether the theory, phenomenology, or computational package is rigorous, testable, and editorially ready.
A practical Neuron submission guide focused on editorial fit, conceptual reach, and what must already be obvious before a manuscript goes to Neuron.
A practical Frontiers in Plant Science submission guide covering section fit, editorial screening, manuscript packaging, and the mistakes that slow or sink review.
A practical guide to submitting to Cancer Cell, including how editors think about fit, patient relevance, mechanistic depth, and package readiness.
A practical guide to submitting to Cell Metabolism, including fit, mechanistic expectations, disease relevance, and how to prepare a review-ready package.
Applied Sciences submission guide covering scope, submission setup, editorial fit, and what to tighten before peer review.
A practical Immunity submission guide focused on editorial fit, mechanistic depth, and what must already be obvious before a manuscript goes to Immunity.
A practical Immunity submission process guide covering what happens after upload, what editors screen for first, and what to fix before you submit.
A practical Journal of Clinical Oncology submission guide: what fits, what editors screen for, and how to tell whether your paper is ready.
A practical Molecular Cell submission guide focused on mechanistic fit, editorial readiness, and what must already be obvious before a manuscript goes to Molecular Cell.
A practical Current Biology submission guide: how to judge fit, shape the story, prepare the package, and avoid obvious editorial misses.
A practical Cell Stem Cell submission guide: how to judge fit, prepare the package, and avoid obvious editorial misses before you submit.
A practical Nature Reviews Cancer submission guide for authors deciding whether a review concept is broad, authoritative, and timely enough to pitch.
A practical Nature Reviews Molecular Cell Biology submission guide for authors deciding whether a review concept is broad, authoritative, and timely enough to pitch.
A practical Molecules submission guide for authors deciding whether the paper is complete, credible, and positioned well enough for editorial screening.
A practical RSC Advances submission guide for authors deciding whether the paper is technically complete, clearly novel, and properly matched to the journal.
Applied Catalysis B is a highly selective environmental catalysis journal. Here is what editors expect on scope, submission setup, cover letter.
A practical Journal of Hazardous Materials submission guide for authors deciding whether the paper is strong enough, broad enough, and validated enough for editorial review.
Applied Surface Science editors want strong surface characterization tied to a real functional outcome.
Astronomy & Astrophysics rewards observational or computational work with real astrophysical consequence.
Biomaterials expects a real biomaterials story: material design, biological mechanism, and convincing performance in a relevant model.
Analytic Methods in Accident Research submission guide covering methodological fit, safety relevance, and what editors screen before review.
Archives of Computational Methods in Engineering is a review-heavy journal for broad, technically serious computational surveys.
How to submit to Biotechnology Advances: scope fit, portal workflow, manuscript preparation, and the editorial signals that matter most.
How Annual Review of Chemical and Biomolecular Engineering submissions work, including invitations, proposal strategy, manuscript scope, and.
How Annual Review of Earth and Planetary Sciences submissions work, including invitations, proposal strategy, manuscript scope, and editorial.
How Annual Review of Food Science and Technology submissions work: invitations, proposal strategy, scope, and editorial expectations.
A practical Nano Letters submission guide for authors deciding whether the manuscript is sharp enough, urgent enough, and complete enough for editorial review.
A package-readiness guide to Remote Sensing covering validation strength, reproducibility, and what must be stable before submission.
How to submit to Blood: ASH requirements, manuscript preparation, and the editorial signals that matter most for hematology papers.
How to submit to Bioresource Technology: Elsevier workflow, manuscript preparation, and the editorial signals that matter most.
How to submit to Clinical Gastroenterology and Hepatology: manuscript requirements, clinical fit, and the editorial signals that matter most.
How to submit to Cell Discovery: formatting requirements, STAR Methods expectations, and the editorial signals that matter most.
Ceramics International submission guide: editorial requirements, common rejection patterns, and what editors actually want from ceramics papers.
EMBO Journal submission guide: scope requirements, desk rejection triggers, cover letter strategy, and failure patterns from real review work.
Practical ACS Catalysis submission guide: what the journal expects, what catalytic papers need to show, and how to avoid the most common editorial.
Practical EMM submission guide: what the journal publishes, where papers fail, and how to frame a stronger translational manuscript.
Practical Food Hydrocolloids submission guide: what the journal publishes, what editors care about, and how to prepare a stronger food-systems.
Practical Frontiers in Immunology submission guide: how the specialty sections work, what editors screen for, and how to frame a stronger.
Practical Frontiers in Microbiology submission guide: what the journal screens for, where papers fail, and how to prepare a stronger mechanistic.
Practical Endoscopy submission guide: what the journal publishes, what editors screen for, and how to prepare a stronger endoscopy-focused manuscript.
Practical Fuel submission guide: what the journal publishes, what editors screen for, and how to prepare a stronger combustion or fuels manuscript.
Practical Global Change Biology submission guide: what the journal publishes, what editors screen for, and how to frame a stronger mechanism-led.
Genome Biology submission guide covering scope, submission setup, cover-letter strategy, and what genomics editors screen before review.
Gut submission guide covering scope, ScholarOne setup, cover-letter strategy, and what editors screen before review.
Practical Hepatology submission guide: AASLD requirements, ScholarOne setup, and what liver-disease editors look for before review.
ACS Nano submission guide covering scope, Paragon setup, editorial fit, and what nanoscience editors screen before review.
Practical Ageing Research Reviews submission guide: scope, review-article requirements, and what editors look for before review.
Practical Allergy submission guide: scope, ScholarOne setup, and what editors look for before review. See what editors expect before you submit.
Carbohydrate Polymers submission guide covering scope, Elsevier setup, characterization depth, and what editors screen before review.
Clinical Psychology Review submission guide covering scope, review-article expectations, editorial fit, and what editors screen before review.
Practical Carbon Neutrality submission guide: scope, submission setup, and what editors look for before review. See what editors expect before you.
Cell Metabolism submission guide: editorial fit, in vivo expectations, cover letter framing, and the preparation issues that stop most manuscripts.
Cell submission guide: mechanistic completeness requirements, figure standards, cover letter framing, and editorial failure patterns from review work.
A practical submission guide for Artificial Intelligence in Agriculture covering editorial fit, article package quality, cover letter framing.
A practical Communications of the ACM submission guide: editorial fit, section choice, broad-audience framing, and the key package decisions.
Practical Clinical Infectious Diseases submission guide: what CID publishes, what editors screen for, and how to frame a clinically useful infectious.
A practical The Lancet submission guide for authors deciding whether the manuscript is broad enough, globally relevant enough, and ready for the journal.
A journal-specific guide to submitting to Advanced Energy Materials: scope fit, article type, cover letter strategy, editor priorities, and what to.
Journal of Cleaner Production submission guide with manuscript limits, formatting rules, cover letter tips. What editors want and how to avoid desk.
Submitting to Nucleic Acids Research? Here's what to prepare for article type, formatting, data sharing, benchmarking, and what editors want before.
A practical JBC submission guide for authors deciding whether the manuscript is mechanistic enough, complete enough, and positioned clearly enough before submission.
Submitting to Sustainability? Learn article structure, formatting priorities, ethics and data requirements, and what editors want before they send a.
Advanced Functional Materials submission guide with manuscript limits, formatting rules, cover letter tips. What editors want and how to avoid desk.
A package-readiness guide to JAMA covering manuscript shape, Key Points, structured abstract, and general-medicine fit before upload.
A practical guide to submitting to Nature Genetics, including what editors look for in large-scale genetics and genomics papers and how to prepare the package.
A practical Lancet Oncology submission guide for authors deciding whether the paper is clinically mature, globally relevant, and package-ready.
Cell Metabolism and Nature Metabolism are the top venues for metabolic research. They have specific reviewer expectations that differ from other biology journals. Here's how to prepare a manuscript that passes their initial screening.
Top oncology journals have among the highest desk rejection rates in medicine. Cancer Cell, JCO, and Cancer Discovery are looking for specific things that most manuscripts don't deliver. Here's what they want and how to close the gap before you submit.
Frontiers in Immunology impact factor is 5.9 in 2024. Here is the Q1 context, the shortlist comparison, and what the number actually means for authors.
Nature rejects most submissions before a single external reviewer reads them. The reasons aren't about writing quality. Here's what the journal's editors actually look for and how to build a manuscript around those standards.
Construction and Building Materials requires 7,000-10,000 word manuscripts with complete durability data, cost analysis, and construction relevance. Here's exactly what editors need.
Journal of Hazardous Materials is a top-tier environmental and chemical safety journal with a 2024 impact factor of 11.3. We explain what the JIF number means and whether it should influence your submission decision.
Should you appeal desk rejection? Use this guide to decide when an appeal is worth it, when to move on, and how to stay credible.
How to avoid desk rejection at JAMA: breadth, endpoint strength, methods, and whether a study truly belongs in general medicine.
Science of The Total Environment processes over 10,000 submissions per year. This guide covers manuscript types, formatting requirements, data sharing policies, and what handling editors check first.
Science of The Total Environment takes roughly 6-10 weeks to a first decision for papers that reach peer review. Desk rejections arrive faster, around 2-4 weeks. Here's what determines your timeline.
Chemical Engineering Journal is one of the most-cited journals in its field with a JIF of 13.2, but it doesn't publish its acceptance rate. Here's what drives acceptance and how to prepare your submission.
Science of The Total Environment doesn't report an official acceptance rate, but desk rejection is significant for scope mismatches. Here's what editors actually look for and where most environmental science papers fail.
JACS handles about 40,000 submissions per year and provides first decisions in 4-8 weeks for most papers. Around 40-50% never reach external reviewers. Here's what the timeline looks like at every stage.
IJMS accepts around 30-40% of submissions, making it one of the more accessible Q1 journals in molecular sciences. Here's the full breakdown on selectivity, desk rejection, and what reviewers look for.
Physical Review B accepts around 60-65% of papers sent to review, but the desk rejection rate is notable. Here's what the selection process actually looks like for condensed matter and materials physics.
JBC doesn't publish its official acceptance rate, but consistent author experience places it around 30-35%. Here's what that means in practice, what triggers desk rejection, and how the review process works.
International Journal of Molecular Sciences (IJMS) is an MDPI journal known for fast review. First decisions typically arrive in 3-5 weeks. Here's what the timeline looks like and what influences your wait.
Chemical Engineering Journal (JIF 13.2, Q1) is one of the top journals in chemical engineering and applied chemistry. This submission guide covers what you need to know before you submit: formatting, scope, common desk rejection triggers, and what reviewers look for.
Advanced Materials (JIF 26.8, Q1) is one of the most selective materials science journals. This submission guide covers format requirements, what passes the desk, what reviewers actually assess, and how to improve your odds.
International Journal of Molecular Sciences (MDPI) accepts a relatively high proportion of submitted papers, but there are still formatting requirements, scope constraints, and common mistakes that trip up first-time submitters. This guide covers everything you need.
IEEE Access is one of the fastest major engineering journals. Most first decisions arrive in 3-6 weeks. Here's how the process works and what to do if things slow down.
If you're searching NEJM Evidence impact factor, the key point is JIF status and how committees in your field view this title.
Genes & Development is the CSHL Press journal for gene regulation with IF 7.5. Here's when your paper fits, how it compares to Molecular Cell, EMBO Journal, and Development, and what editors reward.
A practical Neuron fit verdict for authors deciding whether their neuroscience paper is broad and mechanistic enough for one of the strongest Cell Press journals.
A practical Nature Methods fit verdict for authors deciding whether the method is broadly enabling, benchmarked, and adoptable enough.
A practical Nature Immunology fit verdict for authors deciding whether the manuscript is broad, mechanistically decisive, and field-shaping enough.
A practical Nature Neuroscience fit verdict for authors deciding whether the paper is causal, broad, and mechanistically complete enough.
Molecular Cell (IF 16.6, Cell Press) is the Cell family's mechanism-focused sibling. Here is who should submit and how it compares to Cell, Nature Cell Biology, and EMBO Journal.
A practical Nature Reviews Cancer fit verdict: what the journal is actually good for, who should pitch, and when it is the wrong target.
A fit-first Remote Sensing verdict on what paper types belong here, what weak-fit submissions get wrong, and when another venue is smarter.
Journal of Cleaner Production (IF 10.0) is one of the highest-impact sustainability journals. This guide covers its editorial scope, how it compares to Resources Conservation & Recycling and MDPI Sustainability, and when it fits.
Journal of Hazardous Materials (IF 11.3) is Elsevier's flagship for hazard assessment, contaminant fate, and remediation. Here is who should submit, how it compares to ES&T and Chemosphere, and when another journal is smarter.
Journal of Materials Chemistry A (IF 9.5, RSC) is the go-to venue for materials serving energy and sustainability applications. Here is how it compares to ACS Energy Letters, Advanced Energy Materials, and J. Power Sources.
A practical Sensors fit verdict for authors deciding whether the manuscript is truly sensor-first, validated, and useful enough for this broad journal.
Journal of Neuroscience (IF 4.0) is the Society for Neuroscience flagship. Its IF has declined but it remains the broad-field society journal. Comparison with Nature Neuroscience, Neuron, Brain, and eNeuro.
A practical Sustainability fit verdict for authors deciding whether the manuscript has real systems, policy, or implementation value.
A practical STOTEN fit verdict for authors deciding whether their paper is broad, hypothesis-driven, and strong enough for a cross-sphere environmental audience.
Sustainability (MDPI) impact factor is 3.3 (JCR 2024). Q2, rank 80/191. 103,000+ papers. APC $2,382. See the trend and honest assessment.
Journal of Cleaner Production acceptance rate is approximately 25-30%. IF 10.0 (2024 JCR), Q1. Desk rejection is moderate. Here's what gets through.
A practical NAR fit verdict for authors deciding whether the manuscript or resource has durable value for the nucleic-acid community.
A practical BMJ fit verdict for authors deciding whether the manuscript is broad enough and transparency-ready enough for this journal.
eLife and PLOS ONE both challenged traditional peer review but built very different journals. eLife is a selective, high-quality biology journal. PLOS ONE is a megajournal for technically sound work. Here's why they're not interchangeable.
Impact factor is a simple formula that gets complicated fast. Here's exactly what it measures, what it doesn't, and how researchers actually use it.
NEJM desk-rejects more than 80% of submissions, often within 7 days. The cover letter is your first and sometimes only chance to make the case for why your paper belongs there.
A practical NEJM fit verdict for authors deciding whether the manuscript is decisive enough and broad enough for a flagship clinical audience.
JAMA receives 6,000+ manuscripts per year and publishes fewer than 5%. The cover letter is your argument for why your research belongs in the most-read general medical journal in the US.
JAMA is the AMA flagship with IF 55.0 and 4% research acceptance rate. Here's when it's the right target, what the 2-day desk triage actually evaluates, and when NEJM, Lancet, or a JAMA Network specialty journal is the better choice.
JAMA's overall acceptance rate is around 5%, with over 80% desk-rejected before peer review. Here's what the numbers mean and what actually determines whether your paper clears each stage.
Gut (IF 25.8, BMJ/BSG) is a top-3 gastroenterology journal with a signature strength in microbiome research. This guide covers its 4,000-word limit, new editorial expansions, and how it compares to Gastroenterology, J. Hepatology, and Lancet Gastro.
Nature accepts ~8% of submissions and desk-rejects 75-80% without review. What that 8% have in common and whether your manuscript belongs there.
Lancet Oncology (IF 35.9) publishes practice-changing cancer research with a global perspective. 75% desk rejection rate. How it compares to JCO, Annals of Oncology, and JAMA Oncology.
A practical Science Translational Medicine fit verdict for authors deciding whether their work is translational, clinical, and complete enough.
Nature and Cell are both top-tier for biology, but they want different things. Here's how to choose between them.
Author order disputes usually do not start with bad faith. They start with ambiguity. If the team never made the rules explicit, the paper becomes the place where status, labor, and credit all collide.
Desk rejection is not a side statistic. In many journals it is the main editorial filter. This report looks at the current Manusights journal dataset to show where that filter is harshest and what authors should infer from it.
Fast review times sound attractive until you realize that some of the fastest journals are simply fast at saying no. The slowest journals are not always inefficient either. In 2026, the extremes make sense once you read them as editorial systems rather than as isolated numbers.
Impact factor looks like a simple ratio, and in one sense it is. The confusion starts when authors assume the ratio is more objective, field-neutral, or paper-level than it actually is.
A lot of authors looked at JCR 2024 and thought journals themselves had suddenly changed. In many cases, the bigger change was how Clarivate organized rankings, counted visibility, and surfaced journals in the comparison set.
Top journals do not reject strong papers because they hate good science. They reject strong papers when the question is too narrow, the evidence is too thin, or the framing does not justify elite attention.
A strong abstract does not try to summarize every detail. It tells a busy editor, reviewer, or reader what the paper is about, what was done, what was found, and why it matters, without overselling.
A methods section does not exist to prove that you did something complicated. It exists to let a skeptical reader understand exactly what you did, why you did it, and whether the results can be trusted.
Journal metrics are useful when you know what they measure and dangerous when you assume they answer more than they do. The trick is not picking one winner, but understanding what each metric sees.
A rejection letter is rarely the end of a manuscript. In 2026, a lot of papers move through transfer networks, publisher families, and informal fallback routes before they finally get published. The useful question is not whether transfer exists. It is how much of your review work and momentum survives the move.
The internet answer to 'Are MDPI journals good?' is usually tribal. The useful answer is more conditional. MDPI is a legitimate major publisher, but journal quality inside the portfolio is uneven enough that authors should assess titles one by one.
People talk about Nature, Science, and Cell as if they are one prestige bucket. They are not. The metrics overlap, but the editorial personalities are genuinely different, and those differences matter more than one or two points of impact factor.
APCs are no longer a niche publishing detail. For many labs, they shape journal choice almost as much as scope or impact factor does. The useful question is not whether APCs are high, it is where they are high, why they differ, and what authors can still do about them.
Preprint servers are not interchangeable. The right choice depends on field norms, public-health risk, moderation, journal policy, and whether early visibility helps or harms your workflow.
Acceptance rate sounds like the cleanest statistic in journal publishing. It isn't. The number is often estimated, rarely standardized, and easy to misread without desk rejection, scope, and post-review context.
Salami slicing is not just publishing more than one paper from one project. It is splitting essentially the same research question into thin papers that mislead readers about originality, overlap, or independence.
Self-plagiarism is a messy label because it mixes at least three different problems: text recycling, duplicate publication, and undisclosed overlap. The details matter.
Most papers do not get in trouble because a statistician loves complexity. They get in trouble because the design, analysis, and reporting do not support the strength of the claims being made.
Acceptance is not the end of the publishing process. It is the handoff from editorial decision-making to production, licensing, proofing, and final release, which creates its own delays and mistakes.
JAMA and NEJM are both top-tier clinical journals, but they have different editorial personalities. Here's how to decide between them.
Open access policy is now a workflow problem, not a side note for the acknowledgments section. If you wait until acceptance to think about compliance, you often limit your journal options too late.
Both are high-impact open-access multidisciplinary journals. Nature Communications has the higher IF. Science Advances is more selective. Here's how to choose.
You've hit submit. Now what? Here's everything that happens to your paper from that moment until you get a decision.
After reading 50 cover letters for journal submissions in a single week, the patterns were painfully obvious. Here's what stood out.
You just got desk rejected. Here's what that means, why it happened, and the step-by-step plan for what to do next.
With 18.5% success rate, 81.5% of early-career researchers don't get funded on first try. Here's how to protect your publication record and maximize your odds.
Headlines said budget cuts. Final numbers show budget went up. Both are true. Here's the full story of what happened with NIH funding in 2025.
Desk rejection hurts, but it's not the end of your paper. About 40% of manuscripts get desk rejected at high-impact journals. Here's what to do in the next 2-4 weeks to turn this around....
ACS Nano vs Advanced Materials: scope differences, acceptance rates, and editorial philosophy for nanotechnology and materials science submissions.
ACS Applied Materials & Interfaces (IF 8.2) is the biggest volume ACS journal in materials. This guide covers its application-first editorial test, APC, and how it compares to ACS Nano and Advanced Functional Materials.
Construction and Building Materials impact factor is 8.0 (JCR 2024). Q1, rank 8/183. h-index 340. APC $3,780. Trend, comparisons, and what editors want.
International Journal of Hydrogen Energy has a 2024 JIF of 8.3 (Q1, rank 6/44 in Hydrogen Energy). Learn what the JIF means for energy research authors.
Nature Genetics (IF 29.0) demands scale plus functional follow-up and ancestry diversity. 11-day median first decision. Comparison with Nature, Cell, AJHG, and Genome Research.
Compare Gut (IF 25.8) vs Hepatology (IF 15.8) with JCR 2024 data, scope differences, acceptance rates, and field-specific career impact analysis.
Compare Immunity vs Journal of Immunology: JIF 19.9 vs 5.0 (2024 JCR), scope differences, acceptance rates, and which journal fits your immunology research.
Nature (IF 48.5, ~6% acceptance) vs Science Advances (IF 12.5, ~10% acceptance). How to choose, key differences, and when each is right.
Nature Medicine (IF 50.0) vs Nature Biotechnology (IF 41.7). One publishes disease breakthroughs. The other publishes technology platforms.
Nature Medicine (IF 50.0) vs Cell (IF 45.5). One wants disease mechanism with clinical bridge. The other wants fundamental biological insight.
Compare Science vs Cell: JIF 45.8 vs 42.5, multidisciplinary vs cell biology focus, acceptance rates, and which journal is the right fit.
PLOS ONE (IF 2.6) vs Scientific Reports (IF 3.9). Both are megajournals with rigor-only review. Here's the real difference and which one fits your paper.
Science (IF 45.8, <7% acceptance) vs Scientific Reports (IF 3.9, 57% acceptance). These are not competing journals.
Journal of Materials Chemistry A IF 9.5 in 2024. Q1, rank 63/460. 25-30% acceptance. What it means for your submission.
Applied Energy impact factor is 11.0 (JCR 2024). Q1, rank 12/175 in Energy. h-index 375, APC $4,140. See trend, comparisons, and what editors want.
Cell Reports is fast at the desk and reasonably predictable after that. This guide explains what the timeline usually looks like, what causes delays, and how to interpret the speed of the process without overreading it.
JAMA (IF 55.0) vs The Lancet (IF 88.5). JAMA rewards US clinical utility. The Lancet rewards global consequence. Both desk-reject 80%+.
JCI accepts roughly 10% of submissions. Desk rejection accounts for 60-70%. What the selectivity means for translational and clinical papers.
JCI takes 2-3 weeks for desk decisions and 8-12 weeks to first decision after review. Dual mechanism + disease requirement explained.
Nature (7% acceptance) publishes breakthroughs. PLOS ONE (31% acceptance) publishes sound, reproducible science. Which one your paper belongs in.
Nature: 7% acceptance, breakthroughs only. Scientific Reports: 36% acceptance, sound reproducible science. How to choose between the two.
Applied Physics Letters does not release a verified acceptance rate. The real filter is whether the finding fits a focused 4-page letter with clear applied physics relevance.
Cell formatting guide. Word limits, figure specs, reference format, LaTeX vs Word, and journal-specific formatting quirks you need to know.
Cell Metabolism does not publish a strong official acceptance rate. The better submission question is whether the study reveals a metabolic mechanism with physiological or disease significance.
Cell Metabolism editors are screening for papers where metabolism is the central biological story, not a supporting character. A strong cover letter makes that metabolic focus obvious fast.
Energy (Elsevier) is not Applied Energy. It wants the full picture: technical analysis alongside policy implications and system-level thinking.
Gastroenterology requires AI disclosure in Methods under a dual AGA and Elsevier framework, prohibits AI authorship and AI-generated images, and expects clinical guideline content to remain human-generated.
Gut editors are screening for translational GI research with mechanistic teeth, not descriptive clinical observation. A strong cover letter makes that translational case obvious fast.
Immunity editors are screening for mechanistic immunology that changes field understanding. A strong cover letter makes that conceptual shift obvious fast.
Immunity formatting guide. Word limits, figure specs, reference format, LaTeX vs Word, and journal-specific formatting quirks you need to know.
Chemical Communications publishes 4-page chemistry Communications with 30-35% acceptance and fast 2-4 week review. Learn the format constraints and how ChemComm compares to Angewandte.
Pre-submission guide for ES&T covering environmental relevance requirements, data quality expectations, and the ACS editorial bar.
Pre-submission guide for European Heart Journal covering ESC editorial standards, desk-rejection triggers, and how EHJ compares to Circulation.
Pre-submission guide for Frontiers in Microbiology covering section selection, collaborative review process, and what editors check before peer review.
Pre-submission guide for Frontiers in Plant Science covering section fit, APCs, the collaborative review model, and editorial screening criteria.
Pre-submission guide for Journal of Alloys and Compounds covering structure-property requirements, inorganic materials scope, and editorial expectations.
Molecular Cell accepts 15-18% of submissions and desk-rejects 65-70%. This guide explains the mechanism-first editorial standard and what Cell Press editors screen for.
Nature Immunology accepts 8-10% of submissions and desk-rejects 70-80%. This guide covers the fundamental discovery standard, mechanistic depth requirements, and how it compares to Immunity.
Nature Medicine accepts 7-9% of submissions and desk-rejects ~85%. This guide covers the translational research bar, what separates Nature Medicine from Nature and NEJM, and the cascade transfer pathway.
Nature Methods accepts 8-10% of submissions and desk-rejects 70-75%. This guide covers the methodological innovation bar, benchmarking requirements, and how it differs from Nature Biotechnology.
Renewable & Sustainable Energy Reviews is a review-only journal with IF 16.3 and Q1 ranking. This guide covers what readiness means for a synthesis article, how RSER compares to alternatives, and when it fits.
Science accepts ~7% of submissions and desk-rejects ~75% within 7-10 days. This guide covers what AAAS editors filter for, article type selection, and when Science is a better target than Nature.
Sensors is not predatory. It has a 3.5 Impact Factor and SCIE/Scopus indexing - but MDPI's special issue dominance and fast review timelines are the real concerns.
JAMA requires detailed AI disclosure in Methods including tool name, version, and manufacturer, prohibits AI authorship, and applies the same policy across all 14 JAMA Network journals.
JAMA Oncology editors are screening for clinically important oncology evidence that can survive close methodological scrutiny. A strong cover letter makes both obvious fast.
Journal of Power Sources editors screen for rigorous electrochemical data and practical device relevance. A cover letter that reports material novelty without real performance numbers gets desk-rejected.
The Lancet gives you 300 words. Most journals give you a full page. That constraint changes everything about how you write a cover letter, and most authors get it wrong by trying to compress a standard letter instead of writing a different kind of letter entirely.
The Lancet formatting guide. Word limits, figure specs, reference format, LaTeX vs Word, and journal-specific formatting quirks you need to know.
Molecular Cell Articles allow ~7,000 words with a mandatory 1,200 x 1,200 px graphical abstract. Cell Press numbered references, STAR Methods with a Key Resources Table documenting every reagent, and structural data deposition are required.
Nano Letters editors are screening for physical insight at the nanoscale, not just strong characterization data. A strong cover letter makes that insight obvious fast.
Nature editors are screening for broad scientific consequence, not just excellent discipline-specific work. A strong cover letter makes that flagship case obvious fast.
Neuron Articles allow ~7,000 words with a mandatory 1,200 x 1,200 px graphical abstract. Cell Press numbered references, STAR Methods with Key Resources Table, and exhaustive electrophysiology documentation are required.
Renewable & Sustainable Energy Reviews does not publish a strong official acceptance rate. The better submission question is whether the manuscript is a genuinely analytical review with broad energy value.
Science Advances reaches first decision in 6-12 weeks for papers that pass the desk. Here's how the AAAS academic editor model affects your timeline.
Science Advances is OA-only at $1,900 APC. Nature Communications covers all disciplines with pro editors. Which fits your field and APC budget?
PNAS impact factor is 9.1 (JCR 2024), down from 9.4 in 2023. CiteScore 21.5, SJR 3.414, and the long-term trend explained.
PLOS ONE impact factor is 2.6 (JCR 2024). h-index 589, 12M citations. The most-published journal in science. Honest assessment of what 2.6 means.
BMJ Open impact factor is 2.3 (JCR 2024). CiteScore 4.5, SJR 1.016. Q2 in JCR, Q1 in Scopus. See what the metrics mean for submissions.
JAMA is for oncology papers with broad clinical or policy consequence across medicine. JAMA Oncology is for oncology papers whose main audience is still cancer care.
A practical Physical Review B submission process guide covering the APS portal workflow, editorial triage, peer review stages, and what each status means for authors.
A practical Annals of Oncology process guide covering what happens after upload, what editors test first, and where oncology papers lose momentum.
A practical PLOS ONE submission guide covering what editors screen for, how to pass the soundness bar, and what must be ready before upload.
A practical Nature Biotechnology submission guide for authors deciding whether the platform, method, or biotechnology system is broad enough, benchmarked enough, and mature enough for the journal.
A package-readiness guide to eLife covering preprint readiness, public-review fit, evidence strength, and what must be stable before submission.
JAMA and The Lancet are both elite flagship journals, but they reward different types of clinical importance. The right choice depends less on prestige and more on what kind of consequence your paper actually has.
Cell Reports and Scientific Reports are both open-access biology journals, but they're targeting completely different audiences and selectivity levels.
Both are open-access biology journals, but Cell Reports is selective while PLOS ONE is inclusive. Learn which one fits your work and career stage.
Both are prestigious journals, but JCI leans clinical while Nature Medicine emphasizes translational mechanism. Learn which one matches your paper.
Nature Immunology and Immunity are the top-tier venues for immunology research, with desk rejection rates above 60%. Here's what their reviewers look for and what pre-submission review covers for manuscripts targeting this tier.
BMJ and The Lancet are both elite journals, but they are not interchangeable. One rewards practical clinical evidence with transparency, the other rewards broader international consequence.
Advanced Materials is 3× more selective and cites applied work. ACS Applied Materials is faster, broader, and accessible. Choose AM for materials breakthroughs, ACSA&I for applications that prove value.
Nature Medicine and The Lancet are both top-tier journals, but they serve different audiences. Learn when to submit to each one.
Both Wiley journals, both selective, but Advanced Materials demands novelty in synthesis or characterization. Advanced Functional Materials cares more about application. Here's how to choose.
Both are selective nanoscience journals under ACS. ACS Nano takes comprehensive studies, Nano Letters takes high-impact single results. Same acceptance rate, different article lengths.
Almost identical impact factors. Advanced Energy Materials is 4× more selective in practice because it demands energy application. Advanced Materials demands novelty in the material itself, not the application.
Both selective nanoscience journals. Small publishes comprehensive nano work (Wiley). Nano Letters publishes striking single results (ACS). Choose based on article length you need.
JACS and Scientific Reports are both published broadly, but JACS is selective chemistry and Scientific Reports is inclusive multidisciplinary. For chemists, the choice is mechanistic novelty vs methodological soundness.
Angewandte Chemie and Scientific Reports both publish chemistry broadly. But Angewandte is selective general chemistry with novelty bar. Scientific Reports is inclusive and rigor-focused. Know which your chemistry fits.
Desk rejection rates range from 15% at PLOS ONE to 90% at NEJM. Here is the data for 30+ major journals, what the numbers mean for your submission, and how to reduce your desk rejection risk.
Desk rejection costs more than a setback. The real price includes 3 to 6 months lost, APC exposure averaging $1,626, and compounding career impact for early-career researchers.
JACS is the gold standard in chemistry. Impact factor 15.6, published by ACS since 1879, roughly 20% acceptance rate. Here's an honest assessment of who it's right for and who should look elsewhere.
Journal of Cleaner Production processes most submissions within 6-10 weeks to first decision. Here's how the review process works and what factors affect your timeline.
IEEE Access accepts approximately 45-50% of submissions, making it one of the most open IEEE journals. This guide explains what that high acceptance rate means and what reviewers still look for.
A practical Nature Chemical Biology fit verdict with JCR 2024 comparisons to JACS, Angewandte, and ACS Chemical Biology, plus career impact analysis.
JBC IF 3.9 (JCR 2024), Q2. Founded 1905, fully OA since 2021. 18.3-year citation half-life: the longest in biology. ASBMB flagship, ~50% acceptance.
Nature Communications accepts ~8% of submissions. 8-day desk decision, 4.3-month acceptance timeline. Where papers get filtered and how to improve your odds.
Nature Medicine impact factor is 50.0, SJR 18.333. See the five-year JIF, rank, quartile, and what these numbers mean before you submit.
Publishing your first paper is one of the most disorienting parts of an academic career. Here's the full process, from choosing a journal to responding to reviewers.
Selective OA vs megajournal. NComms ($7,350, ~8% accepted) vs PLOS ONE ($2,477, ~31% accepted). When each is the right target.
PNAS and Science Advances are both broad-scope journals below Nature/Science but above most specialty journals. Here's how they compare.
Nature Communications is fast by high-impact journal standards. Desk decisions in under 2 weeks, first decisions in about a month. Here's exactly what happens at each stage.
Circulation is the flagship journal of the American Heart Association and one of the fastest major journals for desk decisions. Here's what the submission process looks like, what the editorial team prioritizes, and how to avoid the most common rejection reasons.
Science Advances rejects about 90% of submissions, most without external review. Here's the full breakdown: desk rejection patterns, how long each stage takes, and what makes the ~10% that get published.
PNAS accepts about 16-19% of direct submissions after a 54% desk rejection filter. The Significance Statement is the most important 120 words in your submission.
A revision decision is not just a label. It is the editor's shorthand for how much trust remains in the manuscript, how much work is expected, and how close the paper is to acceptance.
PLOS ONE's acceptance rate has dropped from 68% in 2015 to 31% today. That's not a sign the journal got harder to publish in. It's a sign of who's submitting now, and understanding that changes how you should read the number.
Cell Reports' 15-20% acceptance rate sounds daunting. But that number includes papers that never had a shot at this journal. Once you understand how the rate breaks down, submitting to Cell Reports looks very different.
Nature journal impact factor is 48.5 in 2024 after the COVID-era spike normalized. Here is the trend, what drove the change, and what the number means for authors.
Scientific Reports has a 3.9 impact factor, 57% acceptance rate, and carries the Springer Nature name. Some researchers swear by it. Others question the model. Here's the honest answer on all of it.
Nature desk rejects 70% of submissions. Cell rejects 65%. Here's how to avoid desk rejection and get your paper to peer review.
The journal you pick matters more than most researchers think. A great paper sent to the wrong journal gets rejected. Here's how to match your manuscript to the right target.
EMBO Journal impact factor is 8.3 (JCR 2024). Q1, rank 30/319 in Biochemistry & Molecular Biology. Five-year JIF 10.6. What the numbers mean for authors.
Sensors IF 3.5 in 2024. Q2, rank 24/79. 40-50% acceptance. What it means for your submission.
Nature Biotechnology impact factor is 41.7 (JCR 2024). Q1, rank 2/177 in Biotechnology. Five-year JIF 59.5. Acceptance rate, review time, and what editors want.
Cell Host & Microbe fit verdict with key metrics, comparison to Nature Microbiology and Immunity, and practical guidance for host-pathogen and microbiome researchers.
JCO (IF 41.9) is the ASCO flagship for practice-changing oncology. Here's when your paper fits, how it compares to Lancet Oncology, Annals of Oncology, and JAMA Oncology, and what the 15% acceptance rate really means.
Cancer Research (IF 16.6, AACR) is the default top venue for basic cancer biology. Here is who should submit and how it compares to Cancer Cell, Cancer Discovery, and Clinical Cancer Research.
Applied Surface Science (IF 6.9, Elsevier) is a mid-tier applied materials journal strongest for surface characterization with functional consequence. Here's how it compares and who should submit.
Astronomy & Astrophysics (IF 5.4, EDP Sciences/ESO) is the flagship European astronomy journal. Here's how it compares to ApJ, MNRAS, and Nature Astronomy.
Carbohydrate Polymers (IF 12.5, Elsevier) is a niche but high-impact journal for polysaccharide and carbohydrate-based materials. Here's who fits and who doesn't.
Clinical Cancer Research fit verdict: IF 10.2, AACR translational oncology. Here is when it fits and when Cancer Discovery or a disease-specific journal is smarter.
Fuel is Elsevier's flagship for fuel science and technology with IF 7.4. Here's when your paper fits, what gets desk-rejected, and how it compares to Applied Energy, Energy & Fuels, and Combustion and Flame.
Lancet Neurology (IF 45.5) is the #1 ranked clinical neurology journal and the hardest Lancet specialty journal to publish in. Here's what practice-changing neurology actually means and when Brain, JAMA Neurology, or Annals of Neurology is the better target.
Advanced Functional Materials (IF 19.0) sits between Advanced Materials and specialty journals. Here's the editorial distinction: function must drive the story, not composition.
ACS Nano is the ACS flagship for interdisciplinary nanoscience. Here's when the nanoscale makes your paper ACS Nano material, and when Nano Letters, Nature Nanotechnology, or Advanced Materials is the better fit.
Environmental Science & Technology fit verdict: IF 11.3, ACS flagship. Here is when it fits and when Water Research or J. Hazardous Materials is smarter.
Food Chemistry fit verdict: IF 9.8, Elsevier. Here is when it fits and when Food Hydrocolloids or JAFC is the smarter move.
JCP (IF 3.5, AIP) is THE chemical physics journal for theoretical, computational, and experimental molecular science. Here's when your paper fits, how it compares to J. Physical Chemistry, PCCP, and JCTC.
IJBM (IF 8.5) is Elsevier's main venue for biopolymer research, proteins, polysaccharides, nucleic acids. Here's when your paper fits, what editors want, and how it compares to Carbohydrate Polymers and Biomacromolecules.
Circulation Research (IF 16.2, AHA) is the top journal for basic and translational cardiovascular science. Here is who should submit and how it compares to Circulation, EHJ, and JACC.
JAMA Cardiology (IF 14.1) is the JAMA Network's cardiovascular journal. Here's when it's the right target, how the JAMA transfer pipeline works, and how it compares to JACC, Circulation, and EHJ.
Hepatology is the AASLD flagship with IF 15.8, the premier US liver journal. Here's when your paper fits, what editors want, and how it compares to J. Hepatology, Gut, and Lancet Gastroenterology.
Construction and Building Materials fit verdict: IF 8.0, Elsevier. Here is when it fits and when Cement and Concrete Research or Building and Environment is smarter.
Angewandte Chemie (IF 16.6, GDCh/Wiley, Q1) is the most prestigious communication-format chemistry journal. Here is who should submit and how it compares to JACS and Nature Chemistry.
European Heart Journal is the ESC flagship with IF 35.6, the highest impact factor in cardiology. Here's when your paper fits, what editors prioritize, and how it compares to Circulation, JACC, and JAMA Cardiology.
Frontiers in Immunology is a high-volume OA journal with IF 5.7 and a collaborative peer review model. Here's when it fits, the legitimacy question, and how it compares to J. Immunology, JEM, and Immunity.
Gastroenterology (IF 25.1, AGA) is the US GI flagship and counterpart to Gut. Here is who should submit and how it compares to Gut, Journal of Hepatology, and Lancet Gastroenterology.
AJE is good at language polishing and giving anxious authors a familiar workflow. It is less compelling when what you need is deep scientific judgment before a high-stakes submission.
Sometimes reviewers are wrong. Here's how to disagree professionally while protecting your paper's chances of acceptance.
You've finished the draft. You're ready to submit. But are you? Here are the warning signs that your paper needs more work.
Manuscript readiness scoring evaluates whether your paper is ready for a specific journal before you submit. Here is how it works, what the dimensions mean, and how to use the results.
Journal of Biological Chemistry usually takes about 8 to 12 weeks to a first decision. Here is the real JBC review timeline and what slows it down.
Practical Environmental Science & Technology submission guide: what the journal publishes, what editors screen for, and how to package a stronger EST.
A practical BMJ submission guide: how to judge fit, prepare the package, and avoid obvious editorial misses before you submit.
A practical Annals of Oncology submission guide covering package readiness, editorial priority signals, and what to fix before upload.
A package-readiness guide to Nature covering first-page consequence, broad-reader framing, and what must be stable before submission.
Nature, Science, and Cell are often treated as a single prestige tier. They're not interchangeable. Here's how to decide which journal fits your manuscript and why targeting the wrong one wastes months.
21% of ICLR 2025 reviews were fully AI-generated. Not AI-assisted: fully written by an LLM. Here's what that means for your next submission and how to protect your work.
Most desk rejections aren't about bad science - they're about fixable problems editors spot in the first 60 seconds. Here's what they look for.
Construction and Building Materials median time to first decision: ~100-150 days. Full publication timeline from submission to online.
International Journal of Biological Macromolecules IF 8.5 in 2024. Q1, rank 6/94. 32-38% acceptance. What it means for your submission.
Energy IF 9.4 in 2024. Q1, rank 3/79. 18-25% acceptance. What it means for your submission.
Chemical Engineering Journal impact factor is 13.2 (JCR 2024). Q1, rank 3/83 in Chemical Engineering. APC $4,000. Trend, comparisons, and what editors want.
IJMS impact factor is 4.9 (JCR 2024). Q1, rank 72/319 in Molecular Biology. h-index 409. 109,000+ papers. Honest trend analysis and submission guidance.
Advanced Functional Materials accepts 18-22% of submissions. IF 19.0 (2024 JCR), Q1. Here's what editors look for and what drives desk rejection.
Astrophysical Journal accepts approximately 35-40% of submissions. IF 5.4 (2024 JCR), Q1. Moderately selective. Desk rejection rate is roughly 20-25%.
Science Translational Medicine impact factor is 14.6 (JCR 2024). Q1, rank 3/195 in Medicine Research. h-index 357.
Science Advances first decisions usually land in about 4-8 weeks. Stage-by-stage timeline, status meanings, and when waiting should concern you.
Nature Medicine accepts about 7% of submissions. IF 50.0, bridging bench and bedside. Here's what the acceptance rate means and who gets published.
Bioresource Technology impact factor is 9.0. Five-year JIF 9.5, Q1, rank 1/20. See comparisons and what it means for authors.
Blood accepts roughly 15-20% of submissions. What the ASH flagship selects for and how the selectivity breaks down by paper type.
Blood takes 1-3 weeks for desk decisions and 6-10 weeks to first decision after review. ASH flagship process and what each stage means.
BMJ desk-rejects 80-85% within 1-3 weeks. Open peer review means you can see reviewer names. Full timeline and process details.
ChemSusChem impact factor is 6.6. Five-year JIF 7.7, Q1, rank 47/239. See comparisons and what it means for sustainable chemistry authors.
Circulation accepts about 7% of original research submissions. What that selectivity means, where papers get filtered, and when transfer is smarter.
eLife no longer accepts or rejects papers after review. All reviewed papers are published. What this means for selectivity and your decision.
eLife now publishes all reviewed papers with public reviews. No accept/reject. Timeline runs 4-8 weeks to reviewed preprint. How the new model works.
Environmental Science & Technology impact factor is 11.3. Five-year JIF 12.4, Q1, rank 19/374. See comparisons and guidance.
Frontiers in Plant Science impact factor is 4.8. Five-year JIF 5.7, Q1, rank 33/273. See comparisons and what it means.
JAMA desk-rejects 80%+ within 1-3 weeks. Papers entering review get decisions in 6-10 weeks. Full timeline and what each stage means.
The Lancet desk-rejects 80%+ within 1-2 weeks. After review, first decisions take 6-10 weeks. Full timeline and what each stage means.
Nature Biotechnology accepts roughly 8% of submissions. 70-80% desk-rejected. What the selectivity means and how to read it.
Nature Medicine desk-rejects 70%+ within 1-2 weeks. Papers in review get decisions in 8-14 weeks. Translational bridge requirement explained.
NEJM desk-rejects 90%+ within 1-2 weeks. Papers entering review get decisions in 4-8 weeks. Full timeline and what each stage means.
PNAS acceptance rate isn't published as a simple official number. Here's what authors should know about selectivity, rejection, and fit.
Water Research impact factor is 12.4 with a 5-year JIF of 12.9. Q1, rank 2/131. Comparisons, trend, and submission guidance.
If an AI review tool cannot explain how it handles confidentiality, citations, evidence, and adversarial inputs, it is not safe enough for a serious manuscript.
ACS Applied Materials & Interfaces has no strict word limit for Research Articles (most run 5,000-8,000 words). A TOC graphic (3.25 x 1.75 inches) is mandatory, references use ACS superscript numbered style, and Supporting Information is expected with every submission.
ACS Catalysis does not publish a strong official acceptance rate. The better submission question is whether the paper teaches something mechanistically important to catalysis, not just posts a good performance table.
ACS Nano does not publish a strong official acceptance rate. The better planning question is whether the nano dimension is scientifically decisive and backed by real functional proof.
ACS Nano has no strict word limit on full Articles (typically 6,000-10,000 words), while Letters cap at ~4,000 words. A TOC graphic (3.25 x 1.75 inches) is required, references use ACS superscript style, and Supporting Information is expected for nearly every paper.
Advanced Functional Materials limits Full Papers to 10 published pages and Communications to 5 pages. A TOC image (5 x 12.7 cm) is mandatory, references use Wiley numbered style, and exactly 5 keywords are required.
Advanced Materials formatting guide. Word limits, figure specs, reference format, LaTeX vs Word, and journal-specific formatting quirks you need to know.
Analytical Chemistry does not publish a strong official acceptance rate. The better planning question is whether the method is validated enough that another lab would trust and adopt it.
Angewandte Chemie does not publish a strong official acceptance rate. The better planning question is whether the chemistry is broad enough and sharp enough for a flagship Communication.
Angewandte Chemie Communications are limited to 4 printed pages. A TOC graphic (5 x 5 cm) and 450-character TOC text entry are mandatory. References use Wiley numbered style with bracketed citations, and both Word and LaTeX are accepted.
Applied Catalysis B does not disclose an official acceptance rate. The editorial filter that matters is whether your catalysis paper closes the loop from mechanism to environmental or energy application.
Applied Energy does not publish a strong official acceptance rate. The better submission question is whether the paper is really an energy-systems manuscript rather than a narrower component or materials story.
Applied Sciences does not publish a strong official acceptance rate. The better submission question is whether a broad, fast, section-based MDPI venue is actually the right signal for your paper.
Astronomy & Astrophysics does not release a verified acceptance rate. The real filter is whether the work delivers clear astrophysical insight with honest uncertainty quantification.
The Astrophysical Journal has no strict word limit but uses a page charge system. AASTeX (LaTeX) is the near-universal submission format, references use author-year citation style, and machine-readable tables are required for large datasets.
Bioinformatics does not release a verified acceptance rate. The real filter is whether the tool fills a genuine gap, the code is publicly available, and benchmarks against current methods are included.
Bioresource Technology does not publish a strong official acceptance rate. The better submission question is whether the manuscript reads like real conversion or resource-recovery technology rather than narrow lab work.
Blood requires AI disclosure in Methods under ASH rules, prohibits AI authorship and AI-generated images, and applies the same policy across Blood Advances and all ASH publications.
The BMJ requires AI disclosure in Methods and via its submission form, prohibits AI authorship and AI-generated images, and applies BMJ Publishing Group rules across all BMJ specialty journals.
BMJ formatting guide. Word limits, figure specs, reference format, LaTeX vs Word, and journal-specific formatting quirks you need to know.
BMJ Open formatting guide. Word limits, figure specs, reference format, LaTeX vs Word, and journal-specific formatting quirks you need to know.
Cancer Cell does not publish a strong official acceptance rate. The better submission question is whether the study delivers a mechanistic cancer biology advance with translational significance.
Cancer Research does not publish a strong official acceptance rate. The better submission question is whether the paper delivers a real mechanistic cancer advance for a broad AACR readership.
Cell Host & Microbe does not publish a strong official acceptance rate. The better submission question is whether the study reveals a host-pathogen or microbiome mechanism with infection or disease relevance.
Cell Host & Microbe editors are screening for true host-microbe interaction logic. A strong cover letter makes that mechanism obvious fast.
Cell Metabolism formatting guide. Word limits, figure specs, reference format, LaTeX vs Word, and journal-specific formatting quirks you need to know.
Cell Metabolism often tells authors relatively quickly whether a paper belongs in a flagship metabolism journal, but the real submission question is mechanistic consequence, not just speed.
Cell Reports formatting guide. Word limits, figure specs, reference format, LaTeX vs Word, and journal-specific formatting quirks you need to know.
Ceramics International does not disclose an official acceptance rate. The editorial filter that matters is whether your ceramics paper goes beyond structural characterization to demonstrate a clear property or application advance.
Chemical Communications does not release a verified acceptance rate. The real filter is whether a result justifies the strict 4-page rapid communication format.
Chemical Engineering Journal formatting guide. Word limits, figure specs, reference format, LaTeX vs Word, and journal-specific formatting quirks you need.
Chemical Reviews does not publish a strong official acceptance rate. The better submission question is whether the topic and author team are realistic for an invitation-led flagship review.
Chemical Reviews formatting guide. Word limits, figure specs, reference format, LaTeX vs Word, and journal-specific formatting quirks you need to know.
Chemical Reviews does not operate like a normal research-journal review clock. The real timeline includes proposal approval, long-form writing, peer review, revision, and production.
Chemical Society Reviews has no strict word limit for Review Articles (typically 15,000-30,000 words), while Tutorial Reviews run 8,000-15,000 words. Most articles are by invitation. References use RSC numbered style, and color figures are published free of charge.
Circulation formatting guide. Word limits, figure specs, reference format, LaTeX vs Word, and journal-specific formatting quirks you need to know.
Clinical Cancer Research does not publish a strong official acceptance rate. The better submission question is whether the study bridges laboratory cancer science and clinical application at the AACR translational standard.
Clinical Infectious Diseases does not publish a strong official acceptance rate. The better submission question is whether the paper actually changes infectious-disease diagnosis, treatment, prevention, or management.
Clinical Infectious Diseases editors are screening for patient-management relevance, not just interesting pathogen data. A strong cover letter makes that consequence obvious fast.
Construction and Building Materials charges $3,800-$4,200 for open access. Hybrid Elsevier journal. Free subscription track available. Full cost breakdown.
Construction and Building Materials desk-rejects papers that read like pure materials science. The cover letter must prove the material works in a construction context.
Construction and Building Materials formatting guide. Word limits, figure specs, reference format, LaTeX vs Word, and journal-specific quirks you need to know.
Diabetes Care does not publish a strong official acceptance rate. The better submission question is whether the study could change clinical diabetes management or ADA guideline recommendations.
eLife formatting guide. Word limits, figure specs, reference format, LaTeX vs Word, and journal-specific formatting quirks you need to know.
The EMBO Journal does not publish a strong official acceptance rate. The better submission question is whether the study reveals a molecular mechanism with enough novelty and rigor for one of Europe's flagship life-science journals.
ES&T does not publish a strong official acceptance rate. The better submission question is whether your paper moves toward solving an environmental problem.
ES&T formatting guide. Word limits, figure specs, reference format, TOC art, Supporting Information, and journal-specific quirks you need to know.
Environmental Science & Technology is often fast at triage and much slower once the paper enters a real environmental-review process.
European Heart Journal does not publish a strong official acceptance rate. The better submission question is whether the study is large-scale, clinically consequential, and positioned to influence ESC guidelines.
European Heart Journal editors are screening for cardiovascular findings with broad clinical impact. A strong cover letter makes the ESC-flagship case obvious fast.
Food Chemistry limits Research Articles to ~8,000 words, requires mandatory Highlights (3-5 items, 85 characters each), and uses Elsevier numbered references. Graphical abstracts are recommended but not mandatory.
Food Chemistry is often fast at filtering weak-fit submissions and much slower once a paper enters serious review. The useful submission question is fit.
Frontiers in Immunology allows 8,000 words for Original Research with a 350-word structured abstract and up to 15 figures. Author-date references and strict Frontiers template adherence are required.
Frontiers in Microbiology does not publish a strong official acceptance rate. The better submission question is whether the paper is section-ready, review-ready, and suited to the Frontiers model.
Frontiers in Plant Science has 25+ specialty sections. The cover letter's main job is getting the paper routed correctly. Name the section, name the organism, state the finding.
Fuel editors screen for practical relevance to real fuel systems and will desk-reject pure modeling without experimental validation.
Gastroenterology does not publish a strong official acceptance rate. The better submission question is whether the study advances GI or liver science with clinical or mechanistic significance at the AGA flagship level.
Gastroenterology can move quickly at the desk, but the real question is not just speed. It is whether the paper is broad and complete enough to survive flagship-GI review.
Genome Biology does not publish a strong official acceptance rate. The better submission question is whether the paper gives the genomics community something it will actually adopt or reuse.
Gut reports some editorial metrics but does not publish a fully stable official acceptance rate. The better submission question is whether the study delivers GI research with population-level or practice-changing significance.
Gut formatting guide. Word limits, figure specs, reference format, LaTeX vs Word, and journal-specific formatting quirks you need to know.
Gut is often faster than many journals at its level, but the useful question is still fit. A quick desk answer does not change the flagship-GI bar.
Hepatology does not publish a strong official acceptance rate. The better submission question is whether the study advances liver science with the clinical or mechanistic significance the AASLD flagship demands.
Hepatology usually tells you fairly quickly whether the paper is in range, but the real submission question is whether the manuscript has enough liver-specific weight to justify the full review cycle.
IEEE Access formatting guide. Word limits, figure specs, reference format, LaTeX vs Word, and journal-specific formatting quirks you need to know.
Immunity does not publish a strong official acceptance rate. The better submission question is whether the study reveals an immunological mechanism with enough significance and breadth for the Cell Press immunology flagship.
Immunity often tells you quickly whether the paper is in range, but the real submission question is whether the mechanism is deep enough for a flagship immunology review.
IJBM editors desk-reject papers where the biological macromolecule is incidental rather than the central research subject.
IJHE editors desk-reject papers where hydrogen is peripheral rather than the central research subject.
IJMS academic editors screen for scope fit, methodological completeness, and MDPI compliance items before anything else.
International Journal of Molecular Sciences formatting guide. Word limits, figure specs, reference format, LaTeX vs Word, and journal-specific formatting.
Applied Sciences is a legitimate MDPI journal, not a predatory one. The real decision is whether its broad, section-driven, high-volume model is the right fit for your work.
MDPI is not a clean fit for the word predatory, but it is also not a publisher authors should treat casually. The real question is journal-by-journal trust and strategic fit.
ACS Applied Materials & Interfaces requires demonstrated application data, not just material characterization. Learn the editorial bar, acceptance rate, and how to avoid desk rejection.
ACS Nano requires genuine nanoscale science where size-dependent properties drive the findings. Learn the scope fit, acceptance rate, and how it differs from Nano Letters.
Advanced Energy Materials requires quantified device performance data with energy relevance. Understand the IF 24.4, 15-20% acceptance rate, and how AEnM differs from AFM.
Advanced Functional Materials prioritizes demonstrated function over pure novelty. Learn the acceptance rate, scope fit, and how AFM differs from Advanced Materials.
Advanced Materials desk-rejects 50-60% of submissions for insufficient novelty. Understand the IF 26.8 bar, visual quality expectations, and what 'advanced' really means editorially.
Analytical Chemistry requires rigorous method validation and comparison data. Learn the 25-30% acceptance rate, what ACS editors screen for, and how it compares to Analytica Chimica Acta.
Applied Catalysis B requires environmental or energy catalysis with mechanistic insight and benchmarking data. Learn the IF 22.1, 15-20% acceptance rate, and scope boundaries.
Applied Physics Letters publishes concise 4-page applied physics results. Learn the 45-50% acceptance rate, format constraints, and when to choose APL over JAP.
Applied Sciences (MDPI) accepts 45-50% of submissions and evaluates technical soundness over novelty. Understand the APC, review speed, and when this broad open-access venue is the right fit.
Applied Surface Science requires genuine surface science, not bulk materials with XPS data. Learn the 25-30% acceptance rate, scope filter, and surface characterization expectations.
Astronomy & Astrophysics accepts 55-65% of submissions with no page charges. Learn the European astrophysics standard, ESA mission connections, and how A&A compares to ApJ and MNRAS.
Bioinformatics (Oxford) requires novel algorithms with reproducible, freely available code. Learn the 25-30% acceptance rate, Application Note format, and how it compares to BMC Bioinformatics.
Bioresource Technology demands biomass-to-value research with novelty beyond incremental optimization. Understand the IF 9.0, 20-25% acceptance rate, and scope traps to avoid.
Blood desk-rejects 65% of submissions before external review. Learn the ASH editorial bar, $75 submission fee, article-type limits, and how Blood differs from Blood Advances.
BMJ Open accepts 27% of submissions with fully open peer review and named reviewers. Understand the APC, reporting guidelines, and how it compares to PLOS ONE.
Carbohydrate Polymers demands polysaccharide novelty with applied relevance. Understand the IF 10.7, 20-25% acceptance rate, scope traps, and how it compares to IJBM.
Ceramics International requires ceramic-first scope with novelty in composition or processing. Understand the IF 5.2, 30-35% acceptance rate, and how it compares to JECS and JACerS.
Practical guide to Energy (Elsevier) submission standards, covering the systems-level framing editors require and common desk-rejection triggers.
Pre-submission guide for Food Chemistry covering analytical rigor expectations, novel chemistry requirements, and why nutrition-focused studies get desk-rejected.
Pre-submission guide for Fuel (Elsevier) covering scope traps, desk-rejection triggers, and how it compares with Energy & Fuels.
Pre-submission guide for Gastroenterology covering the AGA editorial bar, desk-rejection patterns, and how to position GI research for acceptance.
Pre-submission guide for Gut covering translational GI research requirements, mechanistic depth expectations, and why descriptive studies fail review.
Pre-submission guide for Hepatology covering AASLD editorial standards, word limits, and what separates viable liver research from desk rejects.
Pre-submission guide for IJHE covering the hydrogen-first scope requirement, electrochemistry fit, and what editors screen for before review.
Pre-submission guide for IJMS covering acceptance rates, special issue strategy, review timelines, and when IJMS is the right target.
Pre-submission guide for JACS covering scope expectations for Communications vs Articles, broad-appeal requirements, and comparison with Angewandte Chemie.
Pre-submission guide for JAFC covering scope fit, common rejection patterns, and how it compares with Food Chemistry.
Pre-submission guide for JBC covering mechanistic biochemistry fit, the open-access model, and what ASBMB editors screen for.
Pre-submission guide for Journal of Cleaner Production covering quantified sustainability impact requirements and what editors screen for.
Pre-submission guide for Journal of Hazardous Materials covering hazard-first framing, realistic matrices, and editorial screening criteria.
Pre-submission guide for Journal of Materials Chemistry A covering energy and sustainability materials scope, the RSC A/B/C split, and common rejection triggers.
Pre-submission guide for Journal of Power Sources covering battery and fuel-cell fit, benchmarking requirements, and what editors screen for.
Materials (MDPI) has an IF of ~3.1 and accepts 40-45% of submissions with a ~$2,600 APC. This guide covers what editors screen for, scope boundaries, and how it compares to competitors.
Molecules (MDPI) publishes 5,000+ chemistry papers yearly with an IF of ~4.6 and 35-45% acceptance rate. This guide covers scope, APC, review speed, and the MDPI reputation question.
MNRAS accepts 55-65% of submissions with no page charges. This guide covers what RAS editors screen for, MNRAS vs ApJ trade-offs, and when MNRAS is the better choice.
Nano Letters accepts 25-30% of submissions and emphasizes short-format reports of new nanoscale phenomena. This guide covers the editorial bar, Nano Letters vs ACS Nano, and common desk rejection triggers.
Nature Genetics accepts 8-10% of submissions and desk-rejects 75-80%. This guide covers what editors expect beyond GWAS associations, functional validation requirements, and the Nature cascade pathway.
Neuron accepts 10-12% of submissions and desk-rejects 70-75%. This guide covers what Cell Press neuroscience editors want, from circuit-to-behavior depth to mechanistic completeness.
Nucleic Acids Research has three editorial tracks: standard research, Database Issue, and Web Server Issue. This guide covers fit, deadlines, APC, and what NAR editors expect.
Nutrients (MDPI) has an IF of ~4.8, accepts 40-45% of submissions, and charges a $2,900 APC. This guide covers what editors screen for, MDPI dynamics, and how it compares to BJN and EJN.
Physical Review B publishes 7,000+ condensed matter papers yearly with ~50-55% acceptance. This guide covers what APS editors screen for, PRB vs PRL decisions, and common rejection patterns.
Physical Review D accepts 60-65% of submissions covering particle physics, cosmology, and gravitation. This guide covers APS review norms, PRD vs PRL decisions, and editorial scope.
PLOS ONE accepts ~31% of submissions based on rigor, not novelty. This guide covers the soundness-over-impact model, data sharing requirements, APC, and what editors actually check.
PNAS accepts ~15% of submissions with a 50-60% desk rejection rate. This guide covers the post-2022 reform landscape, the Significance Statement bar, and how PNAS compares to Nature Communications.
Remote Sensing (MDPI) accepts 40-45% of submissions with an IF of ~4.2 and a $2,700 APC. This guide covers scope, review speed, and how it compares with RSE and IEEE TGRS.
RSC Advances accepts 40-45% of submissions with fast 2-4 week reviews and a ~$1,800 APC. This guide covers when the RSC's broad OA journal is the right choice and when to aim higher.
Science Advances accepts 23-27% of submissions and desk-rejects ~50%. This guide covers cross-disciplinary framing requirements, the AAAS editorial bar, and how it differs from Science.
Sensors (MDPI) publishes 8,000+ papers yearly across all sensing technologies with an IF of 3.5 and 40-45% acceptance. This guide covers scope, special issues, and when Sensors fits your work.
Small has an IF of ~13, accepts 20-25% of submissions, and desk-rejects ~40%. This guide covers the nanoscience editorial bar, Communication vs Full Paper formats, and Small vs ACS Nano.
Sustainability (MDPI) accepts 40-50% of submissions with an IF of ~3.3 and a $2,400 APC. This guide covers MDPI scope, special-issue dynamics, and when the journal genuinely fits your work.
Water Research accepts 20-25% of submissions and desk-rejects ~50%. This guide covers scope, APC, review timeline, and how it compares to STOTEN and Water Research X.
JACS does not publish a strong official acceptance rate. The more useful planning question is whether the paper delivers a real chemical advance with enough evidence for the ACS flagship.
JAMA Oncology often tells authors relatively quickly whether a paper belongs in top-tier clinical oncology, but the real submission question is methodological and clinical consequence, not just speed.
JCI formatting guide. Word limits, figure specs, reference format, LaTeX vs Word, and journal-specific formatting quirks you need to know.
Journal of Agricultural and Food Chemistry does not publish a strong official acceptance rate. The better submission question is whether the paper is chemistry-first enough for ACS food and agricultural chemistry readers.
JALCOM editors screen for alloy-system identification, novelty over the journal's massive archive, and characterization depth.
Journal of Alloys and Compounds limits Research Articles to ~6,000 words, requires mandatory Highlights (3-5 items, 85 characters each), and uses Elsevier numbered references. Crystal structure reporting with space groups and PDF card numbers is expected.
Journal of Alloys and Compounds is usually steady rather than fast. The useful submission question is whether the paper teaches something real.
Journal of Applied Physics does not release a verified acceptance rate. The real filter is whether the work is thorough applied physics, not just engineering with physics vocabulary.
JAP covers all applied physics with no page limit. Name the subfield for routing and state the practical relevance.
JBC formatting guide. Word limits, figure specs, reference format, LaTeX vs Word, and journal-specific formatting quirks you need to know.
Journal of Cleaner Production enforces an 8,000-word limit for research articles with mandatory Highlights (85 characters each). Elsevier numbered references and an explicit cleaner production relevance statement are required.
JCO limits Original Articles to 3,000 words with a structured abstract (Purpose, Methods, Results, Conclusion) and up to 5 display items. AMA-style superscript references and a mandatory Protocol Summary for clinical trials.
JCIS editors screen for whether colloid or interface science is the research object, not just the platform. A cover letter that frames the work as general nanomaterials without an interfacial mechanism gets desk-rejected.
Journal of Hazardous Materials formatting guide. Word limits, figure specs, reference format, LaTeX vs Word, and journal-specific formatting quirks you.
Journal of Hazardous Materials is often fast at filtering lab-only or weak-fit studies and slower once a paper enters serious review. The useful submission question is fit.
The Journal of Immunology does not release a verified acceptance rate. The real filter is whether the paper presents functional immunological data with a mechanistic component, not just correlative phenotyping.
JI editors screen for whether the immunological question drives the paper. A cover letter that frames the work as disease biology with an immune component gets returned before review.
JMCA covers materials for energy and sustainability specifically. Your cover letter must prove the work belongs in the A lane, not B (biology) or C (optical/electronic).
Journal of Physical Chemistry C does not release a verified acceptance rate. The real filter is whether the paper advances physical chemistry understanding of surfaces, not just materials characterization.
JPC C editors screen for physical chemistry insight at surfaces, interfaces, or the nanoscale. A cover letter that reports characterization without mechanistic depth gets desk-rejected.
Lancet Oncology editors are screening for practice consequence with broader real-world relevance. A strong cover letter makes that wider oncology case obvious fast.
Molecular Cell does not publish a strong official acceptance rate. The better submission question is whether the study reveals a molecular mechanism with enough depth and novelty for the Cell Press flagship in molecular biology.
Molecular Cell editors are screening for mechanism, not just strong molecular data. A strong cover letter makes that mechanistic case obvious fast.
Molecular Cell often tells you quickly whether the paper is in range, but the real submission question is whether the mechanism is deep enough for a top molecular-biology review.
Molecules can move quickly, but the useful submission question is whether the chemistry is complete enough for a broad MDPI workflow.
MNRAS scientific editors are working astronomers appointed by the Royal Astronomical Society. Keep the letter short and subfield-specific.
MNRAS has no strict word limit for main journal papers (Letters are 5 published pages). LaTeX with the mnras.cls class is required, author-date Harvard references, and large tables must be in machine-readable format.
Nano Letters does not publish a strong official acceptance rate. The better submission question is whether the paper delivers a single sharp nanoscience finding in letter format.
Nature Biotechnology editors are screening for enabling technology, not just strong biology done with modern tools. A strong cover letter makes that distinction obvious fast.
Nature Communications Articles allow ~5,000 words (including Methods), up to 10 display items, and ~60 references. Nature numbered reference style, fully open access, and Methods section sits within the main text.
Nature formatting guide. Word limits, figure specs, reference format, LaTeX vs Word, and journal-specific formatting quirks you need to know.
Nature Genetics does not publish a strong official acceptance rate. The better submission question is whether the study advances genetic understanding with broad significance and rigorous evidence.
Nature Genetics formatting guide. Word limits, figure specs, reference format, LaTeX vs Word, and journal-specific formatting quirks you need to know.
Nature Immunology does not publish a strong official acceptance rate. The better submission question is whether the paper changes immune mechanism broadly enough to clear a flagship editor screen.
Nature Immunology occupies a specific niche: broader than Immunity, narrower than Nature. Your cover letter needs to prove your paper advances fundamental understanding of the immune system, not just report something new happening in an immune context. That distinction determines whether you clear editorial triage.
Nature Immunology formatting guide. Word limits, figure specs, reference format, LaTeX vs Word, and journal-specific formatting quirks you need to know.
Nature Medicine editors are screening for the bridge between mechanism and human-disease consequence. A strong cover letter makes that bridge obvious fast.
Nature Methods does not publish a strong official acceptance rate. The better submission question is whether the method itself is the contribution and benchmarked hard enough to justify a flagship methods screen.
Nature Methods formatting guide. Word limits, figure specs, reference format, LaTeX vs Word, and journal-specific formatting quirks you need to know.
Nature Reviews Cancer does not publish a strong official acceptance rate. The better submission question is whether the topic and author team are realistic for a commissioned flagship review.
NRMCB operates almost entirely on a commissioned model. You submit a proposal, not a manuscript. The editors want authority, timeliness, and clear writing pitched to a broad molecular and cell biology audience.
Neuron does not publish a strong official acceptance rate. The better submission question is whether the study reveals a neural mechanism with the completeness and rigor that Cell Press editors expect.
Physical Review B formatting guide. Word limits, figure specs, reference format, LaTeX vs Word, and journal-specific formatting quirks you need to know.
Physical Review D does not release a verified acceptance rate. The real filter is whether the theoretical work connects to experimental observables, not just mathematical elegance.
PRD asks whether the paper is a sound contribution to particle physics, field theory, gravitation, or cosmology. No need to argue broad significance.
Physical Review D formatting guide. Word limits, figure specs, reference format, REVTeX/LaTeX, SCOAP3 compliance, and journal-specific quirks you need to know.
Physical Review Letters charges ~$2,700 for open access (hybrid). SCOAP3 covers HEP articles free. APS pricing, institutional deals, and cost comparisons.
PRL limits papers to 3,750 words or 4 journal pages with a 600-character abstract. LaTeX with REVTeX 4.2 is the standard format, and APS numbered references are used.
PLOS ONE formatting guide. Word limits, figure specs, reference format, LaTeX vs Word, and journal-specific formatting quirks you need to know.
PNAS formatting guide. Word limits, figure specs, reference format, LaTeX vs Word, and journal-specific formatting quirks you need to know.
Science Advances formatting guide. Word limits, figure specs, reference format, LaTeX vs Word, and journal-specific formatting quirks you need to know.
Science formatting guide. Word limits, figure specs, reference format, LaTeX vs Word, and journal-specific formatting quirks you need to know.
Science of the Total Environment formatting guide. Word limits, figure specs, reference format, LaTeX vs Word, and journal-specific formatting quirks you.
Small does not publish a strong official acceptance rate. The better submission question is whether the nanoscale dimension genuinely drives the science and the function story is strong enough.
Sustainability MDPI formatting guide. Word limits, figure specs, reference format, LaTeX vs Word, and journal-specific formatting quirks you need to know.
Trends in Molecular Medicine does not publish a strong official acceptance rate. The better submission question is whether a Cell Press editor would want this as a sharply argued review or opinion piece.
Water Research does not publish a strong official acceptance rate. The better submission question is whether the study tests a real water problem under realistic conditions.
Water Research editors screen for practical relevance to real water systems. A cover letter that connects your findings to water treatment, supply, or policy moves through triage fastest.
A practical Physical Review Letters submission process guide covering the APS portal workflow, divisional editor triage, the justification paragraph, and what each stage means.
A package-readiness guide to BMJ Open covering reporting discipline, transparency expectations, and what must be stable before submission.
A practical Cancer Research submission guide covering package readiness, broad-oncology fit, and what to tighten before upload.
A practical Clinical Cancer Research submission guide focused on package readiness, translational fit, and what should already be true before upload.
Complete Chemical Communications submission guide: RSC portal steps, formatting requirements, cover letter tips, and what editors actually want.
Analytical Chemistry submission guide: method validation, ACS formatting, cover letter strategy, and what editors want to see.
Astrophysical Journal submission guide with manuscript limits, formatting rules, cover letter tips. What editors want and how to avoid desk rejection.
Chemical Engineering Journal delivers first decisions in 4-8 weeks on average. High volume and an IF of 13.2 make it competitive. Here's the full review timeline.
Nucleic Acids Research is fairly predictable by molecular biology standards. Expect about 45 days to a first decision if your paper reaches review, with faster outcomes for desk rejections.
Advanced Energy Materials does not publish a strong official acceptance rate. The better submission question is whether your paper pairs novel materials science with real energy-device performance.
NEJM's impact factor is high, but the real submission decision is fit. The number tells you the journal's tier, not whether a strong specialty paper will survive triage.
Scientific Reports has a 57% acceptance rate, which sounds like a sure thing. About 30% of submissions never reach peer review. Here's what the editorial check actually evaluates and when Scientific Reports is the right choice.
The Krebs cycle paper got rejected because the journal had too many letters in the queue. The Higgs boson paper was never reviewed. Here's what happened after: and what it means for yours.
Applied Physics Letters submission guide covering length limits, physics novelty, device relevance, and what editors judge first.
Postdoc publications define your independent career trajectory. Here is when pre-submission review has the highest ROI for career-critical papers.
A practical Cancer Cell submission guide covering editorial fit, article package quality, cover letter framing, and the mistakes that make a top-tier oncology submission stall early.
NSMB has a focused audience and strict standards. JIF helps, but your structural and mechanistic depth matters much more.